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P-HEMA formulation of 20% HEMA, 2% E6DM, 19.5% 
methanol, and 58.5% distilled water using 0.25 
Mrad irradiation. Polyethylene terephthalate 
fibers are indicated by arrows. Scale bar = 
100 ym. 15 keV. 
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planted for 21 days. Hemotoxylin and eosin stain. 
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thelial-like cell is designated by an arrow. Hemo­
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Figure 66. Hemotoxylin and eosin stain of the luminal layer of an 
uncoated USCI ®SAUVAGE™ vascular prosthesis implanted 
for 29 days. Polyethylene terephthalate fibers A, 
luminal surface B. Scale bar = 50 ym. 195 
Figure 67. A luminal surface view of a fibrin-platelet entrapped 
red blood cell n^ork. Scanning electron micrograph 
of uncoated USCI© SAUVAGETM prosthetic material ex­
posed to flowing blood for 2 days. Scale bar = 5 ym. 
15 keV. 195 
Figure 68. This SEM photograph shows the smooth homogeneous 
hydrogel coating on the luminal surface. Arrows 
indicate underlying polyethylene terephthalate 
fibers. Scale bar = 50 ym. 15 keV- 20° tilt. 
Figure 69. Scanning electron micrograph of the exterior surface 
of the hydrogel prosthesis which demonstrates a 
heterogeneous microstructured hydrogel (designated 
by A) within the polyethylene terephthalate fabric 
network (B). Scale bar = 50 ym. 15 keV. 20° tilt. 
Figure 70. S EM photograph o^he exterior view of the two-stage 
HEMA coated USCI ® DeBakey® prosthesis which was im­
planted for two days. The heterogeneous nature of 
the hydrogel is evident with entrapped red blood cells. 
Scale bar = 10 ym. 15 keV. 10° tilt. 
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Figure 71. S EM photograph o^he luminal surface of a two-stage 
HEMA coated USCIwSauvageTM prosthesis which was 
implanted for 10 days. The fibrin matrix with flat 
cellular layers is evident. Scale bar = 10 ym. 
15 keV. 10° tilt. 198 
Figure 72. S EM photograph o^he luminal surface of a two-stage 
HEMA coated USCIw SauvageTM vascular prosthesis which 
was implanted for 21 days in the canine carotid artery. 
This section was located 1 centimeter from the proximal 
anastomosis. Scale bar = 10 ym. 15 keV. 10° tilt. 199 
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INTRODUCTION 
Sauvage and coworkers (1974a) report the majority of deaths in the 
western world are due to impairment of arterial flow to distal tissues. 
Since the most practical method for increasing distal flow is the bypass 
graft, there is a great clinical need for arterial prostheses. Recently, 
attention has been directed toward the development of a satisfactory ar­
terial substitute made of synthetic materials. 
Replacement of diseased or traumatized large blood vessels with woven 
or knitted fabric tubes is now generally successful. However, the use of 
synthetic grafts in vessel applications smaller than 5 iran diameter has 
been disappointing. Although the most satisfactory peripheral small ves­
sel or aortocoronary bypass grafts have been autologous veins, not all 
patients have suitable veins and the isolation of the venous segment im­
poses additional surgery. Accordingly, interest continues in pursuit of a 
suitable off-the-shelf prosthesis for small vessel replacement. 
This report establishes that 2-hydroxyethyl methacrylate can be 
polymerized in such a fashion to impart a compound hydrogel coating having 
controlled microstructures on a polyethylene terephthalate (Dacron®) 
substrate. In a preliminary study, 4 mm diameter hydrogel coated grafts 
prepared by a dual-coating process maintained patency over a 21 day im­
plantation period as segmental carotid artery replacements in dogs. His­
tological and scanning electron microscopy evaluation of the implants 
identified endothelial development on one type of hydrogel formulation. 
This exploratory investigation indicates the feasibility of developing a 
small diameter vessel prosthesis which may combine the functional advan-
2 
tages of a hydrogel coated graft with the logistical advantages of an off-
the-shelf prosthesis. 
3 
LITERATURE REVIEW 
Developments in Vascular Prosthetic Research 
Forty years elapsed between the demonstration by Carrel (1908) that 
homologous and heterologous veins and arteries could serve as arterial 
grafts in experimental animals and their first use in man. Modern ar­
terial surgery began in 1945 when Robert Gross (1945) successfully em­
ployed arterial allografts for the treatment of abdominal aortic 
aneurysms. During the period of th' late 1940s and early 1950s, ar­
terial allografts provided highly gratifying results, both technically and 
functionally, for 12 to 35 months. The field of vascular surgery was on 
its way. However, after several years experience, it became apparent that 
such nonviable conduits underwent aneurysmal dilation and/or thrombosis 
(Szilagyi et al., 1957). The maintenance of a reliable supply of such 
material obtained from human cadavers was also a significant problem. This 
led to the search for other, more accessible, durable sources for arterial 
conduits. 
The initial materials evaluated were impermeable to blood, "smooth" 
walled tubes fabricated from polyethylene (Donavan, 1949), methyl methac-
rylate (Hufnagel, 1947), silicone rubber (Egdahl, 1955) and vitallium 
(Blakemore and Lord, 1945). These materials were uniformly unsatisfactory 
and all solid wall prostheses evaluated during this period promptly induced 
vascular thrombosis in a few days. An important breakthrough in the 
resolution of this problem was the introduction by Voorhees et al. (1952) 
of a porous knitted fabric, Vinyon "N" which demonstrated that a porous 
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tube would stay open much better than a solid tube. It was reasoned that 
if the prosthesis was constructed of a mesh type cloth, after a short 
period, leakage of blood through the wall of the prosthesis would be 
halted by the formation of fibrin on the inner surface which might also 
serve as an acceptable blood-prosthetic interface. These investigators 
felt that, in the absence of a significant foreign body reaction, occlu­
sion might not occur. Ultimately, fibroblasts might grow through the 
interstices of the cloth replacing the fibrin plug. This fibroblastic 
encapsulation might serve as a viable basis for endothelial proliferation 
which could undergo sufficient differentiation to form a functional lining 
or "neointima." The porosity permitted capillaries to grow into the wall 
of the graft and nourish the lining. 
There was initial success using this approach which generated a 
search for the most desirable material to be used for a knitted or woven 
porous cloth for the construction of tubes for use as an arterial pros­
thesis. Observations (Harrison, 1958) demonstrated that Nylon lost 85% of 
its tensile strength after 100 days implantation. Various synthetic 
materials such as Ivalon®, nylon, Orion®, Dacron ® , and Teflon ® 
(R) have been used extensively over the past twenty years with Dacron ^ being 
flavored by most investigators, due to its superior handling properties 
during fabrication and implantation. Edwards' (1978a) studies suggest 
that Dacron ^ grafts of standard thickness do lose strength initially but 
stabilize. Ultralight weight Dacron ^ grafts, however, lose strength 
unpredictably and dangerously within short periods (Ottinger et al., 
1976). Edwards (1978b) believes standard Dacron ® grafts are safe for 
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arteriosclerotic patients who are unlikely to live more than 20 years, but 
(B) 
caution should be used when using Dacron ^ material in young individuals 
(R) 
with long life expectancies. In this case. Teflon ^  seems preferable 
since all clinical and experimental evidence indicates that it has the • 
most inertness and durability. 
Woven grafts of Dacron® and Teflon® have been used with a high 
degree of success in large caliber, relatively high flow rate applications 
like the abdominal aorta and the aorto-iliac or aortofemoral regions, 
either as replacement or bypass grafts. But embolization of the "neo-
intima" has occurred occasionally when woven grafts were used in smaller 
vessels such as iliac and femoral vessels. Femoropopliteal bypasses of 
woven materials have also been associated with a high incidence of delayed 
thrombotic occlusion (Edwards, 1960). 
Replacement of small arteries (5 mm or less internal diameter) has 
met with even more limited success. Jacobson and associates (1963) con­
cluded that only autogenous tissue (artery or vein) should be used for re­
placement of such small arteries, since none of the synthetic materials 
was satisfactory. 
Currently, the search continues for a suitable small caliber pros­
thesis. For close to 20 years, the sapheneous vein has been the standard 
by which other vessel grafts have been compared. In the late 1960s and 
early 1970s, the ficin-digested dialdehyde starch-tanned bovine collagen 
heterograft became popular (Wesolowski, 1962; Rosenberg, 1963). Poor 
long-term results such as high late occlusion rates and aneurysm formation 
6 
in significant numbers have caused this graft to be abandoned in recent 
years (Dale and Lewis, 1976), 
The effectiveness of the sapheneous vein as a small artery graft was 
demonstrated by coronary bypass procedures in the late 1960s (Favaloro, 
1968). Exploring the use of autogenous arteries for coronary bypass led 
Green and others (1968) to the greater late patency rate of the internal 
mammary artery. Triple bypass procedures could be performed but the extra 
time required and difficulty in dissecting the arteries made this proce­
dure less than optimal. 
Two new grafts have appeared in the past several years, expanded 
polytetrafluoroethylene, PTFE (Campbell et al., 1975) and human umbilical 
cord veins (Dardik, 1976). Expanded polytetrafluoroethylene (PTFE) is the 
chemical equivalent of Teflon ^  . The grafts are made by extruding a low 
porosity tube composed of polytetrafluoroethylene nodes interconnected by 
fine fibrils of PTFE forming a lattice. The material handles well, 
sutures nicely, and does not need preclotting as do knitted grafts. As 
with any new graft, there are conflicting reports, some enthusiastic 
(Matsumoto et al., 1973; FI crian et al., 1976; Campbell et al., 1979), 
others very discouraging (Hoperoan, 1976; Walley et al., 1978). The same 
may be said for the umbilical cord vein (Mandich et al., 1977). 
Currently, for both leg ischemia and coronary bypass, if there is no 
autogenous leg vein, an arm vein is preferred (Edwards, 1978b). If the 
patient needs a femoropopliteal or tibial bypass, saphenous phlebograms • 
are performed. If the saphenous vein is too small, an arteriovenous 
fistula is established to "arterilize" the arm veins. Arm veins have been 
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used by Edwards (1978b) for coronary bypass, as well as for femoral, 
popliteal, and tibial bypass. The expanded polytetrafluoroethylene grafts 
also showed promise for arterial reconstruction in the lower limb (Fry and 
Robertson, 1978). 
Dacron ^ as a Prosthetic Material: Success and Limitations 
Dacron^ is a registered trademark of DuPont de Nemours Inc. It is 
a polyester made of polyethylene terephthalate which has the following re­
peat unit: 
'"S g - 0 - CHg - CHg - 0-^ 
0 0 
(molecular weight 192). Industrially, the polymer is prepared by a three 
step process: 
a) Esterification of methanol with terephthalic acid to yield di­
methyl terephthalate. 
b) Ester interchange between dimethyl terephthalate and an excess of 
ethylene glycol at 150°C. 
CH3 - f C - 0 - CH3 + 2H0 - (0^2)2 - OH 
0 0 
HO - (CHg), - 0 - C C - 0 - (CHgjgOH + ZCH^OH 
0 0 
c) Poly-condensation of the above product under vacuum at 275°C to 
yield the final polymer. Numerous additives, such as salts of 
heavy metals (antimony, manganese, calcium) accelerate the reac­
tions and minimize undesirable side reactions (Guidoin et al., 
1977). 
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Skelton (1974) suggests that these additives could profoundly affect the 
fiber's performance under implant conditions but very few complaints have 
been listed and the quality of commercially available fabrics for pros­
thetic use has not been discussed. 
Polyethylene terephthalate has superior mechanical handling proper-
ties during fabrication and at implantation. Dacron ^ may be gas or 
steam sterilized. There is little fraying or tearing with trimming and 
suturing of the graft. Thus, Dacron ^ grafts can be easily tailored to 
(R) 
meet anatomic demands. Side branches can be added as required. Dacron ^ 
has generally been thought to be durable without significant deterioration 
during prolonged implantation. However, this property has come under 
close scrutiny in view of the reported cases of aneurysms and long term 
failures previously illustrated (Ottinger et al., 1976; Edwards, 1978b). 
(5) 
There are three main types of Dacron ^ prosthesis commercially 
available: the woven Dacron ® grafts, the knitted grafts and Dacron ® 
velour grafts. The woven grafts have the lowest porosity of the three 
types of grafts because the Dacron ^ fibers are packed closer together in 
the manufacturing process. They still, however, have adequate porosity to 
allow for tissue penetration and adhesion of fibrin. They are mostly used 
for replacement of resected aortic aneurysms or in other vascular proce-
dures when bleeding is a primary concern. The knitted Dacron ^ grafts 
have a porosity much higher than the woven graft. This porosity is due to 
(R) the increased space within the fabric interstices. This type of Dacron ^ 
graft is available in standard weight and ultralight weight forms. To 
minimize bleeding during the operation and to eliminate the risks of 
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hemorrhage, these grafts must be preclotted before allowing blood at a 
normal pressure to flow through the prosthesis. The high porosity of 
these grafts allows for ingrowth of fibrous tissue and strong adherence of 
a pseudointima. They are preferred both for bypass procedures as well as 
for replacement in aneurysmal and occlusive disease of the abdominal 
aorta, visceral arteries, and proximal peripheral arteries. Velour 
Dacron ^ grafts have a high porosity and are either warp or weft knitted 
with loops extending either into the lumen and outside (double velour de­
sign) or only on the outside (external velour design). These loops pro­
mote greater tissue invasion and adherence of the fibrinous lining. Pre-
clotting of the graft must be performed prior to implantation. This type 
of prosthesis has been recommended for the resection of aneurysms of 
peripheral arteries or in bypass procedures for occlusive diseases of 
major peripheral and visceral arteries. 
An inherent disadvantage of all knitted fabric grafts is that they 
must react with blood to form an impervious fabric-thrombus complex, the 
flow surfaces of which are highly thrombogenic. Subsequent healing of the 
graft is the reorganization of the thrombus portion of this fabric-
thrombus complex by the ingrowth of fibrous tissue. Sauvage et al. 
(1975) reports one case of extensive endothelialization but for most 
cases endothelial development has been observed to be incomplete and 
occurring primarily in the portion of the graft near the suture line 
(Berger et al., 1972). The preclotting methods present the following 
shortcomings: The flow surface is not smooth; the graft is not rendered 
impervious sufficiently for use in heparinized flow; and the flow surface 
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is highly thrombogenic due to the concentration of thrombin at the sur­
face. 
The fabric prostheses have been used with a high degree of success in 
relatively high flow rates areas like the abdominal aorta and the aorto-
iliac or aorto-femoral regions either as replacement or bypass grafts. 
But their use in the medium-size arteries (such as for femoropopliteal 
bypass) has been associated with a high incidence of delayed thrombotic 
occlusion. Yates et al. (1978) summarize the results of 300 USCI® 
TM Sauvage filamentous vascular prostheses implanted in patients over a 
three year period (1974-1977). They report that a total of 284 grafts re­
mained patent over a mean implant time of 24.5 months. The patency rate 
for various sites reported by Sauvage et al. (1978) are listed in Table I. 
Noon and DeBakey (1978) reported on the performance of the DeBakey and 
filamentous velour prostheses. Analysis of graft patency in 457 patients 
having aorto-iliac occlusive disease are summarized in Table II. The 
(R) 
table also reports the patency rates of Dacron ^ velour bypass grafts 
from the common femoral to the popliteal artery above the knee. The 
larger diameter grafts used in treating aorto-iliac occlusive disease 
(16-19 mm i.d.^) had much higher success rates. The authors attribute the 
poor performance of smaller diameter grafts to early closure following 
poor preclotting techniques. They suggest that the higher patency rates 
achieved in larger diameter grafts may be due to higher flow rates which 
help to nullify the effect of the thrombogenic surface. 
^mm i.d. = millimeters internal diameter. 
n 
Table I. Patency values for Sauvage^^ filamentous vascular prosthetics 
implanted at various sites (Sauvage et al., 1978) 
Site Patients 
Graft 
number 
Mean im­
plant time 
Limb 
closure Patency 
Aorti c 
bi furcati on 108 216 28.8 months 1 99.5% 
Aorto-femoral 
bypass 77 150 32.4 months 4 97.3% 
Femorofemoral 
bypass 49 51 18.9 months 5 90.2% 
Axillary 
femoral bypass 44 68 20.2 months 15 77.9% 
Femoropopliteal 
bypass 79 95 22.0 months 25 73.7% 
(R) Recently, Sawyer et al. (1979) compared Dacron^ velour and knit 
prostheses with respect to long-term patency when used as canine aortic 
implants. The structure, porosity, weaving, or knitting techniques, as 
well as final cleaning, crimping and chemical finishing procedures used in 
manufacture appear to influence the physiological responses to these 
prostheses (Table III). No evidence of healing of these prostheses was 
seen in periods up to 12 months following implantation. 
To this date, porous polymeric Dacron^ or other types of woven or 
knitted vascular prostheses less than 6 mm diameter have never consistent­
ly remained open for extended periods of time in man or experimental ani­
mals (Sawyer et al., 1979). Diameters of 6 mm or less demonstrate, under 
50%, one-month patency (Wesolowski et al., 1975). In view of the fore-
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Table II. Summary of Noon and DeBakey report (1978) on the performance of 
DeBakey and filamentous velour prostheses 
Time of implantation Patency 
Aorto-iliac occlusive disease 
5 years 
10 years 
15 years 
Common femoral to popliteal artery bypass 
1 year 
2 years 
3 years 
4 years 
5 years 
6 years 
7 years 
8 years 
9 years 
going problems, one finds that there are definite limitations with the 
available types of prosthetic materials and the search continues for im­
provements. 
Hydrogels: Background Information 
The polymerization of 2-hydroxyethyl methacrylate (HEMA) to a brit­
tle, transparent polymer was reported as early as 1936 by DuPont scien­
tists. In the early 1950s, Wichterle and Lim (1960) described and synthe­
sized poly(2-hydroxyethyl methacrylate) gels in which the monomer was 
89.9% 
84.8% 
82.6% 
89% 
84% 
79% 
73% 
69% 
60% 
56% 
45% 
39% 
Table III. Summary of the Sawyer et al. (1979) graft evaluations® 
Patency 
resist­ Net 
ance to Handling Long SEM and Lack of Accepta­ evalu 
Dacron throm­ charac­ term light compli- bility ation 
materials Compacting method bosis teristic function microscopy cations to host index 
Velour I Vapor phase 
hydrocarbon 
4 3 4 3 4 3 3.5 
Velour II Steam 4 4 4 2 3 3 3.3 
Circular- Vapor phase 4 4 4 2 3 3 3.3 
knit III 
Velour IV Steam 3 3 4 2 3 3 3.0 
Circular- Vapor phase heat 3 3 3 3 2 3 2.8 
knit V 
Warp-knit Vapor phase 2 3 3 2 2 2 2.3 
VI halogenated 
hydrocarbons 
Warp-knit Liquid phase acidic 2 3 2 2 2 2 2.2 
VII oxide + halogenated 
hydrocarbons 
Warp-knit Vapor phase 2 3 2 2 2 2 2.2 
VIII halogenated 
hydrocarbon 
Warp-knit Liquid phase acidic 2 3 2 1 1 1 1.7 
IX oxide hydrocarbon 
Warp-knit Liquid phase 1 3 1 1 1 1 1.3 
X halogenated 
hydrocarbon 
®4, excellent; 3, very good; 2, good; 1, poor. 
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polymerized in an aqueous solvent media resulting in a polymer with a 
soft, rubbery consistency and thus named "hydrogels." The reasoning be­
hind their development was to produce a polymeric network composed entire­
ly of stable carbon-carbon bonds, with side groups containing a strong 
hydrophilic property, which could meet the requirements for implantable 
prostheses rather than for nonmedical technology. 
The development of hydrogels as materials for medical applications 
has been reviewed by Ratner and Hoffman (1976) and Hoffman et al. (1977). 
Hydrogels can be prepared by various polymerization techniques or by con­
version of existing polymers. Table IV lists examples of monomers and 
polymers that have been used in preparing these materials. 2-hydroxyethyl 
methacrylate (HEMA), crosslinked with ethylene glycol dimethacrylate, is 
the most widely explored example of this class of materials. An important 
aspect of the hydroxyethyl methacrylate esters is the ease with which the 
combination of cross-linking and simultaneous solution polymerization 
occurs. Descriptions of several methods of synthesis and the resulting 
properties of hydrogels have been published by Refojo and Yasuda (1965), 
Wichterle (1971), and Ratner and Hoffman (1976). 
Reasons for the potential uses of synthetic hydrogels for biomedical 
applications have been outlined by Ratner and Hoffman (1976). First, the 
expanded nature of the hydrogel network allows polymerization initiator 
molecules, solvent molecules and other extraneous materials to be ex­
tracted from the gel network before the hydrogel is placed in a living 
system. The in vivo leaching of initiators and impurities used during the 
fabrication of polymeric materials has been cited as a cause of inflamma-
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Table IV. Monomers used in hydrogel formulations 
CLASSIFICATION-Name Chemical formulation Type 
HYDROXYALKYL 
METHACRYLATES 
2-hydroxyetbyl-
hydroxypropyl-
glyceryl-
N-VINYL-2-
PYRROLIDONE 
ACRYLAMIDE 
DERIVATIVES 
N,N-diethyl-
N-ethyl-
acrylamide-
N-(2-hydroxypropyl) 
methacrylamide 
ACRYLIC ACID 
DERIVATIVES 
acrylic acid 
methacrylic acid 
CROTONIC ACID 
SODIUM STYRENE 
SULFONATE 
AMINOETHYL 
METHACRYLATE 
DERIVATIVES 
dimethyl-
CH2=C-C00-R 
Rf-CHgCHgOH 
R^-CHgCHOH 
CH3 
R^-CHgCHCHgOH 
OH 
Neutral 
CH2=CH 
-N-N 
0 '  
CH,=C-CO-N-R' 2 ! I 
R R" 
R=H, R' and R"=-C2Hg 
R=H, R'=H, R"=-C2H5 
R, R', and R"=H 
R=-CH3, R'=H, R"=CH2jHCH3 
CH,=C-COOH 
2 I 
R 
R=H 
R—-CH« 
CH3-C=CH-C00H 
CH2=CH-W-S03 Na 
CH,=C-COO-CH-CH.-N-R' 
1 ^ I 
R R" 
R=H, R', R"=-CH_ 
Neutral 
Neutral 
Anionic 
Anionic 
Anionic 
Cationic 
t-butyl- R=H, R'=H, R"=C^Hg 
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Table IV. (Continued) 
CLASSIFICATION-Name Chemical formulation Type 
VINYL PYRIDINE 
ETHYLENEGLYCOL 
DIMETHACRYLATE 
DERIVATIVES 
CH2=CH_Q, 
CH,=C-C0WCH,CH.0)„0C-C=CH, d 1 f 6 'n 1 L 
R R 
R=H, -CH3 
Cationic 
Crosslinker 
METHYLENE-BIS-
ACRYLAMIDE 
CHL=C-CONHCHgNHCO-C=CHi 1 \ L 1 Z 
H H 
Crosslinker 
tion and eventual rejection of polymeric materials (Homsy, 1970). Second, 
the soft and rubbery consistency of hydrogels can minimize the physical 
irritation at tissue-polymer interfaces and may prevent hemolysis of blood 
cells in regions of high hydrodynamic shear and turbulence. Third, the 
ability of small molecules and low molecular weight metabolites to diffuse 
throughout the gel matrix may be advantageous for the in vivo performance 
of hydrogels (Levowitz et al., 1968). Fourth, P-HEMA hydrogels have a 
high degree of chemical stability so they will present their intended 
surface at the tissue-polymer interface. And finally, one of the most 
intriguing of the potential advantages for hydrogels is the low inter-
facial free energy and work of adhesion which may be exhibited between the 
hydrogel surface and an aqueous surface (Andrade, 1973). This low inter-
facial tension has been postulated to reduce the tendency of proteins in 
body fluids to adsorb and to unfold upon adsorption (Hoffman, 1974). 
Minimum protein interaction may be important for the biological acceptance 
of foreign materials since the denaturation of proteins at surfaces may 
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serve as a trigger mechanism for the initiation of thrombosis or for other 
biological rejection mechanisms. 
A number of biomedical applications for hydrogels have been discussed 
in the literature and are listed in Table V. Ratner and Hoffman (1976) 
have attributed two reasons for the wide range of biomedical applications 
for hydrogels. These are the hydrogel's satisfactory performance upon in 
vivo implantation and their ability to be fabricated into a wide range of 
morphologies which allows the physical properties of the hydrogel to be 
adjusted specifically for a given application. Hydrogels can be prepared 
in the form of highly porous sponges, less porous gels, optically trans­
parent bulk films, liquids that can be subsequently cross-linked to form 
gels, and coatings (having a variety of morphologies and chemical proper­
ties) bound by either chemical covalent bonds or physical noncovalent 
forces to the substrate material. A point that should be emphasized is 
that a specific hydrogel composition suitable for one biomedical applica­
tion may have to be significantly modified in composition and form to meet 
design considerations for a different application. 
The clinical uses of hydrogel based products are regulated in the 
United States by the Food and Drug Administration (FDA). These items are 
classified as new drugs and before reaching the public in the United 
States they must be approved by the FDA. A limited number of these 
hydrogel based biomedical products have been given FDA approval. Flexi­
ble, hydrophilic contact lenses have been a primary application for the 
P-HEMA hydrogels. The properties and applications for such contact lenses 
have been reviewed by Refojo (1976). During the period 1963-1973, only 
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Table V. Potential biomedical applications 
Coatings "Homogeneous-bulk" materials 
Vascular grafts Contact lenses 
Catheters Burn dressings 
Sutures Dentures 
Electrodes Bone ingrowth sponges 
Patch grafts Artificial corneas 
Implantables Vitreous humor replacement 
Electrophoresis cells Synthetic cartilages 
Cell culture substrates Soft tissue substitutes 
Blood detoxicants Hemodialysis membranes 
Drug delivery systems 
Enzyme therapeutic systems 
two lens formulations out of many investigated have received FDA approval 
for general use. A third lens was approved in 1973 as a therapeutic 
bandage. 
Another FDA approved medical application of hydrogel is the Hydron^ 
burn dressing (Polymer News, 1978). This synthetic barrier-dressing is 
unique since it is formed directly on the wound from a two-compound system 
—a powder, poly(2-hydroxyethyl-methacrylate) and a solvent, polyethylene 
glycol-400. The final preparation leaves no spaces between the dressing 
and the wound for microbial proliferation. Nathan et al. (1974) have 
documented the bacterial barrier-effect of the Hydron ® dressing using 
animal experiments. In vitro data on the effects of hydrogel burn dress­
ings on bacterial growth correlated with 32 clinical cases have been 
reported by Nathan et al. (1976). The barrier dressing formed on the 
wound offered a new, effective procedure for treatment of the burn 
wound. 
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Finally, a unique hydrophilic and biocompatible filling material which 
(R) 
sets to a firm, rubber-like consistency has been introduced as Hydron 
Root Canal Filling System by NPD Dental Systems, Inc., Melville, New York 
(Polymer News, 1979). The filling results from the polymerization reac­
tion of a paste powder mixture {poly-2-hydroxyethyl methacrylate) that is 
easily manipulated and introduced into the canal. The viscous paste fills 
the irregular spaces of the canal and upon setting it expands to form a 
nearly perfect seal. 
Chemical properties and grafting methods 
The polyglycolmethacrylate based gels are chemically stable due to 
the three-dimensional structure of the polymeric chains and the firm C-C 
bonds, and are also hydrophilic due to the presence of large numbers of 
hydroxyl groups within their structure. The principal monomer used in the 
formation of hydrophilic gels is 2-hydroxyethyl methacrylate: 
CH2=C-C00CH2CH20H, which is polmerized in the presence of small 
CH3 
amounts of cross!inking agents such as ethylene glycol dimethacrylate: 
CH2=C-C00CH2CH200-C=CH2, by conventional free radical methods. 
CH3 CH3 
A summary of the synthesis and properties of hydrogels has been pub­
lished by Wichterle (1971). The three-dimensional hydrogels prepared 
from the monomer and cross!inker described above can take up 35 to 90% of 
their weight of water, depending on the solvent content during the poly­
merization. Polymerization of 2-hydroxyethyl methacrylate in the absence 
of solvents for the resulting polymer produces a hard, brittle polymer 
resembling poly-methylmethacrylate, however, when immersed in water, it 
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swells to become soft and pliable with a final water content of approxi­
mately 37%. If, however, HEMA is polymerized in a solution containing a 
nonsolvent for the polymer, precipitation occurs during the polymerization 
and the resulting material is in either the form of an opaque gel or a 
microporous sponge with a range of pore sizes depending on the polymeri­
zation conditions. This aspect of the hydrogel will be discussed in 
further detail in Part III of this dissertation. 
Chemically the P-HEMA hydrogels are very stable. Depolymerization 
can only be achieved by heating to elevated temperatures within a sodium 
hydroxide solution. P-HEMA gels have been found to be resistant to acid 
hydrolysis and reaction with amines (Sevcik et al., 1967). P-HEMA gels in 
neutral or near neutral aqueous solutions are relatively stable and can be 
steam sterilized with no apparent damage (Wichterle and Lim, 1965). 
The mechanical behavior of hydrogels prepared in the presence of 
various concentrations of monomer, crosslinking agent, and polymerization 
solvent has been investigated from several viewpoints. When dry, poly-
HEMA is hard and brittle resembling polymethylmethacrylate. However, the 
material can be hydrated and a soft, pliable polymer results, exhibiting 
low tear strength and low tensile properties. Measurements have been made 
of the equilibrium behavior (Hasa and Janacek, 1967; Refojo and Yasuda, 
1965) and viscoelastic properties (Haldon and Simha, 1968; Janacek and 
Ferry, 1969) of the gel networks with various topologies of the rubber­
like state into which they can be transformed by either swelling or an 
increase in temperature. The ultimate characteristics have been studied 
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mainly on samples swollen to equilibrium with water (Refojo, 1967; Yasuda 
et al., 1966; Allen, 1974). 
The copolymerization of monoesters of methacrylic acid or with their 
diesters in which one component is used in a large excess proceeds readily 
to yield varying degrees of cross-linked hydrophilic polymers. Janacek 
(1973) has reviewed the literature and found that although the copolymeri­
zation of other monomers with glycol methacrylates makes it possible to 
incorporate in the polymeric chain reactive alcoholic groups, data on the 
values of the copolymerization parameters are sparse. 
The major drawback to the widespread use of these hydrogel materials 
in biomedical applications is that the polymer formulations that have 
demonstrated much promise tend to be relatively weak from a mechanical 
standpoint when hydrated. There has been considerable activity among re­
searchers to investigate methods for forming the hydrogel over or sur­
rounding a polymeric mesh, sheet or woven fabric substrate to enhance its 
mechanical strength. 
A number of techniques have been developed to take advantage of the 
hydrogel's hydrophilic properties through the reinforcement with fibers or 
by covalent bonding (grafting) as a surface layer on a mechanically 
stronger substrate. Table VI lists techniques by which hydrogel coatings 
can be deposited on various substrates. 
Surface coatings by the dip-coat methods are occasionally subject to 
problems of surface damage, lack of adhesion, and substrate modification 
requirements. By covalently bonding a hydrogel to the surface of another 
polymer,a new composite material is formed whose mechanical properties 
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Table VI. Techniques for depositing hydrogel coatings 
Dip-coat in pre-polymer and solvent. 
Dip in monomer(s) and solvent then polymerize using catalyst and heat. 
Pre-activate surface using ionizing radiation then contact with monomer(s) 
and heat to polymerize. 
Irradiation while in contact with vapor or liquid solution of monomer(s). 
more closely resembles those of the base polymer than the hydrogel layer. 
Several other advantages can be cited for preparing biomedical hydrogels 
through the use of the grafting techniques. First, the graft polymeriza­
tion technique makes it possible to prepare complex surfaces formed by 
successive graftings using different formulations. Second, the prepara­
tion of hydrogels grafted only on the surface, penetrating into the sub­
strate, or uniformly dispersed throughout a hydrophobic matrix can be 
affected by varying polymerization solvent and other grafting parameters. 
This type of grafted hydrogel, used by Predecki (1974) to impregnate 
silicone rubber, comprises a useful class of materials which utilizes 
mechanical and surface properties reflecting the characteristics of both 
the substrate and hydrogel. Third, the addition of an initiator is not 
necessary using the radiation grafting technique, thereby eliminating one 
potential source of contamination in the final product which would be 
necessary to remove before application in biomedicine. Table VII lists a 
number of research groups who have published papers or reports describing 
grafting techniques for the application of hydrogels to biomedical appli­
cations. 
Table VII. Development of grafting methods for biomedical applications 
Research group Monomer(s) used Substrate(s) used Grafting technique Applications 
Yasuda & Refojo 
(1964) 
Leininger 
et al. (1966) 
Miller et al. 
(1970) 
Hoffman et al. 
(1972) 
Ratner & 
Hoffman (1974) 
Predecki 
(1974) 
Kearney et al. (1975) 
n-vinyl-2-pyrroli-
done 
vinyl pyridine 
acrylic acid, 
methacrylic acid, 
acrylamide, 
ethylene sulfonic 
acid, various 
esters and imides 
hydroxyethyl 
methacrylate, n-
vinyl-2-pyrrolidone 
n-vinyl-2-pyrroli-
done hydroxyethyl 
methacrylate, 
acrylamide, 
methacrylamide, 
propylene glycol 
acrylate 
hydroxyethyl 
methacrylate 
acrylamide, N,N,-
methylene-bis-
acrylamide 
silicone rubber 
polystyrene, 
polyethylene 
polytetrafluoro-
ethylene 
silicone rubber 
silicone rubber, 
polyethylene 
silicone rubber 
silicone rubber 
electron irradiation 
radiation grafting 
electron irradia­
tion, chemical 
treatments 
Co^^ radiation 
grafting 
Co®® radiation 
grafting 
interpenetrating 
network (IPN) heat 
treatment 
Co®® radiation 
grafting 
increase hydro-
phi 1 i city 
nonthrombogenic 
plastic surfaces 
nonthrombogenic 
surface 
enhanced blood 
compatibility 
hydrophilic bio-
materials 
blood compatible 
surfaces 
blood compatible 
i nterface 
Table  VII .  (Cont inued)  
Research group Monomer(s) used Substrate(s) used 
Muzykewicz 
et al. (1975) 
Ratner & 
Hoffman (1975) 
Ratner et al. 
(1975a) 
Sasaki et al. 
(1976) 
Venkataraman 
et al. (1977) 
Boffa et al. 
(1977) 
Peppas & 
Merrill (1977) 
Ratner et al. 
(1977) 
hydroxyethyl 
methacrylate 
hydroxyethyl 
methacrylate, n-
vinyl-2-pyrroli-
done 
hydroxyethyl 
methacrylate, n-
vinyl-2-pyrroli-
done 
hydroxyethyl 
methacrylate, ethyl 
methacrylate 
hydroxyethyl 
methacrylate, 
methacylic acid 
n-vinyl-2-pyrroli-
done 
polyvinyl alcohol 
hydroxyethyl 
methacrylate, ethyl 
methacrylate 
cellulose acetate 
silicone rubber 
silicone rubber 
silicone rubber 
silicone rubber 
polytetra-
fluoroethylene 
reinforcement by 
a 2-state dehydra 
tion annealing 
process 
silicone rubber, 
polyurethane 
Grafting technique Applications 
Co^^ radiation 
grafting 
Co®® radiation 
grafting 
blood contact 
surfaces 
blood contact 
surfaces 
Co®® radiation vena cava ring 
coatings 
Co®® radiation 
Co®® radiation 
vena cava ring 
coatings 
enzyme mobilization 
Co®® radiation 
electron beam 
irradiation 
blood contact 
surfaces 
synthetic articular 
cartilage 
Co®® radiation 
flow grafting 
blood contact 
surfaces 
Table  VII .  (Cont inued)  
Research group Monomer(s) used Substrate(s) used Grafting technique Applications 
Ratner et al 
(1978) 
Greer et al. 
(•(978) 
Dror et al. 
(1979) 
Greer et al. 
(1979) 
Greer & Knoll® 
(in press) 
hydroxyethyl 
methacrylate, ethyl 
methacrylate, n-
vinyl-2-pyrrolidone 
hydroxyethyl 
methacrylate, 
ethylene glycol 
dimethacrylate 
hydroxyethyl 
methacrylate, n-
vinyl-2-pyrrolidone, 
2-hydroxypropyl 
methacrylate 
hydroxyethyl 
methacrylate, 
ethylene glycol di­
methacrylate, n-
vinyl-2-pyrrolidone 
hydroxyethyl 
methacrylate, 
ethylene glycol 
dimethacrylate 
silicone rubber 
silicone rubber, 
polyethylene, 
polyethylene 
terephthalate 
fabric 
poly(ether-ure-
thane) films 
silicone rubber, 
polyethylene 
terephthalate 
fabric 
polyethylene 
terephthalate 
fabric 
Co^^ radiation 
Co radiation and 
heat initiated 
polymerization 
IPN heat initiated 
Co radiation and 
IPN heat initiated 
polymerization 
Co radiation 
initiated 
polymerization 
vena cava ring 
coatings 
increase hydro-
philicity and 
identification of 
microstructure 
increase hydro-
phi 1 ici ty 
soft tissue com­
patibility 
cardiovascular 
prosthetic design 
and implantation 
R. T. Greer and R. L. Knoll. 1980. Controlled microstructure of two-stage polyhydroxyethyl 
methacrylate coatings on polyethylene terephthalate substrates for potential prosthetic applica­
tions. To be published in 0. Johari, ed. Scanning Electron Microscopy/1980/III. SEN Inc., AMF 
O'Hare, 111. 
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B1ood compatibility 
Due to the poor mechanical properties of ungrafted P-HEMA gels, there 
have been experimental difficulties in evaluating the blood compatibility 
of these materials by accepted in vivo techniques (e.g., the vena cava 
ring test or the renal embolus ring test). The blood compatibility of 
P-HEM has been observed in the late I960's by using somewhat less conven­
tional in vivo techniques. Warren et al. (1957) and Levowitz et al. 
(1968) placed molded, unstreamlined, rough P-HEf'IA tubes within the 
superior and inferior vena cava of dogs. It was found, in all cases, to 
be a relatively "nonthrombogenic" (or at least nonthromboadherent) 
material. Thrombus formation was evident at the leading and trailing 
edges of the implant which was attributed to turbulent flow since the 
conduits were neither streamlined nor smooth. 
An experimental study by Singh (1969) was undertaken to determine 
probable tissue reactions or thrombi formation by the implantation of a 
specimen of P-HEMA material in the canine right atrium. The areas of 
implantation were examined between 41 and 59 days. In all cases the P-
HEMA material was free of surface deposit but there were small thrombi 
along the atrial wall adherent to the operation site. The thrombi could 
be easily separated from the P-HEMA implant but adhered to the atrial 
wall. Microscopic examination showed minimal cellular reaction consisting 
of lymphocyte infiltration but no giant-cell formation indicative of 
foreign-body tissue reaction. 
A follow-up study by Singh and Melrose (1971) utilized P-HEMA as a 
coating for terylene sutures. Both coated and noncoated sutures were 
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inserted in parallel rows in the atria of dogs. After two weeks the atria 
were examined for tissue reaction. P-HEMA coated sutures demonstrated 
minimal fibrin deposition and no giant-cell formation. 
The poor mechanical properties of hydrogels prompted the development 
of a variety of techniques for coating hydrogels on substrates to improve 
the hydrogel's strength (Ratner and Hoffman, 1976). Surface immobilized 
hydrogels on mechanically strong supports have made the possibility of 
using hydrogels in vivo in contact with flowing blood a reality. However, 
the blood compatibility test results for hydrogels have been difficult to 
interpret due to problems in reproducing data and conflicting results be­
tween different tests. 
A number of investigators have examined hydrogels by means of the vena 
cava ring test. Some hydrogel formulations appear to be promising materi­
als by the criteria of this test. The reader is referred to Table VIII. 
The vena cava ring test does not appear to be capable of discriminating 
between some hydrophilic materials which are of different formulations and 
which should demonstrate different degrees of interaction with blood 
(Sasaki et al., 1976). Considering that all the hydrophilic materials of 
the Ratner et al. (1978) study performed similarly as vena cava rings in 
spite of significant differences in surface chemistry, wettability, sur­
face texture, water content and electrostatic charge, the sensitivity of 
the vena cava ring test to these differences must be considered to be 
poor. 
The renal embolus test system has been used by Kusserow et al. 
(1972) to study the thrombogenic propensity and patterns of thrombo-
Table VIII. Review of the literature on blood compatibility testing of hydrogel based materials 
Author(s) 
and date Hydrogel composition 
Subject(s) 
used Type of test Comments 
Warren 
et al. 
(1967) 
Levowitz 
et al. 
(1968) 
Singh 
(1969) 
Salzman 
et al. 
(1969) 
Singh & 
Melrose 
(1971) 
2-hydroxyethyl methacry- canine 
late in the form of un-
streamlined tubes (no 
formulations) 
nonstreamlined tubes of canine 
2-hydroxyethyl methacry-
late (no formulations) 
vena cava ring 
vena cava ring 
2-hydroxyethyl methacry- canine 
late (no formulations) 
poly-vinyl alcohol canine 
polymerized with 
sodium heparin 
2-hydroxyethyl methacry- canine 
late polymerized on 
terylene suture material 
atrial swords 
vena cava ring 
right atrium 
4 dogs 1 to 6 weeks, 6 
dogs up to 3 months, 2 
dogs 4 months; at autopsy 
tubes were clear and pli­
able but had buildup of 
thrombus on trailing edge 
11 of 15 dogs lived more 
than one week after im­
plantation, some to 7 
months; thrombus forma­
tion at leading and 
trailing edges of the im­
plant 
Over a period of 2 weeks 
swords of Hydron®showed 
no thrombus surface 
deposition 
Freedom from coagulation 
does not depend upon de-
sorbed heparin has been 
shown by sensitive 35$-
heparin assays 
No complication, no 
giant-cell formation, 
collagen was sparse with 
little fibrin; calcium 
deposition was not evi­
dent 
Table  VI I I .  (Cont inued)  
Author(s) Subject(s) 
and date Hydrogel composition used 
Bruck 2-hydroxyethyl methacry- canine 
(1973) late, polyacrylamide, 
polyelectrolyte complex 
Ratner 2-hydroxyethyl methacry- canine 
et al. late, n-vinyl-2-pyrroli-
(1975a) done radiation grafted 
on silicone rubber 
Muzykewicz 2-hydroxyethyl methacry- canine 
et al. late radiation grafted 
(1975) to cellulose acetate 
Horbett & 2-hydroxyethyl methacry- — 
Hoffman late, n-vinyl-2-pyrroli-
(1975) done radiation grafted 
on silicone rubber 
Weathersby 2-hydroxyethyl methacry- — 
et al. late radiation grafted 
(1976) on silicone rubber 
Type of test Comments 
vena cava ring, renal 
embolus 
vena cava ring 
continuous flow 
platelet adhesion 
albumin, fibrinogen, 
gamma globulin ad­
sorption 
in situ radioiodina-
tion of adsorbed 
plasma proteins on 
surfaces 
Encouraging results are 
summarized for three 
types of hydrogels 
Both types of grafted 
hydrogels showed signifi­
cant patency after 2 
weeks in contrast to un­
treated silicone rubber 
which occluded after 2 
hours 
Platelet adhesion fell 
substantially with in­
creasing surface P-HEMA 
concentration; presence 
of P-HEMA did not affect 
the activated clotting 
times significantly 
Adsorption of fibrinogen 
was least on P-HEMA 
grafted samples versus 
nongrafted samples 
This experiment revealed 
striking changes in the 
adsorbed protein layer on 
P-HEMA only a few minutes 
after exposure to plasma 
Table  VI I I .  (Cont inued)  
Author(s) 
and date Hydrogel composition 
Subject(s) 
used Type of test Comments 
Sasaki 
et al. 
(1976) 
Kronick & 
Rembaum 
(1977) 
Hoffman 
et al. 
(1977) 
Nakashima 
et al. 
(1977) 
Cograft polymerization of canine 
2-hydroxyethyl methacry-
late and ethyl methacry-
late radiation grafted 
onto silicone rubber 
vena cava ring 
Microspheres of 2-
hydroxyethyl methacry-
late and polyacrylamide 
Radiation grafted 2-
hydroxyethyl methacry-
late and n-vinyl-2-
pyrrolidone on silicone 
rubber 
Copolymer of 2-
hydroxyethyl methacry-
late and methyl 
methacrylate 
human 
plasma 
cam ne 
canine 
contact interaction 
of platelets 
vena cava ring 
in vitro kinetic 
method, intravenous 
catheters of grafted 
hydrogel on poly-
olefin and poly-
tetraf1uoroethylene 
2 hour implantations 
showed that P-HEMA, EMA 
co-grafted rings and pure 
P-HEMA grafted rings have 
low thrombogenecity com­
pared to ungrafted sili­
cone rubber 
The two gels have differ­
ent blood compatibility 
which depends more on the 
network structures than 
the H2O structure 
Greatly reduced thrombus 
deposits on P-HEMA and 
NVP rings relative to 
untreated rings 
Copolymers appeared more 
thromboresistant than un­
treated catheters, good 
results up to one week 
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embolism in a number of ring implants composed of different materials. 
The post-mortem findings demonstrated there can be a high incidence of 
embolization (as indicated by the presence of renal infarcts) which was 
associated with several types of ring implant materials that were free of 
thrombus. Kusserow et al. (1972) report that although little thrombus was 
formed within most hydrogel treated test rings, the kidneys almost always 
showed moderate to extensive embolus damage. This indicates that the 
absence of thrombus on the surface of an intravascular prosthetic device 
in no way eliminates the possibility of one or more episodes of thrombosis 
with complete detachment and embolization of thrombotic material into the 
bloodstream. This aspect of hydrogel-blood interaction is in much need of 
further investigation. 
A number of investigators have stressed the importance of initial 
protein adsorption followed by cellular interactions with the adsorbed 
proteinaceous layer when blood is exposed to a foreign interface (Baier 
and Button, 1969; Vroman et al., 1977). It is for this reason that pro­
tein adsorption and cell adhesion studies on hydrogel surfaces are rele­
vant to the design of blood compatible hydrogels and have been the thrust 
of recent investigations. 
Horbett and Hoffman (1975) have noted a reduction in fibrinogen ad­
sorption with increasing levels of hydrogel graft on silicone rubber 
films. The fibrinogen is also desorbed more readily from the grafted 
surface. When tagged fibrinogen is mixed with plasma, there is an 
apparent reversal in the adsorption levels noted with pure fibrinogen 
solutions, and a significant decrease in fibrinogen adsorption on the 
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ungrafted silicone rubber is seen, relative to the almost unchanged ad­
sorption on the P-HEMA grafted silicone rubber. Although albumin and 
gamma-globulin were found to compete with fibrinogen for adsorption sites 
when these proteins were in very high molar excess over fibrinogen (in 
mixed protein solutions), it was concluded that other, unknown plasma 
constituents may be effectively competing with fibrinogen for adsorption 
sites on the untreated silicone rubber surfaces. 
Ratner et al. (1975b) have observed a decrease in chick embryo myo­
blast adhesiveness to radiation grafted P-HEMA on silicone rubber films, 
and Muzykewicz et al. (1975) have noted a gradual decrease in platelet 
adhesiveness with increasing levels of grafted P-HEMA on cellulose acetate 
films. Ratner and coworkers (1975b) also noted a significant increase in 
myoblast adhesion on all surfaces, both hydrogel-grafted and ungrafted 
silicone rubber, after preadsorption of fibrinogen on these surfaces. 
Preadsorption of albumin or gamma-globulin did not produce significant 
changes in cell adhesion on any of the hydrogel surfaces studied. 
Soft tissue compatibility 
Theories abound as to the reasons for the high biocompatibility of 
hydrogels when compared to other polymers. Some theorists believe that 
there is a critical level of equilibrium water, in the 65-75% range, re­
quired to achieve biocompatibility (Bruck, 1973). The presence of quasi-
organized water at the gel-fluid interface, comparable to the intra­
cellular water of biological systems (Drost, 1971) could be a major factor 
(Andrade et al., 1973). Holly and Refojo (1976) have attempted to com­
pare the known properties of hydrogels with that of biosurfaces such as 
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cellular monolayers and tissue boundaries. These data are summarized in 
Table IX. Many of these similar properties may play a role in cellular 
interaction. In properly designed hydrogels these properties may con­
tribute favorably to biocompatibility. In a study of hydrogel sponges 
implanted in dogs, Calnan and coworkers (1971) found the fluid within the 
hydrogel not to be a static pool but rather in dynamic continuity with the 
general interstitial fluid circulation. This may have a particularly 
strong influence on the hydrogel's ultimate biocompatibility rating. 
Until recently, the biocompatibility testing of surgically implanted 
materials was limited to the actual implantation of the material in a 
living system. Homsy (1970) claimed that gross tissue reaction adjacent 
to the implant had usually been the only basis for inspecting a material 
for implantation. Protocols for qualitative evaluation do exist. The 
American Society for Testing and the U.S. Pharmacopeia have developed 
protocols and tentative standards dependent largely on subjective obser­
vation. Quantitative methods of evaluation also exist. The value of 
quantitative methods has been demonstrated in the wound healing and in­
flammatory response literature. Coleman and coworkers (1974) have shown 
the relationship of the foreign body reaction to the inflammatory response 
and thus quantitative methods are feasible. 
The future direction of the biocompatibility testing of implantable 
materials is uncertain. Autian and Dillingham (1973) proposed a general 
acute toxicity program to be used in the general screening of biopolymers. 
A standard for the toxicity testing for biomaterials is currently underway 
by the Bureau of Medical Devices and Diagnostic Products of the Food and 
Drug Administration (Kennedy, 1976). This is an enormous task since a 
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Table IX. Comparison of hydrogel and tissue boundaries (Holly and Refo.lo, 
1976) 
Property Hydrogel Tissue 
PIi abi1i ty Yes Yes 
High water content Yes Yes 
Macromolecular surface composition Yes Yes 
High mobiligy of surface structure Yes Yes 
Negative charge density DMC^ Yes 
Low interfacial tension against water DMC^ Yes 
Large contact angle hysteresis Yes IPL^ 
Biopolymer adsorption and denaturation DMC^ (?) No 
Platelet adhesion DMC^ (?) No 
^Depends on matrix composition. 
^In the presence of lipids. 
test must be specified for use on a particular polymeric biomaterial which 
will be dependent on many factors (i.e., implantation site, application, 
drug release, to name a few). 
To aid in the understanding of biocompatibility within the litera­
ture, the following definitions are outlined from Hall (1972) and Bruck 
(1973): 
(1) biocompatibility is a general term meaning capable of being 
implanted and causing no systemic toxic or allergic reac­
tion, having no carcinogenic qualities, and showing a local 
tissue reaction which neither compromises function nor causes 
pain, swelling, and necrosis in adjacent tissues; 
(2) tissue compatibility is a specific term, similar to the more 
general term—biocompatibility, but relating more to a local 
tissue acceptance; and 
(3) nontoxic means nonpoisonous, causing no local tissue death 
and no systemic reaction due to degraded poisonous byproducts 
from the polymer implant. 
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The bulk of the hydrogel literature does not follow any particular 
standardized procedure. The compatibility testing of hydrogel based 
materials has been primarily limited to the implantation of the materials 
in host animals followed by the evaluation of gross tissue reaction to 
these implants. Table X summarizes the literature reports of the com­
patibility testing of hydrogel materials. The materials were described as 
"tissue compatible" which, upon implantation, showed a normal acute in­
flammation reaction and then rapidly healed to a passive state wherein the 
implant was surrounded by a thin, uniform capsule. In general, most of 
the hydrogel implants were very-well tolerated and did not provoke un­
favorable reactions. P-HEMA gels which were extremely macroporous demon­
strated poor mechanical properties, and certain healing characteristics 
including calcification at the margins were noted. Due to limitations of 
the literature reports (many authors reported little to no information on 
the formulations used nor did they identify microstructural detail spe­
cifically), more research is necessary using families of hydrogel formula­
tions of identified constitution both physically and chemically. 
Table X. Review of literature on ti 
Author(s) 
and date Hydrogel composition 
Barvic ethylene glycol mono-
et al. methacrylate cross linked 
(1967) with ethylene glycol di-
methacrylate 
Hubacek neutral hydrophilic gel 
et al. (no formulation infor-
(1967) mation given) 
Kocvara glycol methacrylate gel 
et al. reinforced with poly-
(1967) ester fibers 
Warren 2-hydroxyethyl 
et al. methacrylate 
(1967) 
compatibility testing of hydrogel based materials 
Subject(s) 
used Type of test Comments 
rats 
rats 
canine 
canine 
subcutaneous and 
intraperitoneal im­
plants 
subcutaneous implan­
tation of gel rods 
and in situ poly­
merization connec­
tion of gel rods 
ureteral prosthesis 
ureteral segment 
replacement 
All samples tolerated 
well; encapsulation began 
at 24 hrs; 10 day firm 
adherance to surrounding 
tissue; 2 to 3 weeks 
vascularization and in­
growth of cellular ele­
ments 
The gel rods developed 
fine encapsulation with­
out inflammatory infil­
tration; residues of the 
polymeric mixture in the 
vicinity of the cemented 
rods showed granulomae 
formation with giant 
cells 
Preliminary report of 
short-term results; the 
gel-fabric was found to 
be nonirritating 
Hydron tubes showed ex­
cellent tissue tolerance, 
no encrustations, satis­
factory functions for 
nine months 
Table X.  (Cont inued)  
Author(s) 
and date Hydrogel composition 
Subject(s) 
used 
LaGuerre 
et al. 
(1968a) 
2-hydroxyethyl 
methacrylate 
canine and 
humans 
Levowi tz 
et al. 
(1968) 
2-hydroxyethyl 
methacrylate 
canine and 
mice 
Kocvara glycol methacrylate gel 
et al. reinforced with a seam-
(1968) less knitted polyester 
tube 
canine 
Kliment ethylene glycol mono-
et al. methacrylate crosslinked 
(1968) with ethylene glycol 
bismethacrylate 
55 human 
cases 
Refojo 2-hydroxyethyl methacry-
(1969) late polyglyceryl 
methacrylate polyelec-
trolyte complex hydrogels 
humans 
Type of test Comments 
indwelling Foley 
catheter 
antibiotic catheter, 
suture, ureteral re­
placement, caval 
conduit 
ureteral prosthesis 
breast augmentation 
corneal membranes 
Hydrogel coated catheter 
with broad-spectrum anti­
biotic were found to re­
duce bladder infection 
rate and well tolerated 
Hydrogel showed no ad­
verse tissue reaction, 
potential as a vehicle 
for delivery of thera­
peutic agents and to 
serve as a compatible 
biologic conduit 
2 year implantations; 
confirms that the hydro-
philic gel is a biologi­
cally inert and non-
irritating material; only 
complication, a certain 
degree of imbibed calcium 
No problems over 3 year 
period; spongy gel with 
pores of 40 to 80 ym in 
size results in tissue 
ingrowth of about 500 ym 
into implant 
Ocular tolerance was 
very good 
Table X.  (Cont inued)  
Author(s) Subject(s) 
and date Hydrogel composition used 
Tollar ethylene glycol mono- rat fibro-
et al, methacrylate coating on blast L-
(1969) polyacrylimide fibers cells 
Chvapil ethylene glycol mono- rats and 
et al. methacrylate with guinea 
(1969) collagen sponge pigs 
Winter & 2-hydroxyethyl pigs 
Simpson methacrylate 
(1969) 
Type of test Comments 
toxicity testing 
subcutaneous and 
subperiostal im­
plantation 
subcutaneous 
Cells cultivated in the 
presence of hydrogel 
coated fibers showed no 
difference in appearance 
from control cells; cells 
with bare fibers became 
degenerated 
Compound materials were 
formed with a density 
varying from a compact to 
a highly porous sponge­
like material, 20-80 ym; 
dynamics of tissue re­
activity was good over 
period of 1 week to 3 
months 
Well tolerated the first 
month, after 31 days 
multinucleated giant 
cells and vascularized 
fibrous tissue permeated 
the implant, woven bone 
was evident at 91 days 
and calcification at 14 
weeks 
Table X.  (Cont inued)  
Author(s) 
and date Hydrogel composition 
Subject(s) 
used 
Michnevic 2-hydroxyethyl methacry-
& Kliment late reinforced with 
(1971) polyester netting 
rabbits 
Barvic 
et al. 
(1971) 
Lazarus 
et al. 
(1971) 
3 types: ethylene rats 
glycol monomethacrylate 
with diethyl aminoethyl 
methacrylate, metha-
crylic acid or a 1 to 1 
mixture of the two 
2-hydroxyethyl canine 
methacrylate 
Sprincl glycol methacrylate 
et al. gels of various 
(1971) porosities 
rats 
Type of test Comments 
liver resection 
subcutaneous 
indwelling urethral 
catheters 
subcutaneous 
Hydrogel foils served as 
bolsters; no haematomas 
or peritoneal exudations 
evident after 25 days 
implantation 
Analysis showed that dif­
ferences in tissue reac­
tions towards the various 
types of hydrogels 
(basic, acidic, neutral) 
were not significant 
Hydrogel was used as a 
vehicle from which an 
antimicrobial agent was 
locally released; de­
velopment of bacteriuria 
was prevented to a sig­
nificant degree 
No unfavorable reactions, 
a fine fibrous capsule 
formed around all sam­
ples; high porosity gels 
were penetrated by capil­
laries within 30 days and 
multinuclear cells were 
present in the margin of 
the implant 
Table X.  (Cont inued)  
Author(s) Subject(s) 
and date Hydrogel composition used 
Majkus 
et al. 
(1969) 
glycol methacrylate gels rats, 
with various antibiotics humans 
Sprincl poly (glycol mono-
et al. methacrylate) and poly 
(1973b) (N-ethyl methacrylamide) 
modified by acidic and 
basic groups and with 
various porosities 
rats, pigs 
Bruck 
(1973) 
2-hydroxyethyl methacry­
late, polyacrylamide, 
loplex 101 
canine, 
human 
cells 
Type of test Comments 
subcutaneous, clini­
cal tympanoplastic 
operations 
subcutaneous 
vena cava ring, renal 
embolus, wish human 
amnion tissue culture 
cells, human whole 
blood 
Rate of diffusion of 
antibiotics determined; 
favorable response re­
sulted after middle ear 
operations 
Over period up to one 
year, all charged and 
noncharged groups were 
encapsulated by a fine 
capsule of fibrous tis­
sue, no signs of pro­
liferation, or calcifica­
tion; high porosity poly­
mers had blood vessels 
penetrate into the depth 
of implant; multinuclear 
cells were observed with 
calcification at the 
margins 
Growth of tissue culture 
cells, low or no ad­
herence of formed ele­
ments, and absence of 
platelet activation were 
considered to be favora­
ble for blood compati­
bility 
Table X.  (Cont inued)  
Author(s) Subject(s) 
and date Hydrogel composition used 
Davis 2-hydroxyethyl methacry- rabbits 
et al. late coated on poly-
(1974) ethylene rods 
Ratner 2-hydroxyethyl methacry- chick 
et al. late, n-vinyl-2-pyrroli- embryo 
(1975b) done radiation grafted muscle 
on silicone rubber cells 
Voldrich 2-hydroxyethyl methacry- human 
et al. late; no formulation 
(1975) details are given 
Murry 2-hydroxyethyl methacry- rabbits 
& Dow late; no formulation 
(1975) details given 
Rubin & 2-hydroxyethyl methacry- canine 
Marshall late reinforced with 
(1975) Dacron® 
Type of test Comments 
intrauterine anti-
fertility device 
tissue culture ad­
hesion test 
plastic operations 
of the nose 
implantation in the 
femur 
implantation in the 
femur and tibia 
No inflammatory reaction 
with the hydroqel coated 
lUD's 
Radiation grafted P-HEMA 
and P-NVP on silicone 
rubber demonstrated low 
adhesiveness in this 
assay 
Using homogeneous gels 
over a 10 year period in 
62 patients, the implants 
were well tolerated, 
calcification did occur 
but show no complications 
Over 6 month period pro­
gressive ossification of 
surrounding connective 
tissue up to the tissue-
polymer junction; there 
was no inflammatory re­
sponse 
In this configuration 
Hydron®sponge did not en­
hance the ingrowth of 
bone into the Dacron® 
Table X.  (Cont inued)  
Author(s) 
and date Hydrogel composition 
Subject(s) 
used 
Kaganov 2-hydroxyethyl methacry- rabbits, 
et al. late on polyethylene human 
(1976) tubing 
Swart 10% phosphorylated 
et al. hydroxyethyl methacry-
(1976) late 
rats 
Hogen-Esch 
et al. 
(1976) 
poly (glyceryl 
methacrylate) 
rabbits 
Rosen 3 types: 2-hydroxy- Swiss 3T3 
et al. ethyl methacrylate with fibro-
(1976) diethyl aminoethyl blasts, 
methacrylate, rats 
methacrylic acid or a 
1 to 1 ratio of the two 
Type of test Comments 
intramuscular, 
catheter for vein 
infusion 
intramuscular 
vitreous humor 
replacement 
cell culture, 
subcutaneous 
No tissue reaction, 18 
patients used hydro-
phi li zed catheters and 
were well-tolerated with 
no complications; coating 
withstood clinical appli­
cation 
3 day to 24 day implants 
well tolerated, phospho-
rylate gels encapsulated 
by thin fibrous lining, 
no calcification; HEMA 
gels had tissue ingrowth 
with calcification, no 
bone formation 
Tissue culture and pre­
liminary studies using 
injection into rabbits 
have been satisfactory 
Cell attachment to elec-
troneutral gels was pro­
portionately lower than 
for any other type; col­
lagen production around 
neutral gels developed 
gradually and remained 
constant 
Table X.  (Cont inued)  
Author(s) 
and date Hydrogel composition 
Subject(s) 
used Type of test Comments 
Gilding 
et al. 
(1978) 
Cipriano 
(1978) 
Greer 
et al. 
(1979) 
Kronman 
et al. 
(1979) 
polyacrylamide gels rats, 
radiation grafted to sheep 
silicone rubber and 
polyurethane 
2-hydroxyethyl methacry- L-929 
late ethylene glycol di- mouse 
methacrylate n-vinyl-2- fibro-
pyrrolidone grafted on blast, 
silicone rubber and rabbit 
polyethylene 
terephthalate 
2-hydroxyethyl methacry- rabbit 
late ethylene glycol di-
methacrylate n-vinyl-2-
pyrrolidone grafted on 
silicone rubber and 
polyethylene 
terephthalate 
2-hydroxyethyl methacry- rats 
late highly porous 
sponges 
subcutaneous 
tissue culture, 
intramuscular, 
blood hemolysis 
intramuscular 
subcutaneous 
8 to 13 week implants had 
tissue ingrowth up to 280 
ym, some lymphocytes, few 
macrophages, no calcifi­
cation 
No major toxic response 
of the formulations test­
ed; good tissue compati­
bility was found for all 
materials in 10 day, 1 
and 3 month trials; low 
hemolytic activity was 
also indicated 
Degrees of encapsulation, 
density of capsule, and 
inflammatory cell count 
were compared to fabrica­
tion variable and micro-
structural details 
No inflammation; penetra­
tion of fibroblast-1ike 
cells in conjunction with 
a well-defined vascular 
bed; calcification proc­
ess resembled crystal­
line growth 
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STATEMENT OF THE PROBLEM 
Nature 
It has been recognized that the wall of an arterial prosthesis must 
be porous if healing is to occur. But fabric prostheses porous enough 
to be healed will bleed excessively at operation unless the walls are 
rendered impervious by preclotting. "Preclotting" refers to the conver­
sion of the porous wall of a fabric prosthesis into one which has been 
rendered impervious by reaction with blood to form thrombus. The pre­
clotting process is absolutely essential if porous fabric prostheses are 
to be employed in heparainized patients. Preclotting is also important 
when such grafts are used in nonheparinized patients. This preclotting 
technique has three serious disadvantages: No preclotting method makes 
the graft adequately impervious for use in the fully-heparinized patient; 
the flow surface of the graft is not necessarily made smooth; and this 
surface is highly thrombogenic. Efforts to use such grafts in small 
caliber replacement or bypass graft applications have been associated with 
a high incidence of delayed thrombotic occlusion or perigraft hematoma 
formation. 
Improvements in cardiovascular implant materials may extend the use­
ful lifetime of a prosthesis. One method for improvement may be to fill 
the fabric substrate with a synthetic material which is both tissue and 
blood compatible. Hydrogels, specifically polyhydroxyethyl methacrylate 
(P-HEMA), are a class of materials showing excellent versatility and per­
formance in a few biomaterial applications but to this date have not been 
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demonstrated as an alternative replacement of thrombus as the ground sub­
stance within the fabric matrix. The development of composite materials 
where hydrogel has been impregnated into or bonded onto polyethylene 
terephthalate fabric requires approaching the problem from several points 
of view, specifically: fabrication considerations, chemical and micro-
structural properties identification, biocompatibility testing, and design 
feasibility. 
Approach to the Problem 
A family of hydrogel/substrates were fabricated using current radia­
tion and thermal initiated polymerization techniques to coat or impregnate 
substrates with hydrogel. The hydrogel graft composition was varied by 
adjustments of the concentration of the monomer, hydroxyethyl methacry-
late, the comonomer n-vinyl pyrrolidone, and crosslinker, ethyleneglycol 
dimethacrylate. These materials were characterized by scanning electron 
microscopic analysis of microstructural detail especially as this is of 
interest for possible cell penetration into the interconnecting pores of 
hydrogel and application as a blood flow surface. A number of SEM prepa­
ration techniques were investigated to determine an efficient method to 
preserve the hydrogel's morphology for best observation. Measurement of 
hydrogel graft to substrate weight ratios and percent water imbibed in the 
hydrogel graft was recorded so that the correlation of fabrication varia­
bles with these properties were cataloged to provide a basis for selection 
in a variety of possible cardiovascular design applications. 
46 
The biocompatibility evaluation of these materials proceeded through 
several stages of screening tests to eliminate unsuccessful materials and 
to focus on promising formulations. Initial screening was performed by 
T. Cipriano (1978) using the mouse fibroblast test to show the response of 
cell cultures to the composite materials. Materials eliciting toxic or 
inhibitory response were eliminated. Blood hemolysis tests were also per­
formed on these samples. To test the acute cellular and early response of 
tissue, samples were surgically implanted into rabbit paravertebral 
muscle. Several stages of biological reaction over a 90-day implantation 
period were analyzed by the author using both histological and scanning 
electron microscopy techniques. The time period and healing process that 
occurs after implantation of specific polymer materials were shown to be 
affected by the choice of substrate material and hydrogel formulation. 
This suggested that several major parameters (i.e., porosity, strength, 
and chemical properties of the hydrogel) could be varied to match spe­
cific design requirements for an improved prosthesis. 
To delineate the microstructure of hydrogels, various formulations of 
CR) both bulk hydrogel and composites on Dacron ^ fabric were investigated by 
scanning electron microscopy techniques. The morphology of the P-HEMA 
hydrogel on a colloidal level was found to be easily and reproducibly con­
trolled by adjustment of cosolvent concentrations holding other fabrica­
tion variables constant. The formulation specifications were cataloged 
with associated parameters such as graft percent, water imbition and 
microstructural evaluations. The acquisition and systematization of these 
data were central to a long range goal of identifying relationships of 
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those properties to control the thrombogenicity and tissue reaction to 
hydrogel composites. This list provided a base from which hydrogel formu­
lations could be chosen with properties to meet design specifications best 
suited for specific implant needs. 
The design of an improved cardiovascular prosthesis was based upon 
the concept that hydrogels appear advantageous as an alternative to 
thrombus as the ground substance within the pervious fabric prostheses. 
The appraisal of hydrogel formulations in tissue and blood contact appli­
cations demonstrated good overall compatibility characteristics. The 
microstructure of the hydrogel could be controlled perhaps to allow 
permeability to cellular ingrowth from the exterior of the prosthesis and 
at the same time provide a smooth, less thrombogenic flow surface. To 
increase mechanical properties the hydrogel layers could be integrated 
with a supporting tubular substrate to provide a reinforced composite 
structure suitable for implantation. 
The fabrication of this compound prosthesis utilized a two-stage 
hydrogel coating process on a porous fabric substrate. The steps by which 
the tubular substrate could be internally and externally coated with a 
fluid-imbibing gel having selectively distinctive microstructures along 
respective surfaces were formulated to achieve an implantable device with 
an inside diameter of 4 mm. 
A preliminary study, using canine carotid artery implantations, 
tested the concept that a substrate material filled with hydrogel of con­
trolled morphology can promote the establishment of an endothelial-like 
layer, accelerate healing, and maintain patency. Initial results of a 
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(R) 
comparison of dual coated hydrogel Dacron ^  prostheses with standard, 
pre-clotted noncoated Dacron® prostheses showed promising results which 
point to the need of further development and refining of hydrogel coatings 
for biomedical applications. 
Significance of the Research 
This work contributed information on the potential application of 
hydrogel based materials which may be fundamental to their use for im­
provements of clinically available prostheses and devices. The investiga­
tion provided information on the success of using hydrogels in the form of 
assemblies of multiply sized polymeric coatings on a scaffolding network 
to achieve favorable tissue response and thereby offering a basis from 
which possible methods useful for small diameter, low velocity blood flow 
applications can be further investigated. 
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PART I. MICROSTRUCTURAL INVESTIGATIONS OF HYDROGEL COATINGS AND IMPREG­
NATIONS IN SILICONE RUBBER, DACRON® AND POLYETHYLENE 
Introduction 
With the increasing interest in biomedical application of hydrogels, 
there have been important discussions raised in the literature as to the 
surface properties particularly in relation to the areas of blood compati­
bility, tissue compatibility, and cell adhesion. Questions concerning 
surface roughness, structure or morphology, and apparent orientation can 
be investigated using scanning electron microscopy (SEM) techniques. 
Recently, a number of attempts to obtain general qualitative de­
scriptions of organic gel structures which directly relate to their in­
tended applications have been described in the literature. Matas et al. 
(1972) described SEM techniques used with hydrophilic contact lenses. 
Freeze dried and critical point dried samples showed better preservation 
of surface detail than air dried samples. Although no formulations (only 
the lenses supplier) of the gels were reported, the surfaces of the lenses 
did not appear to have a porous architecture when observed up to a magni­
fication of 36,000. Ratner and Hoffman (1974) published micrographs (at 
200x) to demonstrate the effects of cupric ion concentration on the 
grafting of a hydrogel (10% n-vinyl-2-pyrrolidone, 10% hydroxyethyl 
methacrylate) onto silicone rubber. Geymayer (1974) reviewed the problems 
involved in high resolution studies of freeze etched gels and recommended 
a "freeze-shock" technique; that is, rapid freezing, transfer to the SEM 
column by means of an airlock, and observation of the sublimated surface. 
Results of an examination of vacuum freeze-dried organic gels by SEM were 
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presented by Blank and Reimschuessel (1974) with a discussion of the im­
portance of gel structure as a crystal growth media. Gourlay et al, 
(1975) demonstrated a radiation grafted 10% HEMA surface coating (lOOx) 
for a potential synthetic wound dressing application. Swart et al. (1976) 
have published a scanning electron micrograph (no details of SEM method 
given) of a bulk hydrogel product prepared by polymerization of HEMA and 
EGDM with an initiator of ammonium persulfate at 50° for 24 hours. 
Andrade et al. (1976) have used freeze drying and freeze etching to ob­
serve bulk HEMA polymer and radiation grafted coatings on polypropylene 
(little detail on fabrication methods was included). The authors sug­
gested that perhaps the best method of SEM observation would be a combina­
tion of several of the possible techniques including rapid quenching, 
fracture under liquid nitrogen, and coating of the freeze-etched sample. 
Thus, many authors have reported on an eclectic selection of both SEM 
preparation techniques and fabrication methods, formulations and composi­
tions. A systematic study was therefore undertaken. This section in­
vestigates methods for the formation of bulk hydrogel and the grafting of 
hydrogel onto a number of substrates. Scanning electron microscopy tech­
niques including air drying, critical point drying, freeze fracturing, and 
freeze drying were utilized and evaluated. The microstructures observed 
suggest that the chemical and radiation initiated polymerization methods 
may offer a variety of microstructural features and other properties to 
meet design considerations for particular medical prosthetic applications. 
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Materials and Methods 
Materials fabrication 
Radiation grafting according to methods outlined by Ratner and 
Hoffman (1974, 1975) was used to coat silicone rubber (Silastic sheet­
ing, lot no. H0608 and HH0699, and Silastic® tubes, lot no. H0083) ob­
tained from Dow Corning, Midland, Michigan and polyethylene tubes 
(Intramedic ®, PE320, lot no. 7456) acquired from Clay-Adams, Inc., New 
(R) York, N.Y. The interstices of polyethylene terephthalate (Dacron^ 
sheeting, USCI ® DeBakey® double velour, cat. no. 7825 lot no. 015984, 
USCI, a division of C. R. Bard, Inc., Bill erica, Mass.) were filled and 
the fibers coated with hydrogel polymerized by the radiation initiating 
method. 1 x 4 cm^ strips (Dacron® and Silastic®) or tubes (poly­
ethylene, 2.69 mm inside diameter, 3.5 mm outside diameter, 4 cm length; 
Silastic , 6 mm inside diameter, 9 mm outside diameter, lengths of 1.0 
or 1.5 cm) were cleaned ultrasonically (5 minute wash followed by 3 dis-
tilled water rinses) with a nonoily soap solution (Ivory ^  flakes). 
2 Specimens were dried in an oven at 100°C, allowed to cool to room tem-
(Ô) 
perature and weighed. The substrate materials were suspended in Pyrex^ 
test tubes with monomer solution of interest (10 to 30% by volume 2-
^cm = centimeter. 
^C = Celsius. 
hydroxyethyl methacrylateJ lot no. 9-11-76, Haven Chemical, Philadelphia, 
Penn., analysis in Appendix, with 0 to 2% by volume ethylene glycol di-
methacrylate lot no. 53-94 Haven Chemical Co., Philadelphia, Penn.) in a 
cosolvent consisting of 25% methanol and 75% distilled water. The tubes 
were then saturated with nitrogen to minimize oxidative reactions and 
cn n 
irradiation in a Co radiation source to receive 0.25 to 1.0 Mrad. 
Hydrogel impregnation of silicone rubber was achieved using 
Predecki's (1974) method of Interpenetrating Network (IPN) fabrication. 
Silastic® sheets cut into squares (1 cm x 1 cm or 2 cm x 2 cm) or sec­
tions cut from tubing (1.0 or 1.5 cm lengths) were washed and weighed as 
described above. The specimens were preswelled by boiling in xylene for 
10 minutes and then were placed in monomer solution of interest for one to 
two hours. Monomer solutions of 5-30% by volume (2-hydroxyethyl 
methacrylate (HEMA), Haven Chemical) with 0 to 2% crosslinking agent 
added (ethylene glycol diemthacrylate (EGDM), Haven Chemical) were pre­
pared in a cosolvent of 95% xylene, 5% ethanol. The reaction was com­
pleted just below the boiling point of the resulting monomer solution 
which is in the range of 118-135°C, depending on the constituent concen­
trations. This procedure was also used to fill the interstices and coat 
the fibers of polyethylene terephthalate fabric although the resulting 
network is not truly an IPN. 
^Based on chemical analysis (Appendix) this lot of stock monomer 
solutions has the following makeup: 
5% stock HEMA contains 4.92% HEMA and 0.08% EGDM by volume; 
10% stock HEMA contains 9.85% HEMA and 0.15% EGDM by volume; 
20% stock HEMA contains 19.70% HEMA and 0.30% EGDM by volume; 
30% stock HEMA contains 29.55% HEMA and 0.45% EGDM. 
2 Mrad = Mega rad of absorbed radiation. 
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In both fabrication methods, a bulk polymeric product was formed in 
the reaction vessel. Depending on the monomer and crosslinking agent con­
centration, this bulk polymer can be a translucent viscous fluid, a brit­
tle white mass, or an opaque white to translucent rubbery material. At 
lower reaction times and lower monomer concentration, the substrate with 
hydrogel composite was easily separated from the bulk polymer. At greater 
monomer concentrations and longer reaction times, the samples became more 
difficult to separate from the bulk polymer and had to be stripped free 
mechanically. The freed samples were rinsed in an ethanol/water (50/50 
v.%)^ solution several times to remove unreacted constituents. The sam­
ples were stored individually in clean glass vials containing ethanol/ 
water solution (50/50 v.%). 
Graft and HgÇ. percent determination 
Samples to be used for graft and water imbibition measurements were 
dried for four hours in an oven at 100°C. The dry samples were weighed to 
determine the percent hydrogel graft acquired and then placed in physi­
ological saline solution for at least 24 hours. Water imbibition was de-
2 termined by blotting the wet samples between sheets of Whatman #1 
filter with a 100 gram weight for 5 seconds and weighing the sample. 
Water imbition is reported as 
weight of water imbibed ..0% 
weight of hydrogel graft 
^v.% = volume percent. 
2 W and R Balston, Limited, London, England. 
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SEM techniques 
Scanning electron microscopy techniques utilized to identify the 
surface morphology of the polymer samples included air drying, critical 
point drying, freeze fracturing, and freeze drying. Each prepared sample 
was mounted on aluminum stubs with a colloidal silver medium;^ coated with 
O O 
100 A carbon and 200 A gold by vacuum evaporation, and observed at 5-25 
2 keV (kilo electron volts) in a JEOL -U3 SEM. Photomicrographs were pre-
3 pared at a 50 seconds per frame scan speed using Polaroid type 52 film. 
Air dried Samples were removed from saline, taken through a 
series of acetone/distilled water rinses (30, 60, 90, 100, 100%, v/v^), 
allowed to air dry, mounted, coated, and observed under conditions de­
scribed above. 
Critical point dried Samples were taken through the same acetone/ 
5 distilled water rinse sequence, critical point dried in a Polaron model 
E300 drier, using COg, mounted, coated, and observed as described above. 
Freeze dried Samples were obtained by freezing samples stored in 
distilled water and then vacuum desiccating the sample for 48 hours. Sam­
ples were warmed to room temperature under vacuum and then mounted, 
coated, and observed as described above. 
^SPI Supplies, Div. of Structure Probe Inc., West Chester, Penn. 
2 Japanese Electron Optics, Tokyo, Japan. 
3 Polaroid Corporation, Cambridge, Mass. 
4 
v/v = volume to volume ratio. 
5 Polaron Instruments, Inc., Warrington, Penn. 
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Cryofracture Samples were frozen by immersion in liquid Ng or on 
a cryoscan stage (JEOL attachment). Ice free fracture surfaces or sub­
limated nonfracture surfaces were used when obtaining SEM micrographs at a 
beam accelerating voltage of 5-15 keV. 
Results 
Materials 
Percent graft data and water imbitition data are presented in Table 
XI for the Silastic ® treated with hydrogel by the IPN technique. Graft 
ranges from 1 to 19% were measured (Predecki, 1974, has reported 50% 
graft with a 20% HEMA, 0.3% EGDM formulation). Polyethylene terephthalate 
fabric coated with poly-HEMA by the IPN procedure had quite variable 
amounts of gel deposited into the velour network. A 400% increase in 
weight was noted in some instances. 
Ratner and Hoffman (1974, 1975) have reported the degree of graft 
and water imbibing properties for several radiation grafted hydrogel 
formulations on a nonporous substrate material such as silicone rubber. 
By comparison, this work reports that radiation initiated polymerization 
methods can be utilized to coat and fill a porous fabric substrate, i.e., 
polyethylene terephthalate. Table XII lists fabrication, percent graft 
and water imbibition data for a number of hydrogel formulations. The 
monomer-crosslinker-cosolvent compositions had marked influences on the 
resulting hydrogel. SEM of these materials revealed a velour network 
filled with the hydrogel. 
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Table XI. Percent graft and percent water imbibition for P-HEMA/Silastic® 
IPN's (Greer et al., 1978) 
% % Reaction % % , 
HEMA EGDM time (hrs) Graft Water 
Tubes, 6 mn inside diameter 
9 mm outside diameter 
(tubes were either 1.0 or 
1.5 cm long) 
20 0 1.5 11 36 
20 0 1.5 14 29 
20 1 1.0 7 40 
20 1 2.0 19 26 
20 2 1.0 ~1 -
20 2 2.0 2 -
10 0 2.0 16 20 
30 0 2.0 13 12 
30 1 0.5 ~1 -
30 1 1.0 8 23 
Sheets, 0.2" thick 
1 cm2 or 2 cm^ 
20 0 2.0 6 30 
20 1 1.0 2 -
20 1 2.0 9 31 
10 0 2.0 ~1 -
30 0 2.0 6 40 
30 1 1.0 5 51 
graft is (dry weight of impregnated sample - orig. weighty ^ 
water is x 100%. 
Table XII. Fabrication data for radiation initiated polymerization of hydrogel on Dacron® velour 
fabrics 
HEMA - % EGDM 
Composition 
- Mrad - Solvent Meth^/HgO 
Percent 
graftb 
Percent water 
imbibedc Observations 
10 1.0 0.10 50/50 1 358 no visible reaction 
10 2.0 0.10 50/50 5 354 no visible reaction 
10 3.0 0.10 50/50 45 357 white flaky loose gel 
20 1.0 0.10 50/50 <1 358 no visible reaction 
20 2.0 0.10 50/50 45 282 translucent loose gel 
20 3.0 0.10 50/50 19 326 partial reaction, trans 
lucent gel 
20 3.0 0.10 25/75 82 264 white flaky loose gel 
10 1.0 0.25 50/50 84 235 translucent gel 
10 1.0 0.25 25/75 92 265 white opaque firm gel 
10 2 . 0  0.25 50/50 85 260 white opaque gel 
^Methanol. 
oraft iq (dry weight of impregnated sample - original weights ^ .nnv 
y ^ original weight ' ^  
water Imb.bad is Cl^l of " 100%. 
Table XII .  (Cont inued)  
HEMA - % EGDM 
Composition 
- Mrad - Solvent Meth/HgO 
Percent 
graft 
Percent water 
imbibed Observations 
10 2.0 0.25 25/75 122 211 white opaque gel 
10 3.0 0.25 50/50 95 274 white opaque gel 
10 3.0 0.25 25/75 286 181 white opaque gel 
20 1.0 0.25 50/50 178 133 translucent firm gel 
20 1.0 0.25 25/75 143 197 white opaque firm gel 
20 2.0 0 .25  50/50 163 128 translucent firm gel 
20 2.0 0.25 25/75 155 193 white opaque firm gel 
20 3.0 0.25 50/50 168 159 translucent firm gel 
20 3.0 0.25 25/75 152 199 white opaque firm gel 
A comparison of SEM preparation techniques (air dried, critical 
point, cryofracture, and freeze dried) is presented in Figures la-Id. Air 
drying proved unsatisfactory for preservation of the microstructure of 
bulk hydrogel and charging problems made observations difficult (Figure 
la). Critical point drying and freeze fracturing preserved similar 
microstructural information of this sample of 10% HEMA, 0% cross linked 
bulk polymer (Figures lb and Ic). Freeze drying (Figure Id) produced a 
more open network in which the bridges between the globules of polymer are 
seen to be much finer than when prepared by either freeze fracturing or 
critical point drying. It is believed that these surface artifacts are 
due to an insufficient rate of cooling during the freezing process. 
When Silastic® sheeting is received from the manufacturer, it has 
been dusted on the surface with sodium bicarbonate to facilitate handling. 
This can be observed in Figure 2a. The removal of the sodium bicarbonate 
was achieved by the Ivory ^  flake ultrasonic wash. Figures 2b and 2c 
show the Silastic® sheeting free of the dusting powder. The pronounced 
microstructural surface character of this lot of sheeting prior to treat­
ments with HEMA is seen in Figures 2b and 2c. 
Figure 3 compares the preparation techniques for an IPN of 20% HEMA, 
fR) 0% EGDM with 2 hour reaction time with Silastic ^ sheeting. The critical 
point dried sample (Figures 3a, 3b) shows an overall surface detail very 
similar to the Silastic^ prior to HEMA grafting. At the higher magnifi­
cation polymerization beading of the p-HEMA can be observed on the surface 
of the Silastic®. The freeze dried sample (Figures 3c, 3d) demonstrates 
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Figure la. Bulk polymer from 10% HEMA, 0% EGOM, at 1,0 Mrad dose, air 
dried (scale bar = 10 ym). 20 keV. 
Figure lb. Same fabrication as Figure la, critical point dried (scale 
bar = 10 vm). 20 keV. 
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Figure le. Same fabrication as Figure la, cryofractured (scale bar = 
10 ym). 5 keV. 
Figure Id. Same fabrication as Figure la, freeze dried (scale bar -
10 ym). 15 keV. 
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Figure 2a. Silastic sheeting as received from manufacturer, dusted with 
sodium bicarbonate—see arrow for example (scale bar = 33 ym). 
20 keV. 
Figure 2b. Silastic®sheeting after Ivor^Pwash—freeze dried (scale bar = 
33 ym). 20 keV. 
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Figure 2c. Higher magnification of Figure 2b (scale bar = 5 vim). 20 keV. 
Figure 3a. Comparison of preparation techniques for 20% HEMA, 0% EGDM, 2 
hour reaction, IPN's on Silastic^ critical point dried (scale 
bar = 33 ym). 20 keV. 
Figure 3b. Higher magnification view of Figure 3a (scale bar = 5 ym). 
20 keV. 
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Figure 3c. Comparison of preparation techniques for 20% HEMA, 0% EGDM, 2 
hour reaction, IPN's on Silastic^ freeze dried, arrow shows 
artifact caused by freeze drying treatment (scale bar = 33 
ym). 20 keV. 
Figure 3d. Higher magnification view of Figure 3c (scale bar = 5 ym). 
20 keV. 
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the hydrogel coating as a series of isolated patches due to the perturba­
tion caused by the freezing process. The air dried sample (Figures 3e, 
3f) appears very similar to the critical point dried sample. With a high­
er percentage of crosslinking agent a slight increase in the amount of 
hydrogel deposited on the surface of Silastic® (Figures 4a, 4b), but no 
gross change of the Silastic® morphology was noted. Also refer to 
Figures 2b and 2c for a comparison with the starting materials. 
(5) 
Figure 5 shows a partially coated Silastic sheet that has been 
grafted with 10% HEf4A, 0% EGDM using 1 Mrad irradiation. The absence of 
p-HEMA coating can be viewed on the left side of the micrograph. The p-
HEMA coating on the right takes on very little of the microstructural 
characteristics of the Silastic^ sheeting and has very low contrast. A 
greater degree of graft is produced at increased irradiation doses with 
(B) 
the surface appearing quite different from the uncoated Silastic^ 
(Figures 6, 7). 
The acid treatment of polyethylene tubing consists of immersion in 
chromosulfonic acid (50 grams KgCrgO^ per liter concentrated sulfuric 
acid) for twenty minutes followed by a rinse with distilled water and 
ethanol (Figure 8a). The coating of polyethylene by the radiation method 
apparently begins with the deposition of spherical masses of polymer in 
etch pit locations on the acid treated polyethylene (Figure 8b). The 
etch pits may afford nucleation sites for the polymer. With increasing 
poly-HEMA deposition, the spherical masses enlarge, form bridges, overlap, 
and establish layers (Figure 8c). 
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Figure 3e. Comparison of preparation technioues for 20% HEMA, 0% EGDM, 2 
hour reaction, IPN's on Silasticff air dried (scale bar = 33 
ym). 20 keV. 
Figure 3f. Higher magnification view of Figure 3e (scale bar = 5 ym). 
20 keV. 
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Figure 4a. Interpenetrating networks (IPN) of chemical grafted HEMA to 
Silastidf^ IPN chemical graft of 20% HEMA, 1% EGDM, 2 hour 
reaction, critical point dried (scale bar = 33 ym). 20 keV. 
Figure 4b. Higher magnification view of Figure 4c (scale bar = 5 ym). 
20 keV. 
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% 
Figure 5. Partially coated Silastic^with 10% HEMA, 0% EGDM, at 1 Mrad. 
air dried (scale bar = 33 ym). 20 keV. 
Figure 6. SilasticPsheet coated with 20% HEMA, 0% EGDM, at 0.25 Mrad 
(scale bar = 33 ym). 20 keV. 
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Figure 7. Silastic®sheet coated with 20% HEMA, 0% EGDM, at 1.0 Mrad 
(scale bar = 33 ym). 20 keV. 
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Figure 8a. Radiation grafted HEMA on polyethylene. Acid treated poly­
ethylene before coating, air dried (scale bar = 5 ym). 20 
keV. 
Figure 8b. Radiation grafted HEMA on polyethylene. Hydrogel coating of 
10% HEMA, 0% EGDM, at 0.25 Mrad dose, critical point dried 
(scale bar = 10 ym). 20 keV. 
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Figure 8c. Radiation grafted HEMA on polyethylene. Hydrogel layer of 20% 
HEMA, 0% EGDM, at 0.50 Mrad dose, critical point dried (scale 
bar =10 ym). 20 keV. 
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Prior to coating with hydrogel, polyethylene terephthalate (Dacron ^  
velour fabric has open interstices within afiberous matrix (Figure 9a). 
Using the IPN method, deposition of the hydrogel into the interstitial 
(K) 
spaces of the Dacron begins while the external phase is only partially 
polymerized (flecks of polymer having become visible within the reaction 
(R) 
solution). The polymer forms and fills the openings within the Dacron^ 
before complete gellation of the external phase occurs (Figure 9b). At 
higher magnification the initial deposition of polymer on the Dacron ® 
fiber can be seen (Figure 9c). In the case of radiation initiated poly-
merization of HEMA, a similar infilling of Dacron ^ is observed (Figures 
10a, 10b). At low dose rates and low monomer-crosslinker concentrations, 
the amount of gel grafted was minimal as determined by differential 
1 (R) 
weighings (Table XII) and deposition on Dacron ^ fibers was not evident 
through SEM observations. 
Conclusions 
Comparison of the preparation of sample techniques for SEM observa­
tion showed that air drying, which caused charging problems and loss of 
microstructural detail, is unacceptable. This freeze fracture technique 
also combines "freeze etching" since any residual ice is allowed to subli­
mate under beam exposure. Freeze fractured samples appear similar to 
critical point dried samples in the SEM. Critical point drying is a sim­
pler process than freeze-fracturing and it produces satisfactory results 
^Weight of dried grafted substrate minus weight of substrate prior to 
grafting equals amount of grafted hydrogel. 
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Figure 9a. Dacron®velour, uncoated, air dried (scale bar = 20 ym). 25 
keV. 
Figure 9b. DacrorPvelour coated by IPN technique, 20% HEMA, 0% EGDM, 1.5 
hour reaction, critical point dried (scale bar = 20 ym). 15 
keV. Arrow indicates region shown at higher magnification in 
Figure 9c. 
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Figure 9c. Higher magnification view of region shown by arrow in Figure 
9b (scale bar = 5 ym). 15 keV. 
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Figure 10a. Dacron®velour coated by the radiation initiated technique, 
^0% HEMA, 0% EGDM, 0.25 Mrad, critical point dried (scale bar 
= 100 ym). 15 keV. 
Figure 10b. Higher magnification view of Figure 10a (scale bar = 10 ym). 
15 keV. 
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(e.g., in terms of charging effects and preservation of microstructure). 
Freeze drying generated obvious surface and bulk polymer microstructural 
artifacts. A more rapid freezing process may offer advantages. 
Polyhydroxyethyl methacrylate (P-HEMA) and silicone rubber interpene­
trating networks can be formed by chemical methods. The amount of P-HEMA 
incorporated in the silicone rubber ranged from zero to 20% depending on 
the concentration of monomer-crosslinker and on the reaction time. Up to 
50% water imbibition within the gel network could also result. The IPN 
(R) 
technique had minimal effects on the character of the Silastic ^  surface. 
(R) An open fabric structure such as polyethylene terephthalate (Dacron^) 
velour can be filled with P-HEMA hydrogel by the IPN method of grafting 
although the resulting network is not truly an IPN. 
A radiation initiated polymerization method can be used to deposit a 
P-HEMA layer on the surface of nonporous substrates such as silicone 
rubber and polyethylene. This layer imparts a microstructure of its own 
to the surface of the substrates depending upon the monomer-crosslinker 
(R) 
concentrations and the radiation dose. In similar fashion the Dacron 
velour can be coated with P-HEMA hydrogel to achieve a specific micro-
structure and amount of graft. The dominance of a porous material like 
(R) Dacron ^ velour may be controlled by the amount and type of hydrogel 
coating applied and a degree of hydrophilicity can be introduced by the 
hydrogel. These factors are regulated by the concentrations of the 
monomer, crosslinking agent, cosolvents and the amount of radiation. 
This work is a preliminary step in the cataloging of hydrogel-
composite materials. The SEM observations suggest that the chemical (IPN) 
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and the radiation grafting treatments offer a variety of microstructural 
and other physical/chemical properties to meet design considerations of 
particular medical applications. It is anticipated that, by matching a 
specific hydrogel formulation to the demands of a particular prosthetic 
application, favorable tissue responses can be obtained. The next step in 
the evaluation of P-HEMA hydrogel coatings is a tissue compatibility re­
sponse both on an in vitro and in vivo level. 
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PART II. EVALUATION OF TISSUE-RESPONSE TO HYDROGEL COMPOSITE MATERIALS 
Introduction 
The hydroxyethyl methacrylate monomer can be cross!inked with 
ethylene glycol dimethacrylate to form stable, three-dimensional, fluid-
imbibing gel networks. It is believed that the presence of imbibed fluid 
within the polymeric system is intrinsically related to its potentially 
high biocompatibility (Ratner and Hoffman, 1976). Questions concerning 
the relationship of the polymer's surface and bulk properties to the areas 
of tissue compatibility, cell adhesion and blood compatibility have been 
raised in the literature. A better understanding of basic interactions 
between material parameters and biological responses is needed so that a 
higher level of control over the amount of biological reaction can be 
attained compared with current technology. 
The amount of graft and fluid imbibed can be varied by changing sub­
strate material, monomer concentrations, percent of crosslinking agent, 
and grafting methods. The biocompatibility evaluation of several hydrogel 
formulations coated on either silicone rubber or polyethylene terephtha-
late velour substrates by chemical and radiation polymerization methods 
proceeded through several screening tests to eliminate unsuccessful 
materials and to focus attention on promising hydrogel formulations. 
Tests performed by T. Cipriano (1978) included testing the response of 
L-929 mouse fibroblast cells to various formulations of hydrogel com­
posites, a rabbit blood hemolysis test (to check for red blood cell 
toxicity) and surgical implantation of specimens into the paravertebral 
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muscles of healthy, albino New Zealand rabbits to test the acute response 
of soft tissue to the hydrogel materials. Cipriano (1978) reports that 
all hydrogel materials exhibited a noncytotoxic response and very low 
level hemolytic activity. The results of the rabbit paravertebral im­
plantation test determined that the materials tested showed no cytotoxic 
activity when examined histopathologically at 10 days, 1 month, and 3 
month intervals. This initial investigation was expanded since the degree 
of surface roughness of pre-implant materials, the extent of biological 
tissue penetration into the pores of the hydrogel, and the organization of 
the fibrous capsule can be examined using light microscopy and scanning 
microscopy techniques. The SEN microstructural details (e.g., the rela­
tionship of tissue penetration to the interconnecting pores of the hydro­
gel) may indicate that a variety of microstructural features can be corre­
lated with the fabrication variables (radiation initiated polymerization 
compared with chemical grafting; and the composition of monomer with 
various crosslinking agent formulations). 
Materials and Methods 
Materials fabrication 
Radiation initiated polymerization method (Ratner and Hoffman, 1974, 
(6) 
1975) was used to coat polyethylene terephthalate fabric (USCI DeBakey^ 
double velour, Dacron ^  cat. no. 007826, lot no. 015984) and silicone 
rubber (Dow Corning, Silastic sheeting, lot no. HH1404). 1 x 4 cm 
(R) (fô 
strips of Dacron and Silastic were ultrasonically cleaned (5 minute 
wash followed by 3 distilled water rinses) with a nonoily soap solution 
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CK) (Ivory ^  flakes). Specimens were dried in an oven at 100°C, allowed to 
cool to room temperature in a desiccator, and weighed. Monomer solutions 
of 10-20% 2-hydroxyethyl methacrylate^ (HEMA, Haven Chemical Co., Phila­
delphia, Penn., lot no. 700-238-22), and 0-15% n-vinyl pyrrolidone (NVP, 
Haven Chemical Co., lot no. 700-205-2) with additions of 0-2% crosslinking 
agent ethylene glycol dimethacrylate (EGDM, Haven Chemical Co., lot no. 
53-95) were mixed in a cosolvent consisting of 25% methanol and 75% dis-
tilled water. The substrate materials were suspended in Pyrex ^ test 
tubes to which the monomer solution of interest was added. The test tubes 
were then saturated with nitrogen to minimize oxidative reactions and 
irradiated in a ^^Co radiation source to receive a 0.25 Mrad dose. 
Impregnation was achieved using an Interpenetrating Network fabrica­
tion (IPN) method (Predecki, 1974). Silastic® sheets cut into strips 
(1 cm X 4 cm) were washed and weighed as described above. The materials 
were preswelled by boiling in xylene for ten minutes and then were placed 
in the monomer-crossiinker solution of interest (10-25% HEMA, 0-2% EGDM in 
a solvent of xylene with 5% ethanol) for 2 hours. The reaction was com­
pleted just below the boiling point of the resulting monomer-crossiinker 
solution which is in the range of 118-135°C. This technique was also used 
to coat 1 cm X 4 cm strips of Dacron^ fabric with hydrogel although the 
resulting network is not truly an IPN. 
^Based on chemical analysis (Appendix) this lot of stock monomer 
solutions have the following makeup: 
5% stock HEMA contains 4.81% HEMA and 0.19% EGDM by volume 
10% stock HEMA contains 9.62% HEMA and 0.38% EGDM 
20% stock HEMA contains 19.24% HEMA and 0.76% EGDM 
30% stock HEMA contains 28.86% HEMA and 1.14% EGDM 
82 
In both fabrication methods, a bulk hydrogel product was formed in 
the reaction vessel. The hydrogel coated substrates were stripped free 
mechanically from the bulk polymer. The freed substrates with residual 
hydrogel coatings were rinsed in an ethanol/water (50/50 v.%) solution (3 
rinses over 24 hours) to remove any unreacted monomer, crosslinker and 
solvent constituents. Samples for graft and HgO percent determinations 
were stored in distilled water. Samples for surgical implantation were 
stored at least 24 hours in sterile physiological saline. Prior to im­
plantation, 5 mm diameter disks of the test materials in physiological 
saline were steam autoclaved at 121°C, 15 psi for 20 minutes. 
Graft and jlgO^ percent determination 
Samples to be used for graft and water imbibition measurements were 
dried for four hours in an oven at 100°C and stored in a desiccator. The 
dry samples were weighed to determine the percent hydrogel graft acquired. 
Water imbibition was determined by blotting wet samples (stored in dis­
tilled water for at least 24 hours) between sheets of Whatman^ #1 filter 
paper with a 100 gram weight for 5 seconds and weighing the sample. Per­
cent water imbition is reported as: 
weight of water imbibed nnn% 
weight of dry hydrogel graft 
SEM techniques 
Critical point drying of nonimplanted samples involved taking the 
samples through a series of acetone rinses (30, 60, 90, 100, 100% v/v). 
and R Balston, Limited, London, England. 
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from the distilled water storage medium. Samples were critical-point 
dried in a Polaron^ model E3000 drier using liquid CO^, mounted on 
2 o 
aluminum stubs with a colloidal silver medium, sputter coated with 300 A 
gold by a Polaron Instruments SEM coating unit E5100, and observed at 5 to 
3 20 keV in a JEOL -U3 scanning electron microscope. Photomicrographs were 
4 
obtained at a scan speed of 50 seconds per frame using Polaroid type 52 
film. 
Surgical implantation 
Rabbit paravertebral muscles were used as the site of implantation 
for hydrogel composite test discs according to the method suggested by 
Coleman, King, and Andrade (1974). Surgery was performed by T. Cipriano 
(1978). Briefly summarized, the method was a sterile technique performed 
under general anesthesia: A one-centimeter incision was made approximate­
ly two centimeters from the vertebral spines in the midlumbar region over 
the right and left paravertebral muscles (iliocostalis lumborum and 
longissimus lumborum); each 5 mm disc was implanted into a pocket formed 
by blunt dissection (separating the muscle fibers longitudinally) with an 
iris scissors; the muscle sheath, fascia, and skin were closed with 000-
5 prolene sutures. Sham surgery sites did not receive an implant. The 
^Polaron Instruments Inc., Warrington, Pa. 
2 SPI Supplies, Div. of Structure Probe Inc., West Chester, Pa. 
3 Japanese Electron Optics Limited, Tokyo, Japan. 
4 Polaroid Corporation, Cambridge, Mass. 
^Ethicon Inc., Somerville, N.J. 
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rabbits were given a single post-operative intramuscular injection of 
200,000 units of Combiotic^ (a penicillin and streptomycin combination). 
Ten animals per material type were used. Six sites per animal were em-
ployed, one being a control Silastic ^  implant, one being a sham surgical 
site, and four being hydrogel'material implantation sites. 
Harvested specimen preparation 
Tissue and material samples were harvested at 10 days, 30 days, and 
2 90 days. 1 cm blocks of tissue containing the samples were excised from 
the freshly killed rabbits, fixed in buffered 10% formalin. The indi-
fR) 2 TM 
vidual specimens were embedded with Paraplast^ using an Autotechnicon 
3 
model 2A. The paraffin blocks were chilled and the samples were visually 
aligned in the microtome to achieve a perpendicular cut. Sections of 
approximately six micrometers were taken through a representative inter­
face of tissue and implant. Sections were prepared with the Gomori (1950) 
one-step trichrome stain to demonstrate collagen. Aniline blue was sub­
stituted for light green resulting in the blue staining of collagen. Sam­
ples were also stained using haemotoxylin and eosin (Luna, 1968) for cell­
ular types identification. Other sections intended for both light 
miscropscopy and ultimately scanning electron microscopy were similarly 
prepared with the exception that no cover slip was applied. Photographs 
Tpfizer, Agricultural Division, New York, N.Y. 
2 Lancer, A Brunswick Company, St. Louis, Mo. 
3 The Technicon Company, Chauncey, N.Y. 
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of sample viewings were taken through a Leitz Dialux 20 microscope 
(Rockleigh, N.J.) using Kodak™ Ektachrome® (tungsten 50) professional 
film.^ 
Histological evaluation 
Several histological features were chosen to be evaluated for each 
implant specimen. These included: the number of inflammatory cells per 
field around the implant surface; the depth of the encapsulation; the 
amount of ingrowth into the polymeric specimen; the degree of muscle de­
terioration around the implant; and the amount of fat encircling the im­
plant. Samples stained with the Gomori trichrome stain were used for the 
analysis although parallel preparations of hematoxylin and eosin stained 
samples were used as a basis for the identification of cell types. The 
parameters were quantified as follows: 
Inflammatory cell count Monocyte derived cells were counted in a 
circular area of sample equal to 20,000 square micrometers, which was bi­
sected by the interface of tissue and implant. Measurements were taken at 
four sites, two from both of the long sides of the implant. The disc 
shaped implants appear rectangular in cross section and the long sides of 
the rectangle are used as the characteristic interface. Both ends of the 
rectangle often demonstrate a higher degree of reactivity due to stress 
concentrations at that site. 
Total encapsulation response The "healing in" process of a 
foreign body reaction includes both the initial inflammatory response and 
^Eastman Kodak Company, Rochester, N.Y. 
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the subsequent collagen deposition. In the case of the paravertebral 
muscle implantation studies presented here, a course from healthy muscle 
traversing to the center of the implant would pass through a layer of de­
generating muscle, a collagenous layer whose cell population is primarily 
fibroblasts, an inflammatory cell layer and in some cases a final monocyte 
layer of cells which are of an endothelial nature. The total encapsula­
tion response is the measured distance from the outermost edge of the 
collagenous layer to the innermost cell layer, which may be at the surface 
of the implant or may have considerably penetrated the material depending 
upon its nature. Measurements were taken at four sites, two from both of 
the long sides of the implant. 
Collagenous portion of capsule As described above, the collage­
nous layer has primarily fibroblasts as its cellular elements and repre­
sents a connective tissue layer. This layer stains light blue in the 
Gomori preparation and is usually distinguishable from the inner inflamma­
tory layer in that the latter stains dark blue. The collagen is often 
more diffuse than in normal granulomatous reactions (Rosen et al., 1976). 
When viewed with a polarizing microscope, the collagen is only slightly 
refractile, suggesting imaturity or incomplete organization. The layer 
is measured at the same four sites as the total encapsulation response. 
Amount of ingrowth The penetration of tissue, measured from the 
outer edge of the polymer to the innermost layer of cellular activity, was 
recorded for four sites, two from both of the long sides of the implant. 
Muscle cell deterioration A zone of muscle surrounding the im­
plant often demonstrated an increase in the number of centralized nuclei. 
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a proliferation of interfascicular connective tissue, and swelling or 
waviness of muscle fascicles. These properties are often indicative of 
localized trauma. The condition of surrounding muscle was graded accord­
ing to the following scale. 
1. Deterioration extends completely around the implant to a distance 
greater than 750 micrometers. 
2. Deterioration distance is less than 750 micrometers, but greater 
than 250 micrometers for a representative amount of sample. 
3. Deterioration does not exceed 250 micrometers, but more than half 
the sample is surrounded. 
4. Less than half the sample is surrounded by less than 250 microm­
eters of deterioration. 
Amount of fat A layer of fat cells filled with lipid material was 
often observed peripheral to the collagenous portion of the capsule. This 
was graded and reported in the following manner: 
1. No fat cell layers. 
2. Fat cells on one or both ends of implant. 
3. Fat cells on any three sides. 
4. Fat cells completely surrounding the capsule. 
SEM techniques on harvested samples 
Samples observed in the SEM were parallel sections obtained from the 
histological preparation. Specimens were mounted on glass slides without 
the application of a covers!ip. Since these samples undergo air drying 
some shrinkage does occur before they are coated for SEM observation. 
These samples were adhered to aluminum stubs with colloidal silver. 
sputter coated with 300 A of gold, and observed at 5-20 keV in a JE0L-U3 
SEM. The priorities of this work were first to determine the general 
level of biocompatibility and secondly, to assess the range of responses 
for both the degree of encapsulation and amount of ingrowth. In this 
context, the qualitative nature of the SEM investigation was sufficient to 
demonstrate the nature of the collagenous portion of the capsule and the 
morphology of the polymeric surfaces. 
Results 
Sample fabrication and histological evaluation data are presented in 
Table XIII. The following discussion emphasizes observations first for 
fabrication considerations (controls, chemical grafted and radiation 
grafted) and then for tissue response characteristics. 
Silicone rubber materials 
Uncoated silicone rubber discs were used as the control. Like all 
the hydrogel coated silicone rubber substrates, it had the smallest amount 
of collagen in its capsule at 90 days (the thickness of the collagenous 
portion of the capsule is plotted against days of implantation in Figure 
11). This general pattern in collagen over 90 days implantation was seen 
for all materials listed in Table XIII. Several samples had a 30-day 
value that was higher than either the 10-day or the 90-day value. 
The basic character of the silicone rubber substrate as observed in 
the SEM was not found to change with the application of hydrogel with the 
IPN fabrication procedure (Greer et al., 1978). Similarly, the inclusion 
of n-vinyl pyrrolidone with hydroxyethyl methacrylate in the radiation 
Table XIII. Sample fabrication and histological evaluation data (Greer et al., 1979) 
Inflam-
Collagen Capsule Ingrowth matory 
Sample Days im- thickness thickness thickness cell Fat Muscle 
fabrication Graft Water planted ym ym ym count score score 
Silastic® mm aw mm 10 36±4 59+12 0+0 28+5 1 2 
control 30 8±2 14±3 0+0 8+5 2 2 
90 5±1 8±2 0±0 7+2 3 4 
Si 1asfi 8% 40% 10 14±3 19±6 0+0 14+7 1 3 o 1 1  o u 1V ) 
OM UPMA 30 38±13 44+13 0+0 8+2 1 1 A) ntnMj 
1.5% EGDM, IPN 90 5±1 7±2 0+0 3 ±2 3 4 
Silastic® 11% 38% 10 28±15 39±15 0±0 24±10 1 3 
10% HEMA, 30 17±15 24±15 0±0 15±3 2 3 
0% EGDM, IPN 90 7+4 17±3 0±0 17+9 3 3 
Silastic*? 2% 44% 10 17±3 25+5 0+0 20+10 1 2 
10% HEMA, 10% NVP 30 13±0 17±3 0±0 11 ±4 2 2 
Radiation 90 8+3 17±4 0±0 8+2 - -
Silastic*? 3% 30% 10 14+8 22+8 0+0 10±6 1 3 
20% HEMA, 1.5% EGDM 30 30+17 61 ±22 0+0 2±1 2 3 
Radiation 90 9±4 13±0 0±0 3 ±2 2 4 
Silastic*? 2% 35% 10 63+33 78±45 0±0 34±14 1 2 
20% HEMA, 2.0% EGDM 30 27±28 53±21 0±0 31 ±13 2 2 
Radiation 90 11+6 22+6 0±0 17±10 4 3 
Silastic*? 4% 45% 10 48±26 66±18 0±0 27±16 1 3 
15% HEMA, 5.0% NVP 30 86+52 103+39 0±0 26±18 2 2 
Radiation 90 20±13 23±16 0±0 13±9 2 3 
Table XIII. (Continued) 
Inflam-
Collagen Capsule Ingrowth niatory 
Sample Days im- thickness thickness thickness cell Fat Muscle 
fabrication Graft Water planted ym pm ym count score score 
Bulk, — — — — 10 23+6 234+94 47±21 30+9 1 1 
20% HEMA, 
o
 
CV
J 
EGDM 30 13+7 44+22 20+9 19±9 1 2 
Radiation 90 8+3 66+25 38+9 71 ±17 2 2 
Dacron® 163% 201% 10 32+9 220+94 163±83 46+13 1 2 
20% HEMA, 1.5% EGDM 30 13+5 119±47 91 ±45 37±10 2 3 
Radiation 90 13±7 175+79 125+61 71+12 3 2 
Bulk, 10 55±29 106+65 23±26 43+15 1 1 
20% HEMA, 1.5% EGDM 30 16±12 42±13 35±16 15±6 2 4 
Radiation 90 34±12 48±13 42±34 24+12 3 2 
Dacron® 128% 152% 10 75+76 750±228 700±191 54+23 1 2 
20% HEMA 30 25+9 688±125 606+108 67±7 1 2 
1.5% EGDM , IPN 90 18±6 644+105 631±83 56±7 2 3 
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Figure 11. Thickness of collagen capsule surrounding a noncoated silicone 
rubber specimen. 
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technique produces a surface penetration effect and the basic microstruc­
ture was left intact (Ratner and Hoffman, 1975). An example of these 
material types where fabrication did not greatly alter the surface texture 
is the silicone rubber substrate impregnated with 20% HEMA and 1.5% EGDM 
by the IPN technique. Figure 12 is a low power light micrograph of the 
implant at 30 days showing the increased collagen deposition and tissue 
reactivity at the ends of the implant compared to that at the sides due to 
mechanical stress variations. The layers of collagen and inflammatory 
cells forming the capsule can be seen in Figure 13. A densification of 
the capsule may account for the decreased thickness commonly measured at 
90 days. Figure 14 shows the capsule around a 20% HEMA, 1.5% EGDM, IPN 
silicone rubber sample at 30 days. At 90 days, shown in Figure 15, the 
capsule is of a denser arrangement. The organization of a high density 
capsule for a 10% HEMA, 10% NVP, radiation-grafted silicone rubber sample 
at 90 days is shown in Figure 16 (tissue face which was in apposition with 
the polymer). 
The radiation treatment without n-vinyl-2-pyrrolidone results in a 
coating of the substrate as shown in Figure 17 for 20% HEMA, 1.5% EGDM 
radiation grafted onto silicone rubber which has a different general sur­
face character. The resultant capsule in Figure 18 is typical of low 
density collagen organization features seen for 10-day specimens. 
Bulk hydrogel materials 
Figure 19 shows the condition of the bulk porous hydrogel material 
prior to implantation. An open three-dimensional network (interstices on 
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Figure 12. Light micrograph of 20% HEMA, 1.5% EGDM IPN in silicone rubber 
sample at 30 days (scale bar = 1 mm). Lower left represents 
increased encapsulation due to mechanical stress (arrows). 
94 
Figure 13. Light micrograph of 20% HEMA, 1.5% E6DM IPN in silicone rubber 
sample at 30 days (scale bar = 100 ym). A is implant, B is 
inflammatory cell layer, C is collagen layer, and tissue is D. 
Figure 14. Scanning electron micrograph of 20% HEMA, 1.5% EGDM IPN in 
silicone rubber sample at 30 days (scale bar = 5 ym). Face A 
was in contact with implant surface. 10 keV. 40° tilt. 
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Figure 15. Scanning electron micrograph of 20% HEMA, 1.5% EGDM INP sili­
cone rubber sample at 90 days (scale bar = 2 ym). Face A was 
in contact with implant surface. 15 keV. 20° tilt. 
Figure 16. Scanning electron micrograph of 10% HEMA, 10% NVP, silicone 
rubber radiation grafted sample at 90 days (scale bar = 1 ym). 
15 keV. 20° tilt. 
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Figure 17. Scanning electron micrograph of 20% HEMA, 1.5% EGDM, radiation 
grafted on silicone rubber sample before implantation (scale 
bar =10 ym). 10 keV. 0° tilt. 
Figure 18. Scanning electron micrograph of capsule around 20% HEMA, 1.5% 
EGDM, radiation grafted onto silicone rubber at 10 days im­
plantation (scale bar = 5 yni). The implant was in contact 
with upper surface (arrow); tissue side view. 10 keV. 30° 
tilt. 
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the order of 5 micrometers and less in diameter) is present within the 
polymer. This sample was fabricated with 20% HEMA and 1.5% EGDM using the 
radiation polymerization technique. The nature of tissue ingrowth and 
encapsulation is presented in the SEM micrograph. Figure 20. This view of 
a 30-day implant shows the bulk hydrogel-collagen interface in cross sec­
tion. The bulk hydrogel comprises the left half of the image, and the 
dense, organized collagen capsule is to the right. Figure 21 demonstrates 
that at 30 days the collagen capsule becomes more organized than at 10 
days for the samples studied. The attachment of the collagen at the 
interface showed some ingrowth into the bulk polymer (~30-40 ym penetra­
tion). This fact is shown by the trends indicated on the graph in Figure 
22 (data in Table XIII). 
Hydrogel coated polyethylene terephthalate 
The hydrogel resulting from the radiation polymerization of 20% HEMA, 
1.5% EGDM within the Dacron ^ velour is shown in Figure 23. The openings 
(R) 
among Dacron ^ fibers have been packed by hydrogel deposited during the 
polymerization. The nature of the encapsulating tissue at 30 days im­
plantation period is shown in Figure 24. The field of view shows the 
hydrogel packed within the Dacron® fiber network (top two-thirds of 
photograph). In this cross section, the Dacron® fibers (~15 ym in 
diameter) are seen as short cylinders. The collagen capsule (-30 ym 
thick) and muscle tissue are located in the lower third of the photograph. 
The thickness of the collagen layer remained fairly constant after 10 days 
of implantation (-13 ym). The amount of ingrowth is graphed in Figure 25 
for the three harvesting times. A substantial amount of ingrowth appears 
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Figure 19. Scanning electron micrograph of bulk hydrogel polymer composed 
of 20% HEMA, 1.5% EGDM—radiation initiated polymerization 
(scale bar = 10 ym). 10 keV. 10° tilt. 
Figure 20. Scanning electron micrograph of capsule around bulk polymer 
composed of 20% HEMA, 1.5% EGDM—radiation initiated poly­
merization (scale bar = 10 ym). Arrow indicates the interface 
between bulk hydrogel and collagen. 10 keV. 10° tilt. 
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Figure 21. Collagen thickness of 20% HEMA, 1.5% EGDM radiation initiated 
polymerization bulk hydrogel sample. 
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Figure 22. Extent of tissue ingrowth of a 20% HEMA, 1.5% EGDM radiation 
initiated polymerization bulk hydrogel sample. 
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Figure 23. Scanning electron micrograph of 20% HEMA, 1.5% EGDM—radiation 
initiated polymerization into the Dacron (B) velour network be­
fore implantation (scale bar = 50 ym). 10 keV. 30° tilt. 
Figure 24. Scanning electron micrograph of 20% HEMA, 1.5% EGDM—radiation 
initiated polymerization into the Dacron®velour network at 
30 days implantation (scale bar = 50 ym)^ Example features 
shown as : A = Dacrorff B = hydrogel, C = coll agen, and D = 
tissue. 5 keV. 40° tilt. 
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Figure 25. Amount of tissue ingrowth into a 20% HEMA, 1.5% E6DM radiation 
initiated polymerization of hydrogel within a Dacron® fabric 
matrix. 
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over the 90 days of implantation. The inflammatory cell count at the 
three harvesting times is graphed in Figure 26. The cell count increase 
at 90 days is probably due to fragmentation of the hydrogel that fills the 
(R) Dacron network. 
CR) The IPN hydrogel-Dacron composite has considerable ingrowth at 10 
days (-700 pm) that was maintained in thickness through the 90-day im­
plantation period (data graphed in Figure 27). Figure 28 shows the nature 
of the infiltrating tissue around Dacron^ fibers. Tissue penetrates 
into the hydrogel and small areas of hydrogel are encapsulated. The in­
flammatory cell count is higher for these samples compared with the radia-
(ÏÏ) tion initiated polymerization of hydrogel within the Dacron ^  fabric 
matrix. The IPN hydrogel system was found to be more porous than the 
radiation grafted samples and therefore may account for the rapid occur­
rence of tissue ingrowth. The IPN hydrogel was more susceptible to frag­
mentation and thus a high inflammatory cell count was observed to be con­
tinuous through the 90-day implant period. 
Conclusions 
While many approaches have been used in the attempt to define the 
soft tissue response to hydrogel implants (refer to literature review of 
soft tissue compatibility), the resultant data from those studies have not 
conclusively demonstrated the roles of specific parameters such as water 
content and porosity. Barvic et al. (1967) defined three categories of 
tissue response dependent on porosity (which was a function of water con­
tent of the starting material). Sprincl et al. (1971) found that higher 
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Figure 26. Inflammatory cell population for implantation of 20% HEMA, 
1.5% EG^ radiation initiated polymerization of hydrogel into 
Dacron® velour. 
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Figure 27. Amount of tissue ingrowth into a 20% HEMA, 1.5% EGDM IPN 
hydrogel on Dacron® fabric. 
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Figure 28. Scannina electron micrograph of 20% HEMA, 1.5% EGDM, IPN in 
Dacron® velour sample at 30 days (scal^ar =10 ym). 
Features are designated as: A = Dacron®, B = hydrogel frag­
ment, and C = collagen. 10 keV. 30° tilt. 
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porosity hydrogels produced narrower capsules around the implant. 
Gilding et al. (1978) report no ingrowth for samples with less than 90% 
water in the final gel. 
In an attempt to investigate the range of responses of soft tissue to 
hydrogel implants, we have used a protocol (Coleman et al., 1974) which 
satisfactorily demonstrated a range of degrees of encapsulation and in­
growth as shown in Table XIII. The in vivo response to these implanted 
materials was used to determine the extent of possible chemical interac­
tions between host and implant as a result of possible cytotoxic moieties 
released to contiguous tissue. The study confirmed that no chronic in­
flammation or acute cytotoxic activity results over the implantation 
period that would exclude these materials from further research for bio­
medical applications. Implant stability (mechanical integrity and healing 
properties) were determined to depend on substrate, hydrogel composition 
and polymerization methods. 
The silicone rubber hydrogel composite materials were surrounded by a 
thin, dense encapsulating membrane of collagen with little suggestion of 
tissue ingrowth. The cellular reaction to the Dacron ® composite materi­
als suggests that fibroblasts, macrophages, and small blood vessels can 
advance into the Dacron^-hydrogel matrix due to the filamentous nature 
of the Dacron ^ velour, the relative hydrogel porosity of 5 to 35 ym, and 
low mechanical strength of the hydrogel filling the Dacron® interstices. 
In studies of both subcutaneous and intramuscular implants in rab-
bits, noncoated Dacron^ materials have been observed to elicit a dense 
fibrous capsule and some chronic inflammation (Lee and Neville, 1971). 
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Davila and coworkers (1968) have found that Dacron^ felt implants (13 
1/2 months old) show a loosely fibrous (collagen) organization of a cap-
(G) 
sule around each Dacron ^  fiber. A few nuclei of fibroblasts are seen in 
close proximity to the Dacron ^ fibers. Arterioles, venules and capil­
laries invaded the interstices of the felt. Arterioles no larger than the 
plastic fibers are abundant. These arterioles are found close to clumps 
of fibroblasts which form and maintain the collagenous framework in which 
the Dacron ^  is enmeshed. 
In a similar fashion, the encapsulating tissue of the hydrogel-
Dacron^ composite materials was found to be a loosely fibrous organiza-
tion with fibroblasts surrounding both Dacron^ fibers and small areas of 
hydrogel. The depth of fibroblast and collagen penetration was found to 
depend on formulation and grafting technique. The IPN chemical grafted 
hydrogel-Dacron composite had considerable ingrowth at 10 days (-700 
ym) compared with the radiation grafted material which had tissue ingrowth 
of approximately 120 ym. The IPN system was more macroporous and more 
susceptible to fragmentation of the hydrogel than the radiation grafted 
system. This may account for the significant ingrowth and for the in­
crease in inflammatory cell count. Some vascularization of 90-day im­
plants was noted especially in the hydrogel-Dacron®composite materials 
prepared by the IPN method. Evidence of small vessels at 10 days within 
this fibrous capsule layer was found. No serous exudate nor calcification 
was evident in any of the implant materials of this study. 
The time period and nature of the healing process that occurs after 
implantation of specific polymer materials can be affected by the choice 
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of material substrate and hydrogel formulation. Results of implant 
studies over a 90-day period for silicone rubber and polyethylene 
terephthalate coated or impregnated with hydrogel suggest that several 
major parameters (i.e., porosity, strength, chemical makeup of the hydro­
gel) can be varied to meet specific site and design requirements. These 
parameters may be controlled according to fabrication conditions. 
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PART III. IDENTIFICATION OF A METHOD TO CONTROL P-HEMA MORPHOLOGY 
Introduction 
The control of polymer morphology for biomedical applications is dis­
cussed in detailed reference to the tailor-making polyhydroxyethyl 
methacrylate gel coatings on polyethylene terephthalate fabric for poten­
tial prostheses, a case in which control of morphology is necessary on a 
microstructural level. A two-step approach was taken to identify a con­
trol method of P-HEMA morphology on a colloidal level. The first step was 
the preparation of bulk hydrogel samples using a range of cosolvent ratios 
holding other fabrication parameters constant. The microstructural detail 
of each fabrication was identified by scanning electron microscopy tech­
niques. The second step was the application of hydrogels having con­
trolled microstructures to fabric substrates. Radiation initiated poly­
merization of hydroxyethyl methacrylate was used to coat polyethylene 
terephthalate fibers and fill the interstices of the fabric. Particular 
emphasis was placed on determining if variations in formulations (i.e., 
proportion of nonsolvent for the polymer in the cosolvent system) would 
result with differences in two important physical properties, porosity and 
fluid imbition. The tabulation of these data ultimately aided in design 
consideration for an application of hydrogels to cardiovascular pros­
thetics. 
ni 
Materials and Methods 
Bulk hydroqel samples 
Monomer solution of 2-hydroxyethyl methacrylate (lot no. B763E8) was 
obtained from Alcolac Inc., Baltimore, Maryland. The HEMA obtained from 
Alcolac was found to be more pure than the HEMA supplied by Haven Chemi­
cal. Crosslinking agent solution of ethylene glycol dimethacrylate (lot 
no. 53-94) was supplied by Haven Chemical Co., Philadelphia, Pennsylvania. 
All other chemicals were of reagent quality. Glass distilled water was 
CR) 
used for all solution mixtures. Pyrex ^ glass culture tubes of dimen­
sions 12 cm long by 1.5 cm wide were used. Irradiation from a cobalt 60 
source initiated polymerization of the HEMA mixtures. 
Two types of cosolvents, methanol with distilled water and ethanol 
with distilled water, were used in a range of 20 to 80% by volume ratios. 
The volume percent of the monomer, hydroxyethyl methacrylate was 20% and 
that of the crosslinker, ethylene glycol dimethacrylate was 3%. A radia­
tion dose of 0.25 Mrad was used to initiate polymerization within the 
Pyrex® culture tube. The bulk polymerized hydrogel was removed from the 
reaction vessel and stored 24 hours in a 50% ethanol:50% distilled water 
mixture to remove unreacted constituents. 
The resulting bulk polymers were observed grossly and ranked on a 
scale defining three degrees of visual properties: transparent, trans­
lucent and opaque. These properties are dependent upon the hydrogel 
materials' ability to scatter light due to potential inhomogeneities 
(i.e., macropores filled with fluid) within the polymer. 
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Scanning electron microscopy techniques were utilized to identify the 
surface morphology of the bulk polymer samples. 5mmx5mmx2mm speci­
mens were cut from the bulk samples using a number 11 scalpel^ blade. 
From the 50% ethanol:50% water storage medium, the samples were taken 
through a series of acetone/distilled water rinses (30, 60, 90, 100, 
2 100%, v/v). Samples were critical point dried in a Polaron model E3000 
drier using COg and mounted on carbon stubs with a colloidal silver 
O 
medium. A Polaron Instruments SEN coating unit E 5100 was used to 
O 
sputter coat 300 A gold. The samples were observed at 5-15 keV using a 
JE0L^-U3 scanning electron microscope. To obtain permanent records for 
sample reviewing, photographs were taken using Polaroid^ type 52 film. 
Hydroqel coatings on polyethylene terephthalate 
Polyethylene terephthalate fabric (USCI DeBakej^double velour. Cat. 
No. 007826, Lot No. 620100) was cut into strips 1 centimeter by 4 centi­
meters and such strips were cleaned ultrasonically (5 minute wash followed 
(R) by 3 distilled water rinses) with a nonoily soap solution (Ivory ^  
flakes). Specimens were dried in an oven at 100°C, allowed to cool to 
room temperature, weighed and stored individually in labeled clean glass 
vials. 
^Bard-Parker, Division of Becton, Dickinson and Company, Rutherford, 
New Jersey. 
2 Polaron Instruments, Inc., Warrington, Pennsylvania. 
3 Ted Pella Company, Tustin, California. 
^Japanese Electron Optics, Limited, Tokyo, Japan. 
5 Polaroid Corporation, Cambridge, Massachusetts. 
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2-hydroxyethyl methacrylate monomer solution (Alcolac, Inc., Lot No. 
B171K7) and crosslinking agent, ethylene glycol dimethacrylate (Haven 
Chemical Co. Lot No. 53-94) were used to prepare the following concentra­
tions of monomer-crosslinker solutions: 20% HEMA monomer with 1, 2 and 
3% EGDM crosslinker (percent volume basis). A cosolvent mixture consist­
ing either of 50% methanol/50% distilled water or 25% methanol/75% dis­
tilled water (percent volume basis) was added to the monomer-crosslinker 
solution to bring the total volume to 100%. The monomer-solvent system 
was degassed by bubbling Ng through the liquid for 20 minutes. Each sub­
strate sample was suspended in a Pyrex®culture tube to which the final 
polymerizable solution of interest was added. The tubes were irradiated 
in a ®^Co radiation source to achieve a radiation dose of either 0.1 Mrad 
or 0.25 Mrad. 
Following polymerization, each sample was removed from the reaction 
vessel, excess polymer carefully peeled from the substrate, and placed in 
a rinse solution (50% ethanol:50% water v/v) for twelve hours to remove 
unreacted monomer-crosslinker constituents. For 24 hours the samples were 
placed in distilled water (3 rinses). The amount of water imbibed by the 
grafted samples was determined by blotting the wet samples between sheets 
of Whatman #1 filter paper with a 100 gram weight for 5 seconds and 
weighing the sample (three weighings per samples). Thereafter, each was 
dried either by critical point drying (samples for the SEM) or by oven 
drying at 100°C for 4 hours. Each sample was weighed three times to de­
termine the percent hydrogel graft acquired by the substrate material. 
Finally, SEM studies were undertaken to determine microstructural differ­
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ences due to changes in formulations and amount of irradiation used to 
initiate the polymerization process. The resulting data are reported in 
Table XIV. Four substrate strips per formulation with three weighings at 
each determination were used to obtain these data. 
Results 
Buik hydrogel samples 
Poly (HEMA) is not soluble in water (Yasuda et al., 1966), and 
accordingly, when more than 40% water is used in the polymerization mix­
ture, hydrogels become translucent to opaque, indicating that precipita­
tion of the polymer occurs at higher concentrations of water (refer to 
Figure 29). These particles of the polymer appear early in the polymeri­
zation process and act as nucleation sites for further polymerization. A 
schematic diagram of hydrogel polymerization in a poor solvent medium for 
the resulting polymer is shown in Figure 30. 
Scanning electron micrographs of samples prepared within the range of 
54 to 58% distilled water in the monomeric cosolvent mixture identified a 
superstructure of beaded polymer with Feret (Fischmeister, 1968) 
diameters^ in the range of 1-3 ym. The Feret diameter distance between 
the interstices of the superstructure polymer network was 1-30 ym. The 
reader is referred to Figures 31 and 32a. Within the polymeric super­
structure there was identified a finely divided substructure polymer 
^The average Feret diameter is equal to the diameter of a circle with 
the same circumference as the average figure observed on a line scan 
basis. 
Table XIV. Polyhydroxyethyl methacrylate coatings on polyethylene terephthalate fabric 
Imbibed Macrovoid Microvoid 
Formulation (volume percent) % graft % HgO size size Polymer bead size 
20% HEMA 19% methanol 
3.0% EGDM 58% Hgg 
0.25 Mrad 
(25% methanol/75% HgO cosolvent) 
20% HEMA 19% methanol 
2.0% EGDM 58.5% H,0 
0.25 Mrad 
(25% methanol/75% HgO cosolvent) 
10% HEMA 43.5% methanol 
3% EGDM 43.5% H2O 
0.25 Mrad 
(50% methanol/50% HgO cosolvent) 
10% HEMA 43.5% methanol 
3.0% EGDM 43.5% H9O 
0.1 Mrad 
(50% methanol/50% HgO cosolvent) 
20% HEMA 38.5% methanol 
3.0% EGDM 38.5% H,0 
0.25 Mrad 
(50% methanol/50% HgO cosolvent) 
20% HEMA 39% methanol 
2.0% EGDM 39% H,0 
0.25 Mrad ^ 
(50% methanol/50% HgO cosolvent) 
157 200 20-50 ym 
150 200 20-40 um 
93 270 15-70 ym 
52 315 20-30 ym 
162 155 smooth 
161 145 smooth 
5-10 ym mostly 1-2 ym; 
some 5 ym 
5-15 ym 2-3 ym 
5-10 ym 3-4 ym z! 
cn 
5-10 ym flakes; <1 ym 
centers 
<1 ym beads 1-2 ym 
<1 ym <1 ym 
Table XIV. (Continued) 
Imbibed Macrovoid Microvoid 
Formulation (volume percent) % graft % HgO size size Polymer bead size 
20% HEMA 39.5% methanol 160 
1.0% EGDM 39.5% H,0 
0.25 Mrad 
(50% methanol/50% HgO cosolvent) 
10% HEMA 44% methanol 89 
2.0% EGDM 44% H,0 
0.25 Mrad 
(50% methanol/50% HgO cosolvent) 
10% HEMA 44.5% methanol 95 
1.0% EGDM 44.5% H,0 
0.25 Mrad 
(50% methanol/50% HgO cosolvent) 
120 smooth <0.8 ym <0.1 ym 
241 smooth 0.1-0.4 ym 0.1 ym 
211 smooth <0.1 ym <0.1 ym 
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Figure 29. Transparency of HEMA hydrogels in HEMA-HpO-ethylene glycol 
system: (O) transparent gels; (•) translucent gels; (•) 
opaque gels (Yasuda et al., 1966). 
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Figure 30. Schematic diagram of hydrogel polymerization in a poor solvent 
medium for the resulting polymer. The three frames show the 
time course of the polymerization process. Frame 1 depicts 
the nucleation. Frame 2 the precipitation, Frame 3 the re­
sulting hydrogel. 
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Figure 31. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of composition 20% HEMA, 3% EGDM, 
23% methanol, 54% distilled water (volume percent). Scale 
bar = 10 ym. 15 keV. 
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Figure 32a. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% E6DM, 19% methanol, 
58% distilled water (volume percent). Polymer beads can be 
distinguished by the arrows. Scale bar = 10 ym. 15 keV. 
Figure 32b. Scanning electron micrograph of a hydrogel of composition 20% 
HEMA, 3% EGDM, 19% methanol, 58% distilled water (volume per­
cent). The fine microstructure of the substructure is indi­
cated by an arrow. Polymeric beads are identified by a B. 
Scale bar = 1 ym. 
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network filling much of the interstices of the superstructure. Figure 32b 
indicates that this substructure network has microvoids of the order 0.3 
to 0.8 ym in diameter with polymeric interstices of diameter less than 0.1 
ym. 
Increasing the amount of water in the monomer cosolvent mixture re­
sulted in a hydrogel formed primarily of polymeric aggregates of bead 
diameter 0.8 to 1.5 ym (refer to Figure 33). A fine substructure of 
polymer was not evident. The distances between polymeric aggregates was 
measured to be in the range of 10 to 30 ym. These formulations having 
greater than 43% HgO in the monomeric system demonstrated opaque visual 
properties. These light scattering effects are due to the presence of 
microvoids within the polymeric network. The SEN verification demon­
strated microvoids of diameter 0.1 ym and greater. 
For the monomer-methanol water cosolvent systems with a volume per­
cent of water 50% and less, the polymerization system did not separate 
into two interdispersed phases prior to gellation so a dense, uniform 
hydrogel resulted. Figure 34 is a schematic diagram demonstrating this 
process. As the concentration of distilled water in the cosolvent system 
decreased over the range 50 to 15% water by volume, the polymer bead size 
decreased from 1 ym to 0.1 ym and less (refer to Figures 35a and 35b). 
The polymeric beads became uniformly distributed and the spacing between 
the beads varied from 0.3 ym to less than 0.1 ym at the lowest water con­
centration in the cosolvent mixture. 
The ethanolidistilled water system followed similar trends as that of 
the methanolidistilled water cosolvent system. The visual transition 
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Figure 33. Scanning electron micrograph of a hydrogel prepared from a 
monomer-cosolvent mixture of composition 20% HEMA, 3% EGDM, 
15% methanol and 62% distilled water (volume percent). Scale 
bar = 5 ym. 15 keV. 
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Figure 34. Schematic diagram of hydrogel polymerization in a good solvent 
medium for the resulting polymer. The three frames show the 
time course of the polymerization process with the resulting 
dense, uniform hydrogel depicted by Frame 3. 
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Figure 35a. Scanning electron micrograph of a hydrogel prepared from a 
monomer-cosolvent mixture of composition 20% HEMA, 3% EGDM, 
37% methanol and 40% distilled water (volume percent). 
Scale bar = 5 ym. 15 keV. 
Figure 35b. A higher magnification view of Figure 35a. Scale bar = 1 ym. 
15 keV. 
125 
between the translucent and the opaque resulting gels was observed to 
occur between 50 and 54 percent by volume water in the total monomer 
crosslinker-cosolvent composition. Examination by SEM techniques showed 
that bulk hydrogel systems resulting from monomeric systems with water 
concentrations of 50% by volume or less, to be homogeneous with polymeric 
bead size of 0.1 to 0.3 ym and with microvoids between the polymeric beads 
of less than 0.1 vim (Figures 36 and 37). Raising the concentration of 
distilled water in the monomeric mixture to the range of 54 to 66% caused 
the polymeric bead size to increase from 0.3 ym to 2 ym in diameter. Re­
fer to Figures 38 through 41. This heterogeneous type of hydrogel had a 
microstructural appearance similar to that of the methanol cosolvent 
system with increased water content. Figures 41b and 42 compare the re­
sulting microstructure of the hydrogels using the two types of cosolvents. 
Hydrogel coatings on polyethylene terephthalate fabric 
While analyzing the results of heterogeneous hydrogel coatings repre­
sented by the first four entries of Table XIV, it was apparent that with 
high concentrations of distilled water in the cosolvent medium and HEMA 
monomer formulations of 20% (the volume percent of water in the polymeri­
zation mixture was well above 45%), fairly uniform macrovoids of 20 to 40 
micrometers were found with polymeric beads of the size 1 to 2 micro­
meters. Some polymeric beads formed aggregates on the order of 5 to 8 
micrometers. The microvoids between such beads were generally of the 
order of 5 to 10 micrometers. The reader is referred to Figures 43 through 
46. 
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Figure 36. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 58% ethanol 
and 19% distilled water (volume percent). Scale bar = 5 ym. 
15 keV. 
Figure 37. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 27% ethanol 
and 50% distilled water (volume percent). Scale bar = 5 pm. 
15 keV. 
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Figure 38. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 23% ethanol 
and 54% distilled water (volume percent). Scale bar = 5 ym. 
15 keV. 
Figure 39. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 19% ethanol 
and 58% distilled water (volume percent). Scale bar = 5 ym. 
15 keV. 
128 
Figure 40a. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 15% ethanol, 
62% distilled water (volume percent). Scale bar = 10 ym. 
15 keV. 
Figure 40b. A higher magnification view of Figure 40a. Scale bar = 5 ym. 
15 keV. 
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Figure 41a. Scanning electron micrograph of a hydrogel prepared from a 
monomer cosolvent mixture of 20% HEMA, 3% EGDM, 12% ethanol 
and 65% distilled water (volume percent). Scale bar = 5 ym. 
15 keV. 
Figure 41b. A higher magnification view of Figure 41a. Scale bar = 1 ym. 
15 keV. 
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and 54% distilled water (volume percent). Scale bar = 1 ym. 
15 keV. 
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Figure 43a. Polyethylene terephthalate fibers coated with a P-HEMA formu­
lation of 20% HEMA, 3% EGDM, 19% methanol, and 58% distilled 
water (on a volume percent basis), with 0.25 Mrad irradia­
tion. Scale bar = 10 ym. 15 keV. 
Figure 43b. Another area demonstrating polyethylene terephthalate fibers 
(arrows) coated with a P-HEMA formulation of 20% HEMA, 3% 
EGDM, 19% methanol, and 58% distilled water. Scale bar = 
10 ym. 15 keV. 
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Figure 43c. Higher magnification of a polyethylene terephthalate fiber 
coated with P-HEMA formulation of 20% HEMA, 3% EGDM, 19% 
methanol, and 58% distilled water with 0.25 Mrad irradiation. 
Scale bar = 5 ym. 15 keV. 
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Figure 44a. P-HEMA formulation of 20% HEMA, 2% EGDM, 19.5% methanol, and 
58.5% distilled water using 0.25 Mrad irradiation. Poly­
ethylene terephthalate fibers are indicated by arrows. Scale 
bar = 100 ym. 15 keV. 
Figure 44b. Higher magnification of Figure 44a showing a polyethylene 
terephthalate fiber coated with P-HEMA hydrogel. Scale bar 
= 10 ym. 15 keV. 
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Figure 45a. Polyethylene terephthalate fabric coated with a P-HEMA formu­
lation of 10% HEMA, 3% EGDM, 43.5% methanol, and 43.5% dis­
tilled water with 0.25 Mrad irradiation. Scale bar = 10 ym. 
15 keV. 
Figure 45b. Higher magnification of Figure 45a showing the polyethylene 
terephthalate fiber (A) coated with the hydrogel polymeric 
beads. Scale bar = 5 ym. 15 keV. 
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Figure 45c. High magnification view of the hydrogel of formulation 10% 
HEMA, 3% E6DM, 43.5% methanol, and 43.5% distilled water with 
0.25 Mrad irradiation which filled the interstices of the 
fabric network. Scale bar = S wm. 15 keV. 
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Figure 46a. Polyethylene terephthalate velour fabric coated with hydrogel 
of formulation of 10% HEMA, 3% EGDM, 43.5% methanol, 43.5% 
distilled water using 0.1 Mrad irradiation. Scale bar = 
100 pm. 15 keV. 
Figure 46b. Higher magnification of Figure 46a demonstrating the hydrogel 
coating the polyethylene terephthalate fiber (A). Scale bar 
= 10 ym. 15 keV. 
137 
Figure 46c. High magnification view of Figure 46b showing hydrogel coat­
ing the polyethylene terephthalate fiber. Scale bar = 5 ym. 
15 keV. 
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Changing the concentration (from 2 to 3%) of the cross!inker EGDM in 
the 20% HEMA monomer formulations with a high concentration of water in 
the cosolvent mixture did little to change the properties of the resulting 
gel, as demonstrated by the first two entries of Table XIV and comparison 
of the micrographs (Figures 43a and 44b). However, there was a marked 
influence of the cross!inking agent with concentrations of the HEMA 
monomer at 10% in a cosolvent medium having a low concentration of dis­
tilled water. Formulations with EGDM concentrations below 3%, a trans­
parent smooth hydrogel was formed with polymeric bead sizes on the order 
of 0.1 micrometers (Figures 50a and 50b), whereas at 3% EGDM in the 10% 
HEMA monomer mixture, low concentration of water in the cosolvent medium, 
the rough heterogeneous hydrogel was formed with a bead size of the order 
of 3 to 4 micrometers (Figure 45). Using a radiation dose of 0.1 Mrad 
resulted in a heterogeneous structured hydrogel with a "flaky" appearance 
(Figure 46) when compared to the previous gels which appeared beaded. 
These "flaky" hydrogels were also measured to have the greatest amount of 
imbibed water. 
With regard to the homogeneous gel coatings on the velour fabric sub­
strates, smooth hydrogel coatings were formed with formulations of 20% 
HEMA, 1 to 3% EGDM, in a cosolvent that results with the total concentra­
tion of water less than 40% (Figures 47 through 49). No significant dif­
ferences were observed with changes in cross-linking agent concentration. 
Bead sizes were uniformly less than 1 micrometer and spaces between the 
beads were less than 0.8 micrometers. 
139 
Figure 47a. Hydrogel formulation of 20% HEMA, 3% EGDM, 38.5% methanol, 
38.5% distilled water using 0.25 Mrad of irradiation. Scale 
bar = 10 ym. 15 keV. 
Figure 47b. Higher magnification of 
texture of the hydrogel 
network. Scale bar = 5 
Figure 47ashowing the overall smooth 
filling the interstices of the fabric 
pm. 15 keV. 
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Figure 48a. Hydrogel formulation of 20% HEMA, 2% EGDM, 39% methanol and 
39% distilled water (percent volume) using 0.25 Mrad irradia­
tion. Scale var = 10 ym. 15 keV. 
Ks^a 
Dj HBl 
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Figure 48b. Higher magnification of Figure 48a showing the texture of the 
hydrogel which fills the interstices of the velour fabric. 
Scale bar = 5 ym. 15 keV. 
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Figure 49a. Polyethylene terephthalate velour fabric coated with hydrogel 
of formulation 20% HEMA, 1% EGDM, 39.5% methanol and 39.5% 
distilled water using 0.25 Mrad irradiation. Scale bar = 
100 ym. 15 keV. 
Figure 49b. Higher magnification of Figure 49a demonstrating the smooth 
texture of the hydrogel filling the interstices of the velour 
fabric. Scale bar = 5 ym. 15 keV. 
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A formulation of 10% HEMA, 2% EGDM, 44% methanol and 44% distilled 
water (on a total volume percent basis) resulted in a smooth homogeneous 
gel network (Figure 50a). At higher magnification (Figure 50b), an open 
highly microporous network was evident which probably explained the in­
creased capacity of the hydrogel substrate to imbibe fluid. 
Conclusions 
In accordance with theoretical conclusions outlined by Kopecek and 
Lim (1971), the phase separation during the three-dimensional polymeriza­
tion of 2-hydroxyethyl methacrylates will depend in the first place on the 
concentration of water (or another poor solvent for the resulting polymer) 
and to a lesser extent on the concentration of the cross!inking agent, 
ethylene glycol dimethacrylate. Consequently, merely altering the co-
solvent ratio in the initial monomeric mixture allows us to pass con­
tinuously from the homogeneous to the heterogeneous course of polymeriza­
tion. When phase separation takes place during polymerization, the re­
sulting polymer has a porous composition. Sprincl et al. (1973a) dia­
grammed the situations that arise during the copolymerization of glycol 
monomethacrylate and glycol dimethacrylate in an aqueous medium without a 
cosolvent. The observations from the viewpoint of the resulting state of 
the polymer can be seen in Figure 51. A transparent, homogeneous gel is 
formed up to a concentration of about 50% water in the initial mixture 
(region A). Above this limiting concentration, an opaque, heterogeneous 
polymer is formed. With increasing concentration of water in the initial 
mixture the porosity of the resulting polymer also increases from micro-
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Figure 50a. Hydrogel of formulation 10% HEMA, 2% EGDM, 44% methanol and 
44% distilled water (volume percent) using 0.25 Mrad irradia­
tion filled the polyethylene terephthalate velour fabric net­
work. Scale bar = 50 ym. 15 keV. 
Figure 50b. Higher magnification of Figure 50a showing the uniform tex­
ture of the hydrogel filling the interstices of the velour 
fabric. Scale bar = 2 ym. 15 keV. 
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Figure 51. Regions of formation of homogeneous (A), heterogeneous micro-
porous (B), and heterogeneous macroporous (C), poly-hydroxy-
ethyl methacrylate. No polymerization occurs in region D. 
(from Sprinci et al., 1973). 
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porous (region B, hatched area) to a macroporous spongy polymer with 
interconnecting channels (region C, cross-hatched). The monomeric mixture 
is immiscible in region D. The addition of a cosolvent would shift the 
placement of these regions on this diagram. 
The procedure described above can be used to modify the physical 
structure of the hydrogel. The microstructure of these polymeric groups 
can be identified by scanning electron microscopy techniques. This infor­
mation adds greatly to the previous literature descriptions of these gel 
types which has been primarily on a gross observation level (i.e., opaque 
versus translucent). This study demonstrated hydrogels having controlled 
microstructure can be incorporated into a fabric matrix with the initial 
formulation having primary influence on the physical properties of the 
resulting hydrogel. This tabulation of data on a family of hydrogel 
formulations will help in matching the type of hydrogel coating desired 
to achieve particular functions when applied to an improved prosthetic 
design. 
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PART IV. CONSIDERATIONS IN THE DEVELOPMENT OF SMALL ARTERY PROSTHESES 
Introduction 
The primary concern of synthetic grafts is maintenance of a patent 
channel without embolic complications. An inherent disadvantage of all 
pervious grafts is that they must react with blood to form an impervious 
fabric-thrombus complex, the flow surfaces of which are highly thrombo-
genic and are constantly subject to the danger of thrombotic occlusion. 
DeBakey et al. (1964) found that over a period of years, the inner flow 
surface of porous arterial prostheses in man was seldom formed by tissue 
but rather by fibrin in most instances. 
It is felt that the best assurance of long term patency without com­
plication is the attainment of complete healing of the prosthetic wall, 
which includes an endothelialized flow surface (Sauvage et al., 1974a). 
This final healed state is believed to be mainly dependent upon the in­
growth of peri graft tissue through the interstices of a pervious graft 
wall. There is also the possibility that an impervious prosthesis having 
a flow surface of optimal characteristics (resistant to thrombus forma­
tion) could be developed which could remove the need for healing of the 
inner surface. 
In view of the problems with cardiovascular prostheses, the following 
discussion is based upon the search either for a truly satisfactory arti­
ficial flow surface--a means to eliminate the healing process—or for 
means to accelerate healing by aiding the ingrowth of perigraft tissues 
within a biocompatible synthetic material. 
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Design Concepts 
Investigational efforts in the development of prosthetic materials in 
contact with blood have been directed to the above two fundamentally dif­
ferent approaches. The first approach aims at devising a thromboresistant 
surface using materials that are generally nonporous and impervious to 
blood. A theoretical advantage of a synthetic flow surface is that it 
would not need to be preclotted, and thus need not begin its work with an 
initial thrombus layer. Optimal characteristics would be present imme­
diately and problems such as delayed healing, perigraft hematoma, would 
not affect this kind of graft (Sauvage et al., 1974a). 
For a workable, impervious prosthesis, it must meet five rigid speci­
fications: (1) thrombus resistant flow surface; (2) high degree of con-
formability; (3) ease of suturability; (4) outer surface to which sur­
rounding tissue can firmly attach; and (5) inner surface to which any 
thrombus that does form can attach securely to discourage embolization. 
The nature of the flow surface must be permanent, since the body is given 
no opportunity to create its own surface. In similar fashion, since the 
perigraft tissue cannot grow through the impervious graft, a means of ad­
herence is required to prevent the graft from tearing loose. 
A wide variety of materials, such as polyurethanes, fluoro-silicone, 
elastomers, heparinized silicones, and pyrolytic carbons have been pro­
posed and evaluated (Salzman, 1971; Nyilas et al., 1972; Bruck, 1972), but 
at present have proved to be unsatisfactory. Expanded polytetrafluoro-
ethylene (e-PTFE) developed by W. B. Gore and associates has been found to 
meet specifications 2 through 5, but not the all important number 1 (Smith 
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et al., 1975). The surface of e-PTFE is formed of small openings a few 
microns in size which allow perivascular tissue to penetrate superficially 
and cling to the outer surface of the graft. Thrombus forms in the minute 
openings of the flow surface, and these thrombi cause the flow surface to 
attract a thin, uniform thrombus deposit. 
The search continues for the development of a material that satisfies 
all five criteria which would provide a graft free from clotting problems 
at the time of implantation onward. Unless a material is found that pro­
vides a thrombus resistant flow surface, the best hope for better pros­
theses rests with fabrication designs that will allow quicker and more 
complete healing prosthesis than is available today. 
The second approach is based upon the concept that any implanted 
prosthetic represents a foreign material from which the body will try to 
isolate itself. Virtually all vascular prostheses in clinical use today 
are fabric with open interstices. These interstices must be closed by 
thrombus, either before or after implantation. The prosthesis, porous 
before contact with blood, becomes a "blood-tight" fabric-thrombus complex 
permeable to cellular ingrowth. Figure 52 demonstrates the stages of 
graft construction necessary for the porous knitted prostheses over a 
period of time. Sauvage et al. (1974b) have termed this design of a 
microporous fabric arrangement as the "trellis concept" of graft construc­
tion. 
The whole blood thrombus sealing with interstices of the prosthesis 
may be thought of as the ground substance of the prosthesis. The com­
bination of the fibers and the permeability of the whole-blood thrombus 
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Figure 52. The stages of graft construction require different periods of time, with Stage III being 
the longest and Stage II the shortest. There is a sharp transition from Stage I into 
Stage II construction (as the prosthesis framework is covered over by fibrin in the pre-
clotting process). The rapidity of this transition is in contrast to the slow transi­
tion that occurs in Stage III to form a fabric-tissue complex, the change occurring by 
creeping substitution from without, inward (Sauvage et al., 1974). 
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provides a trellis for fibroblasts to infiltrate and encourage tissue in­
growth allowing for the possibility of complete healing although very few 
clinical cases attain a completely healed flow surface. 
Unfortunately the whole blood thrombus filling the interstices and 
forming the luminal surface of these prostheses is exceedingly thrombo-
genic, and thrombus will continue to accumulate on the flow surface unless 
the velocity of blood is above a critical point which has been termed the 
"thrombotic threshold velocity" (Sauvage et al., 1974a). This value has 
not been quantified but it has been conjectured that when a thrombogenic 
prosthesis is implanted in a flow environment of insufficient velocity, 
blood reacts to the flow surface by laying down laminae of thrombus until 
the flow velocity rises just above the thrombotic threshold. The in­
creased flow velocity prevents further thrombus formation, but this throm­
bus layering is highly undesirable. The additional layering probably 
prevents complete healing from ever occurring since the thickness of 
thrombus is too much for the ingrowing tissue to vascularize. As a con­
sequence, the surface remains thrombogenic and lumen patency is maintained 
only through a tenuous equilibrium which may become unbalanced in favor of 
sudden thrombotic occlusion by an event such as a drop in cardiac output. 
Fabric prostheses have been used with a high degree of success in the 
relatively high flow rate applications but their use in the medium size 
arteries such as femoropopliteal bypass has been associated with a high 
incidence of delayed thrombotic occlusion. Research has led to the de­
velopment of many formats of fabric materials for example, knitted, woven, 
velours, and filamentous which are to achieve an acceleration of the heal­
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ing process. The goal is to keep the inner thrombus layer very thin and 
to attain complete inner wall healing in the shortest time possible, thus 
leading to an endothelial-like layer on the luminal surface. Such a proc­
ess would provide for significant protection against thrombotic closure. 
But to this day, success has been limited to the larger, higher velocity 
flow vessels. 
In principle, it would be a great advantage if the interstices of the 
"trellis construction" could be closed with a nonthrombogenic material 
that was at least as permeable to cellular ingrowth as thrombus. The con­
cept of a coated fabric mesh, so far a rather promising concept, has not 
been an accepted means to increase the biocompatibility of these materi­
als. The use of a compound material has been limited to an absorbable 
component which is an integral part of the fabrication. 
Runderman et al. (1972) have developed and preliminarily examined a 
biodegradable vascular prosthesis using poly-lactic acid. The device was 
a woven cylinder 5 to 6 cm in length, 8 mm inside diameter, and 0.14 mm 
wall thickness with a final composition of 24% poly-lactic acid and 76% 
© Dacron by weight. The canine abdominal aorta was the site of implantation 
and, after 100 days, all grafts were patent with no evidence of inflamma­
tion or calcification. Small thrombi were noted as well as a very thick, 
well-adherent pseudo-endothelium with extensive tissue ingrowth and ad­
herence of external tissue. The estimated loss of the poly-lactic acid 
component was 60 to 100 percent. Poly-albumin membrane has also been 
shown to be antithrombic (Lyman et al., 1970) and Guidoin et al. (1974) 
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have developed a process by which reticulated albumin can be impregnated 
into a porous prosthesis and thus prevent thrombus formation. 
An alternative approach to the development of blood-compatible sur­
faces is to produce cellular linings on the luminal surface. Cardio­
vascular materials are cultured with cells in vitro prior to implantation. 
In some studies, these precultured devices are as thrombogenic as the bare 
substrates (Mansfield, 1971), while other results (Mansfield et al., 1975) 
indicate that cell lined devices are less thrombogenic. Recently Eskin 
et al. (1978) have reported success with the growth of cultured calf 
aortic smooth muscle cells on cardiovascular prosthetic materials. 
Rationale for Hydrogel Coated Prostheses 
Theoretically, hydrogels appear advantageous as an alternative to 
thrombus as the ground substance within a trellis construction prosthesis. 
Appraisal of hydrogel formulations in tissue and blood contact applica­
tions demonstrate good overall compatibility characteristics. A clear 
correlation between surface hydrophilicity of grafted hydrogels and their 
biocompatibility has not been firmly established. However, a comparison 
of poly-2-hydroxyethyl metacrylate with the blood vessel wall indicates 
there is a definite resemblance of hydrophobic and hydrophilic sites. The 
backbone methyl groups of P-HEMA are very similar to the hydrophobic 
lipid sites of the vessel wall. In similar fashion the hydrophilic sites, 
protein and polysaccharides of the vessel wall, can be simulated by the 
P-HEMA hydroxyl groups. In theory, this material holds much promise for 
desirable biocompatibility properties for cardiovascular applications. 
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Controlled microporosity is thought to be very important to the suc­
cess of synthetic medium and small arterial prostheses (Sharp et al., 
1968). Porosity of the prosthesis wall allows initial deposition of a 
thin layer of fibrin along the luminal surface that is later stabilized by 
pannus ingrowth of fibrous tissue and endothelium from the host vessel and 
also by fibrous tissue and capillary ingrowth from periadventitial tissue 
through the microporous wall (Wesolowski et al., 1968b). 
The microstructure of the hydrogel may be controlled so as to estab­
lish permeability for cellular ingrowth from the exterior and yet at the 
same time provide a smooth, nonthrombogenic flow surface. To increase 
mechanical properties, the hydrogel coatings can be integrated with a 
supporting tubular substrate to provide a reinforced composite structure 
suitable for implantation. This compound prosthetic approach combines the 
characteristics of the before mentioned design considerations—an im­
pervious synthetic, thrombus-resistant flow surface with a semi-pervious 
prosthesis to accelerate the healing process. 
The main principle in this concept is based upon the assumption that 
the best prosthesis should approach in its structure the characteristics 
of the original tissue. By structure it is not necessarily the properties 
of the material at the time of its implantation, but those present after 
a period of time at which the interactions with tissue have reached a 
"steady-state" or the stage of final organization. Complete healing of 
the luminal wall, including establishment of an intact endothelial cover­
ing for the flow surface, could lower the thrombogenicity of the flow 
surface to essentially that of a normal artery. 
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Design of Hydrogel Coated Substrates for 
Cardiovascular Applications 
Very little discussion in the literature has taken place concerning 
the development and testing of hydrogel reinforced prostheses. Weslo-
lowski et al. (1975) reported trials of 4 mm internal diameter polyester-
reinforced hydrogel implants. No formulation or substrate parameters were 
cited. These authors stated that reinforced hydrogel prostheses were not 
successfully developed for small or large-caliber arterial implantations 
because of disruption of the material at the suture lines (one 4 mm 
carotid, one 4 mm abdominal aorta, and five 10 mm thoracic aortoa im­
plants) within 15 days. Wichterle et al. (1975) in a United States patent 
gave examples of using hydrogel polymerized as an outer coating bonded to 
tubular knitted textile material having a diameter of 9 mm. No remarks 
concerning controlled microstructure, dual-coating, tissue ingrowth or 
implantation results were reported in this patent. 
The hydrogel used for coating or impregnating a tubular substrate to 
form a vascular prosthesis embodying the design considerations previously 
outlined is a poly (hydroxyalkyl methacrylate) which is sparingly cross-
linked to provide a resilient and essentially nonthrombogenic ground sub­
stance for controlled cellular ingrowth. Such a hydrogel has a micro-
structure of interconnecting pores which may be regulated at the luminal 
and outer strata of the graft by the fabrication methods which ultimately 
may control the tissue response and ingrowth characteristics of the graft. 
The selected hydroxyalkyl methacrylate monomer undergoes polymeriza­
tion using any one of a number of initiators, i.e., Co®^ radiation, heat. 
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electron irradiation, ultraviolet light, and microwave, in the presence of 
a solvent system and a small amount of cross-linking agent. Ethylene 
glycol dimethacrylate (EGDM) has been found particularly effective as a 
cross-linking agent. The proportion of cross-linker will ordinarily be 
within the range of about 1 to 5% by volume. The monomer concentration 
should fall within the range of 5 to 30%. The remainder of the volume 
would be a cosolvent for the monomer and polymer. The ratio of the co-
solvents will regulate the resulting microstructure of the hydrogel. 
The substrate for the hydrogel takes the form of a support tube of a 
mesh of polyethylene terephthalate (Dacron®). This type of material has 
been found to be effective, although any of a variety of porous and non-
porous materials might be used. A mesh or porous structure is ideally 
suited because the foraminous network permits a continuous impregnation by 
the hydrogel which serves as the ground substance for tissue ingrowth, and 
because such a gel/substrate interrelationship insures secure support for 
the hydrogel during the healing period of cellular invasion. 
The hydrogel layers which define the inner and outer surfaces of the 
final prosthesis are fabricated to have different porosities. Specifi­
cally, the luminal surface of the prosthesis would be lined with a thin 
layer of homogeneous hydrogel having microvoids or pores well under 10 lom 
preferably within the range 0.1 to 1.0 ym. On the other hand, the 
hydrogel layer along the exterior of the prosthesis should have larger 
pores or macrovoids within the range of 20 to 30 ym. The fabrication re­
sult is a prosthesis in which the hydrogel along the outer surface is 
heterogeneous, having macrovoids particularly well-suited for the rapid 
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ingrowth and attachment of tissue, and in which the hydrogel composition 
along the inner surface is relatively smooth and homogeneous in character, 
having micropores of adequate size to prevent the escape of blood elements 
while at the same time provide sufficient adhesion of possible protein ad­
hesion products for an eventual "endothelial-like" lining. Ideally, the 
inner and outer hydrogel coatings or layers are simply exposed portions of 
the hydrogel compositions which impregnate the full wall thickness of the 
tubular substrate. 
The potential of tailoring the hydrogel coatings to achieve desirable 
healing properties with the prostheses is thus readily recognized. The 
general characteristics of the hydrogel layers such as the microporosity, 
fluid imbibition, pliability, layer thickness, surface charge and wetta­
bility can be easily controlled by the manipulation of a number of fabri­
cation parameters. 
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PART V. FABRICATION OF A DUAL HYDROGEL COATED VASCULAR PROSTHESIS 
Introduction 
The hydrogel system can be significantly modified in composition and 
identified in form. These advantages can be coupled to a synthetic sub­
strate which would provide a reinforced vascular prosthesis. The surfaces 
of this type of prosthesis would be composed primarily of hydrogel having 
a controlled composition. A two-stage polymerization process is described 
whereby the respective surfaces of a tubular substrate are coated with 
hydrogel having selectively distinctive microstructures. By controlling 
the proportions of constituents during the stages of forming the tubular 
prosthesis, the hydrogel layer along the inside diameter of the graft may 
have a smooth, homogeneous microstructure while the outer layer may have a 
heterogeneous, porous microstructure. Both coatings merge within the 
interstices of the supporting structure, thereby providing an integrated 
and reinforced prosthesis. 
Materials and Methods 
Materials 
(G) 
Knitted Dacron ^  velour substrates were purchased from U.S. 
1 Catheters and Instruments. The two types used in this study were: USCI^ 
DeBakey® Vasculour ®-D, cat. no. 007930, lot no. QE 84229 and USCI ® 
Sauvage^^ filamentous cat. no. 007906, lot no. QH 84368. 2-hydroxyethyl 
^USCI, a division of C. R. Bard, Inc., Billerica, Mass. 
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methacrylate monomer solution (log no. B763E8) was obtained from Alcolac, 
Inc., Baltimore, Maryland. Results of the manufacturer's analysis of this 
solution are reported in Appendix A. Ethylene glycol dimethacrylate (lot 
no. 53-94) was supplied by Haven Chemical Co., Philadelphia, Pennsylvania. 
All other chemicals were of reagent quality. Glass distilled water was 
used for all solution mixtures. Soft glass rodding and tubing were 
utilized as well. 
Prosthetic support tube preparation 
The knitted polyethylene terephthalate (Dacron®) support tubes, 
which served as the substrates for receiving the dual hydrogel coatings, 
were sectioned into 3.5 cm lengths from the USCI prosthetic material. 
These specimens were cleaned ultrasonically (5 minute wash, 3 rinses dis­
tilled water) with a nonoily soap (Ivory® flakes) and dried in an oven 
at 100°C. The samples were handled by clean forceps and stored individu­
ally in clean glass vials. Soft glass rods used in the prosthetic pro­
duction were etched by the following procedure: Stage 1. Soft glass 
rodding was polished with 400 mesh AlgO^ paper for five minutes followed 
by submersion in technical grade 49% hydrofluoric acid for eleven minutes 
to achieve a rough etched surface. Stage 2. The 49% hydrofluoric was 
diluted with distilled water to give a 16.3% solution (v/v). This solu­
tion was agitated by means of an ultrasonic cleaner. Glass rodding placed 
in the solution for one hour resulted in a smooth etched surface. After 
etching, both types of glass rodding were scrubbed with a bristle brush to 
remove magnesium fluoride deposits, rinsed copiously with distilled water, 
and then dried in an oven at 25°C for 12 hours. 
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Fabrication 
The steps by which the tubular substrate may be internally and ex­
ternally coated with a porous fluid-imbibing gel having selectively dif­
ferent microstructures along the respective surfaces is indicated by the 
sequence of diagrams in Figures 53 through 56. In Figure 53, a support 
tube (1) is shown being fitted upon an inert rod (2) of glass. This rod 
(2) was previously etched using a hydrogen fluoride etching medium to 
impart a rough etch. The diameter of the rod is 4.9 mm. The support 
tube (1) is composed of the knitted polyethylene terephthalate cut to 3.5 
cm lengths. 
After the support tube (1) is completely fitted upon rod (2) and 
stretched, the covered rod (2) is coaxially positioned in a glass tube 
(3) which has the properties of a rough etched inner surface and an inside 
diameter of 6.8 mm (Figure 54). This assembly is placed in a Pyrex^ 
culture tube (4) of dimensions 12 cm long by 1.5 cm wide. 
A first stage monomer-solvent system is prepared to have a composi­
tion which will impart a heterogeneous morphology to the resulting polymer 
(formulation: 20% HEMA, 2% EGDM, 19% methanol, 58.5% HgO). This monomer-
solvent system is degassed by bubbling Ng through the liquid for 30 min-
(S) 
utes. The monomer-solvent solution is placed in a Pyrex ^ culture tube 
with the substrate assembly. The open mesh substrate acts as a wick which 
facilitates penetration of the monomer-solvent medium throughout the sup-
(R) port tube (1). The Pyrex ^ culture tube with contents is placed in a 
glass bell and a low magnitude vacuum is applied for 5 minutes. This de­
gassing step removed entrapped air bubbles from the interstices of the 
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Figure 53. Schematic diagram of polyethylene terephthalate support tube 
(1) being fitted upon glass rod (2). 
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Fioure 54a 
X 
Figure 54b 
Figure 54a, 
Figure 54b. 
Schematic diagram of assembled polyethylene terephthalate 
support tube (1) fitted upon glass rod (2), coaxially posi­
tioned with glass tube (3), placed in glass culture tube (4) 
with first stage monomer-solvent system(6). 
Schematic diagram of resulting fabrication after radiation 
initiated polymerization. Polyethylene terephthalate fabric 
(1) filled with hydrogel (6) having macrovoids (5) compressed 
between glass rod (2) and glass tube (3). 
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[H Figure 55a 
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Figure 55b 
Schematic diagram of the second stage assembly. Rod (7) 
positioned within the lumen of the support tube (1) and 
Figure 55a. i 
 i 
placed in culture tube (4) with the second stage monomer-
solvent system (6a) filling the annular space (8). 
Figure 55b. Schematic diagram of the resulting second stage fabrication 
after radiation initiated polymerization. Polyethylene 
terephthalate fabric (1) with homogeneous hydrogel (6a) 
layered between the smooth surface (8) of the rod (7) and 
the macroporous (5) hydrogel filling the interstices of 
the fabric. 
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6a 
Figure 56. Schematic illustration of the composite hydrogel coatings on 
the polyethylene terephthalate support tube (1). The in­
terior homogeneous layer (6a) penetrates to a degree into the 
heterogeneous layer (6) with macrovoids (5). 
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fabric and assures the imbibition of the monomer-solvent solution into the 
fabric network which is compressed between the glass tubing (3) and the 
glass rod (2). After completion of the degassing process, the monomer-
solvent solution is decanted and replaced with fresh solution of the same 
composition. The tubes are sealed and left to stand one to two hours in a 
container concealed from exposure to light. Polymerization is initiated 
by irradiation from a cobalt 60 source. A typical dose level is 0.25 
Mrad. 
In Figure 54b, the fibrous nature of the tubular substrate (1) is 
diagrammatically depicted to reveal graphically that the liquid reaction 
mixture (6) invades the interstices of the substrate, extending complete­
ly from the inner surface of the glass tube (3) to the cylindrical surface 
of rod (2), a thickness of 0.9 mm. The proportion of water (or nonsolvent 
for the polymer) in the reaction medium controlled the extent of macro-
voids formed (schematically illustrated in Figures 54-56 and designated by 
numeral 5). 
Following polymerization the Pyrex ^ culture tube is carefully 
shattered and the excess polymer surrounding the outer surface of tube (3) 
is removed. The rough etched Rod (2) is withdrawn allowing the hydrogel 
surface layer to be slightly abraded. This abrasion permits the second 
stage grafting layer to invade the first stage matrix to a sufficient de­
gree to provide a firm bond between the inner and outer grafts. 
Any nonpolymerized materials are rinsed away by introduction of a 
rinse solution (50% ethanol:50% water v/v) into the space formly occupied 
by the rod (2). After soaking the polymer and prosthesis with this clean­
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ing solution for 12 hours, the rinse solution is removed and a second rod 
(7) is inserted into the lumen of the support tube (1). This rod (7) is 
similar to the first rod (2) except that it is of a smaller diameter 4.4 
mm along a designated length and is of a smooth etch design. The result 
is to provide an annular space (8) between the outer surface of rod (7) 
and the inner surface of the impregnated support tube (1) (Figure 55a). 
At one end of rod (7) the diameter is the same as rod (2). This wider end 
of rod (7) facilitates its positioning within the lumen of the support 
tube. 
The second stage monomer-solvent system (formulation: 20% HEMA, 2% 
EGDM, 39.5% methanol, 39,5% HgO) is prepared so that polymerization pro­
ceeds in a solvent medium for the polymer. The monomer-solvent system is 
degassed by Ng for 30 minutes. This second polymerizable mixture (labeled 
6a in Figure 55) is introduced into the annular space, as indicated by 
the arrows in Figure 55a. 
Consequently, following irradiation and polymerization of the second 
polymerizable mixture, and removal of rod (7), the substrate (1) is in­
ternally coated with a smooth homogeneous microporous hydrogel layer along 
its internal surface. Rod (7) is sufficiently polished so that minimal 
abrasion of the homogeneous surface results. As illustrated in Figure 56, 
the inside layer (6a) penetrates some of the macrovoids of outside layer 
(6), resulting in a smooth transition between the two layers. 
Completion of the fabrication of the prosthesis is achieved by with­
drawing the substrate and polymer from the glass tube (3) which abrades 
the outer hydrogel coating. This outer surface of the coated substrate 
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would have an open porous surface (5) (Figure 56), which will assist even­
tual tissue invasion upon implantation. The hydrogel impregnated pros­
thesis is stored in a suitable solvent for at least 24 hours Csuch as 
equal volumes of water and ethanol) to protect the structure, leach out 
unreacted constituents, and prevent bacterial growth. Prior to utiliza­
tion the prosthesis is stored for 24 hours in physiological saline and 
then steam sterilized. 
SEM techniques 
Scanning electron microscopy techniques were utilized to identify the 
surface morphology of the hydrogel coated substrates. From the 50% 
ethanol:50% water storage medium, the samples were taken through a series 
of acetone/distilled water rinses (30, 60, 90, 100, 100%, v/v). Samples 
were critical point dried in a Polaron^ model E3000 drier using COg and 
2 
mounted on carbon stubs with a colloidal silver medium. A Polaron 
O 
Instruments SEM coating unit E 5100 was used to sputter coat 300 A gold. 
3 The samples were observed at 5-15 keV using a JEOL -U3 scanning electron 
microscope. 
Resul ts 
The two-stage hydrogel coatings imparted to the fabric substrate 
two different morphologies and the inherent chemical properties of 
^Polaron Instruments, Inc., Warrington, Penn. 
2 SPI Supplies, Div. of Structure Probe Inc., West Chester, Penn. 
3 Japanese Electron Optics, Limited, Tokyo, Japan. 
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the hydrogel such as fluid imbibition and pliability. The fabric support 
tube had a luminal surface formed of a smooth, homogeneous hydrogel having 
relatively small pores or microvoids which could be characterized using 
previously described SEN techniques. Figure 57a,b shows this type of 
hydrogel layer. The fibers on the luminal surface were found to be 
covered by the homogeneous hydrogel coating thus imparting a smooth sur­
face for potential blood-flow applications. The outer surface of the 
prosthesis was formed with a hydrogel formulation having a heterogeneous 
structure (Figure 58a,b) which includes relatively large pores or macro-
voids especially suited for cellular ingrowth. A cross-sectional view 
(Figure 59) demonstrates that both coatings merge within the interstices 
of the supporting structure. 
Conclusions 
A strategy to fabricate tubular fabric substrates coated with multi­
ple controlled porosity hydrogel layers has been developed and character­
ized. These coatings offer several major advantages for potential pros­
thetic service applications such as controlling the extent of hydro-
phi li city and overall microstructure which can be selected to meet spe­
cific implant site design requirements including the degree of tissue in­
growth, attachment, and influence on cellular development at contact 
interfaces. 
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Figure 57a. Micrograph showing the smooth homogeneous hydrogel coating of 
the luminal surface. Arrows indicate underlying polyethylene 
terephthalate fibers. Scale bar = 50 ym. 15 keV. 
\ 
Figure 57b. Higher magnification of the luminal surface of the hydrogel 
coated polyethylene terephthalate prosthesis. Scale bar = 
5 vim. 15 keV. 
169 
B- ^ 
' •  %  
Figure 58a. Exterior surface of the hydrogel prosthesis demonstrates a 
heterogeneous microstructured hydrogel (designated by A) 
within the polyethylene terephthalate fabric network (B). 
Scale bar = 50 ym. 15 keV. 
Figure 58b. Higher magnification of the coarse, heterogeneous hydrogel 
layer. Scale bar = 5 pm. 15 keV, 
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Figure 59. Scannit^electron micrograph of hydrogel composite coatings on 
Dacron® vascular velour prosthesis viewed in cross section. 
Scale bar equals 100 ym. A designates the smooth hydrogel 
coating (20% HEMA. 2% EGDM, 39% methanol, 39% HoO, 0.25 Mrad) 
on the lumen side of the prosthesis. B designates the coarse 
hydrogel (20% HEMA, 2% EGDM, 19.5% methanol, 58.5% H2O, 0.25 
Mrad) coating impregnated into the DacrorPfiber network. C 
designates the Dacrorrfiber network. 
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PART VI. COMPATIBILITY TESTING AND EVALUATION OF A DUAL 
HYDROGEL COATED VASCULAR PROSTHESES 
Introduction 
It has become apparent to those researchers in the field of vascular 
prosthetics that the experimental evidence condemning or condoning one 
particular synthetic over another is confusing. The confusion centers on 
the manner in which the materials are tested in vivo. There have been a 
multitude of test sites used w,thin the vascular system. The most common 
sites are the large artery, abdominal or thoracic aorta; the venous sys­
tem, superior of the inferior vena cava; and the heart, valves, atrial 
patches, and atrial swords or flags. These techniques have inherent 
problems with disturbances in blood-flow patterns, the formation of thick 
neointima, difficulty in evaluating degrees of clotting in situ, and 
limitations incurred by the physical hardness of the materials (Harrison, 
1958; Phillips et al., 1961; Wesolowski, 1962). 
Experience with these sites has led investigators to characterize 
other areas for suitability, as well (Sharp and Falor, 1963; Sharp et al., 
1965, 1968). Several materials that had demonstrated good antithrombo-
genic properties in larger arterial positions were tested in vessels 
having a diameter of 3 to 4 mm and it was found that these materials 
failed to stay patent for more than 30 minutes. Thus, success in the 
vascular system was determined in a period of minutes instead of days. 
A critical factor appeared to the lack of the development of a neointima, 
and the maintenance of its viability for a prolonged period of time. 
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The small diameter artery site has been suggested as a stringent 
discriminator of ultimately successful material formulations for cardio­
vascular applications. Wesolowski et al. (1968b) and Sharp (1970) have 
found the canine carotid artery an excellent site for the testing of 
small-vessel prosthetics. The advantages listed for this site are: (1) 
an easily accessible area, (2) a vessel sufficiently long without branches 
to allow for rapid mobilization, (3) testing against normal systolic 
arterial pressure of 120-150 mm of Hg, (4) a blood flow of 100 to 150 cc 
per minute, (5) easy monitoring of vessel patency by means of ultrasound, 
(6) places the prosthesis in a local environment more closely simulating 
that of its intended use (i.e., allows for fluid imbibition and tissue 
ingrowth from the prosthesis exterior), and (7) causes very little 
morbidity to the animal. 
The work reported in this dissertation describes experimental studies 
conducted using the canine carotid artery site to assess the in vivo 
thrombogenicity of polyethylene terephthalate fabric having a dual coating 
CR) 
of controlled microstructure hydrogel. Noncoated Dacron^ prostheses, 
preclotted to the manufacturer's specifications, served as controls. 
Grafts were compared and characterized by both histological and scanning 
electron microscopy techniques. Results of these initial specific canine 
artery implantations indicated that hydrogel coated substrates can remain 
patent beyond the crucial first 24 hours and that within 21 days, a thin 
endothelial-like cell layer can be established on the luminal surface. 
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Materials and Methods 
Noncoated vascular prostheses 
Both the USCI ® DeBakey® Vasculour®-D^ and the USCI ® Sauvage^^ 
filamentous protheses of internal diameter of 4 mm were sectioned to 
stretched three centimeter lengths. These specimens were cleaned ultra-
sonically (5 minute wash, 3 distilled water rinses) with a nonoily soap 
(Ivory® flakes^). Specimens were individually placed in separate glass 
vials containing physiological saline. Sterilization was achieved by 
steam autoclaving at 121°C, 15 psi for 20 minutes. 
These porous fabric conduits were preclotted according to instruc­
tions supplied by the manufacturer (USCI®). The proximal end of the 
DeBakey® Vasculour®-D prosthetic material was anastomosed according to 
the technique outlined in the implantation section. Then a small quantity 
of the host's nonheparinized blood (2 milliliters) was allowed to flow 
through the prosthesis by a temporary release of the proximal bulldog 
clamp. After 2 to 3 minutes, the graft was blotted by a sterile sponge. 
The distal end of the prosthesis was then occluded by minimal pressure of 
the surgeon's fingers and a second small quantity of blood was allowed to 
flow into the graft. In this fashion the graft was readily tested for 
complete sealing of the graft's interstices. Finally, a temporary release 
of the proximal occluding clamp with the distal end of the graft free, 
flushed out any accumulated clot or debris. The surgical area was flushed 
^USCI, a division of C. R. Bard, Inc., Billerica, Mass. 
2 Procter & Gamble, Cincinnati, Ohio. 
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with physiological saline and aspirated to remove the clotted blood which 
had accumulated. The distal end of the graft was then ready for 
anastomosis. 
The instructions with the USCI ® Sauvage^^ filamentous prosthesis 
required a different preclotting technique. During the surgery approxi­
mately 10 milliliters of nonheparinized blood was withdrawn from the host 
and placed in a stainless steel basin. The prosthetic graft was kneaded 
with this blood to wet it thoroughly. The graft was stretched to full 
length to force the blood through all interstices. After 2-3 minutes, the 
graft was pulled gently through a sterile 2x2 inch sponge to remove 
excess blood. The graft was then exposed for 20 to 30 seconds to a 
second sample of withdrawn nonheparinized blood. The graft was pulled to 
full length and the excess blood was removed with a clean sterile sponge. 
The final step was to test the prosthesis for leaks by injecting a small 
quantity of physiological saline. This step also removed intraluminal 
clot formations. The noncoated Sauvage^^ vascular prosthesis was now 
ready for implantation. 
Hydrogel coated vascular prostheses 
Twenty-four hours before the intended implantation, the hydrogel 
coated specimen was transferred from its storage fluid to a 100 ml quanti­
ty of physiological saline. The saline was changed at 8-hour intervals. 
The samples were then placed in separate glass vials containing physiolog­
ical saline. Sterilization was achieved by steam autoclaving at 121°C, 
15 psi for 20 minutes. The samples were ready at this stage for surgical 
implantation. The hydrogel coated vascular prostheses were notpreclotted. 
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Surgical implantation procedures; Implantation method 
Adult mongrel dogs weighing between 18 to 24 kg each were obtained 
and maintained through Laboratory Animal Resources, Iowa State University. 
These dogs were quarantined one or more weeks, treated for internal para­
sites, and vaccinated for canine distemper, hepatitis, leptospirosis, 
kennel cough and rabies by veterinarians. 
Preoperative Each animal was taken off feed the day before 
surgery. Anesthesia was accomplished using intravenous injection of 
pentobarbital sodium.^ Additional increments of the same agent were used 
to maintain surgical anesthesia. The hematocrit of each dog was deter­
mined by withdrawing a small quantity of venous blood to fill two non-
2 heparinized hematocrit capillary tubes. These capillary tubes were 
3 
centrifuged for 5 minutes in an Adams Micro-hematocrit centrifuge. A 
3 Spirocrit tube reader was used and the values recorded. The activated 
coagulation time (ACT) was determined by withdrawing two milliliters of 
venous blood into a vacuum glass tube containing twelve milligrams of 
purified siliceous earth (Vacutainer #3865^). The drawn blood specimen 
was incubated at 37°C, and one minute after the introduction of the blood 
^Pentobarbital sodium solution. Fort Dodge Laboratories, Inc., Fort 
Dodge, Iowa, 1 cc/2.3 kg bodyweight. 
2 Nonheparinized hematocrit capillary tubes B4415-IA, Scientific Proc-
ucts. Division of American Hospital Supply Corporation, Evanston, 111. 
^Clay-Adams, Inc., New York, NY. 
4 Becton-Dickinson, Division of Becton, Dickinson and Company, 
Rutherford, NJ. 
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the tube was gently tilted every five seconds so as to observe the 
appearance of the first visible clot. The time required for the first 
unmistakable clot to appear was recorded to the nearest 5 seconds. Dogs 
with values beyond normal ranges were rejected. 
The neck was extended with the anesthetized dog in the supine posi­
tion. Electric clippers were used to remove hair from a sufficient area 
on the neck. The skin was scrubbed by hand with surgical soap^ and the 
excess removed with wet cotton sponges terminating each scrub. This pro­
cedure was performed three times. An organic iodine surgical scrub solu-
2 tion followed. This procedure was performed twice after the host had 
3 been transferred to the operating table. A thermoregulated blanket was 
placed between the dog and the operating table. Temperature was main­
tained at 36.5°C. 2x2 inch sterile gauze sponges were used to remove 
excess solution. The neck was then coated with a tincture of benzalkonium 
chloride^ (1 fl. oz. Zephiran chloride, 64 f1. oz. alcohol USP, 63 f1. oz. 
distilled water). Sterile 2x2 inch gauze sponges were placed over the 
proposed incision site, coated with tincture of benzalkonium chloride, and 
remained positioned until the animal's body was draped with sterile 
towels. 
Operative The carotid artery site was chosen as the most desira­
ble site. The advantages of this method include: a relatively fast and 
^Vestasol, Vestal Laboratories, St. Louis, Mo. 
2 (B) 
Betadine ^  Scrub, The Purdue Frederick Co., Norwalk, Conn. 
3 Hamilton Aquamatic model K-20, Hamilton Industries, Cincinnati, OH. 
^Zephiran chloride, Winthrop Laboratories, New York, NY. 
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efficient technique, reproducible results, easy determination of patency, 
quick screening of materials, ease of removal, testing against normal 
systolic arterial blood pressure, and causing very little morbidity to 
the animal (Sharp, 1970). 
All surgical procedures were performed by the author using standard 
aseptic techniques. A midline incision was fashioned and carried through 
the subcutaneous tissue of the neck. The sternocleidomastoid muscle was 
retracted laterally by Gel pi self-retaining retractors with blunted tips. 
The carotid artery was exposed lying immediately adjacent to the trachea. 
The carotid sheath in the dog consists of the common carotid artery meas­
uring 8 to 12 cm in length, the vagus nerve, and a very small and insig­
nificant internal jugular vein. The carotid artery was mobilized to the 
extent of 6 cm by separating it from the vagus nerve. Bleeding points 
were encountered in the platysmal muscle layer. Hemorrhage was controlled 
through the application of hemostats with persistent bleeders being 
ligated by 3-0 silk suture material.^ 
The isolated carotid artery was immobilized by two 5-0 cardiovascular 
2 
silk stay sutures placed 6 cm apart in the adventitia. Two bulldog 
clamps were used at these points to occlude the flow of blood in the 
artery. At no time was there an anticoagulant used. The vessel was tran­
sected and redundant adventitia was removed from the free ends. The opera­
tive field was kept constantly moist and irrigated with physiological 
saline. All blood was washed away to minimize vascular spasm. Low power 
^Ethicon, Inc., Somerville, N.J. 
^K870-H, Ethicon, Inc., Somerville, N.J. 
178 
^R) 1 
magnification of the field was obtained by an Optivisor ^  . The pros­
thesis was positioned and two 5-0 silk guide sutures were inserted 120° 
apart (O'Brien, 1977). This biangulation technique enabled the posterior 
wall to fall away from the anterior wall and so lessened the possibility 
of catching the posterior wall in a suture. To tie the knot there was an 
initial double throw, followed by two single throws. The ends of the 
sutures remained and a continuous suture pattern was used between the two 
guide sutures, tying at the remaining ends. Excessive suture tension, 
which can result in necrosis of the wall, was avoided. Approximately 
fifteen to twenty sutures could be taken around the circumference of the 
vessel. In similar fashion the distal end of the prosthesis was joined to 
the free end of the artery. The area was then flushed with physiological 
saline and the anastomoses checked. If potential leak areas existed, 
interupt sutures were placed to correct the anastomosis. The bulldog 
clamps were released and if the anastomoses leaked a "cuff" of sterile 
gauze was formed around the anastomosis sites. Gentle gauze pressure for 
about three minutes would achieve an ultimately leak-free anastomosis. 
Coagulated blood was removed and the area was flushed with physiological 
saline. At this stage, patency was determined by palpation of a pulse 
both proximal and distal to the prosthetic implant. 
Closure of the wound required that all dissected tissues be re-
appositioned. The carotid sheath was apposed using 3-0 silk in a con­
tinuous suture pattern. A continuous pattern was used to appose the 
sternocleidomastoid muscle. The subcutaneous tissue layers were apposed 
^Donegan Optical Company, Kansas City, Mo. 
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by a continuous suture pattern. Taughtness of these suture lines v/as 
determined by that which gave adequate apposition without deformation of 
the tissue layer. A layer of interrupted 3-0 Vetafil^ skin sutures was 
spaced according to the requirement of good skin apposition. No dressing 
was applied. 
Post-operative Following surgery, the host was allowed to recover 
from anesthesia. Heat retention was maintained by covering the animal 
with clean surgical drapes. A directional doppler ultrasonic blood flow 
2 device was used to determine a patent-flow signal in the carotid artery 
tR) 3 distal to the implant. Aquasonic^-100 gel was used as an acoustic 
coupler. Upon return of jaw tone reflexes, the endotracheal tube was re­
moved. The host was returned to its cage where feed and water were set 
out for consumption. No antibiotics were administered post-surgically, 
but the animals were observed closely for indications of any complication. 
The animals were checked at frequent intervals and flow determination by 
the ultrasound technique was recorded throughout the implantation period. 
The animals were not exercised except for that received during examina­
tion. A high nutritional level was maintained during the implantation 
period. 
^Bengen & Co., Hannover, W. Germany. 
2 Model 806, Parks Electronics Laboratory, Beaverton, Oregon. 
3 Parker Laboratories, Inc., Irvington, N.J. 
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Surgical implantation procedures : Implant retrieval 
The host was brought from its living quarters in Laboratory Animal 
Resources to a surgical preparatory area. The animal was weighed, clipped 
if necessary, and anesthetized by an intravenous injection of pento­
barbital sodium solution^ (1 cc/2.3 kg body weight). Additional incre­
ments of the same agent were used to maintain surgical anesthesia. An 
activated coagulation time was measured using the previously described 
procedure. The animal was placed in the supine position for retrieval of 
the implant. The directional doppler ultrasonic blood flow device was 
placed at the cutaneous surface in order to measure flow signals in the 
carotid artery both proximal and distal to the implant. A midline inci­
sion was employed and followed by blunt dissection to separate the tissue 
layers which were apposed during surgical closure. Hemorrhage was con­
trolled through the application of hemostats. The carotid sheath was ex­
posed and 3 centimeter lengths of the carotid artery, both proximal and 
distal to the implant, were mobilized. Encapsulating tissue of the im­
plant was excised from the surrounding fascia. 
2 Heparin sodium solution was administered via the cephalic vein at a 
dosage rate of 3 mg/kg body weight. The heparin was allowed to take 
effect during which time (5 minutes) blood flow through the implant was 
determined by placement of the ultrasonic probe directly on the vessel. 
^Fort Dodge Laboratories, Inc., Fort Dodge, Iowa. 
2 Nutritional Biochemicals Corporation, Cleveland, Ohio. 
181 
Bulldog clamps were then placed at each end of the artery. Ten milli­
liters of physiological saline were gently flushed through implant by 
gravity flow. 
The free ends of the carotid artery were ligated with 3-0 silk 
suture material. The bulldog clamps were removed and the animals were 
euthanized by an intravenous injection of Sleepaway®^ (1 cc/2.25 kg 
body weight). 
Surgical implantation procedures: Prosthesis analysis 
After the prosthesis and the entire block of tissue surrounding it 
was removed "en bloc," the excised implant was fixed in 2% glutaralydehyde 
Sorensen phosphate buffered solution (Hayat, 1970) for 24 hours. 
Gross evaluation Gross visual observation included assessment of 
patency, handling characteristics, and long-term function. The specimens 
were hemisected longitudinally (bivalved) to permit luminal observation. 
A low power dissection microscope aided the visual observation of the 
implants. Using stylized sketches modeled after Gott and Furuse (1971), 
the degree of thrombus formation is reported in the Results. The long-
term function of the prosthetic graft as a conduit for blood was an im­
portant aspect of the gross inspection in terms of total thrombosis. 
Hemorrhage through the pores into the surrounding tissues was recorded. 
Each graft was photographed, coded and placed in a vessel containing fresh 
2% glutaraldehyde buffered solution for subsequent histologic light 
microscopy and scanning electron microscopy evaluation. 
Vort Dodge Laboratories, Inc., Fort Dodge, Iowa. 
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Histological The fixed prosthesis with surrounding tissue was cut 
into 3 mm sections, for example, cross sections from the proximal, mid-
portion, and distal end. The individual specimens were embedded with 
Paraplast®^ using an Autotechnicon^^ model 2A.^ Sections 6 ym thick 
were stained with haemotoxylin and eosin (Luna, 1968) to permit cellular 
identification. The Gomori (Gomori, 1950) one-step stain was used to 
demonstrate connective tissue. Aniline blue was substituted for light 
green stain resulting in the blue staining of collagen. Photographs of 
sample viewings were taken using Kodak® Ektachrome®^ (tungsten 50) 
professional film. 
Scanning electron microscopy Fixed cross sections of 3 mm thick­
ness were cut from the distal, mid-portion and proximal ends of the im­
plant. The samples were taken through a series of distilled water/acetone 
rinses (30, 60, 90, 100, 100%, v/v). Once saturated in acetone, the sam-
4 pies were transferred to a Polaron model E3000 critical point drying 
apparatus. The acetone was replaced with liquid carbon dioxide by sub­
mersion of the samples for 60 minutes at a pressure of 800 psi (pounds per 
square inch). Following adequate perfusion, the temperature of the drying 
apparatus was increased until the critical point (31.5®C, 1100 psi) of 
carbon dioxide was passed, leaving only gaseous carbon dioxide within the 
^Lancer, A Brunswick Company, St. Louis, Mo. 
2 The Technicon Company, Chauncey, N.Y. 
3 Eastman Kodak Company, Rochester, N.Y. 
4 Polaron Instruments, Inc., Warrington, Penn. 
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samples and the chamber. The high pressure gaseous carbon dioxide was 
slowly vented at the elevated temperature, leaving the samples dried. 
Samples were mounted on carbon stubs using colloidal silver medium.^ 
A Polaron Instruments SEN coating unit E 5100 was used to sputter coat 
O 
300 A of gold. The samples were observed using an electron gun filament 
voltage of 15 keV. 
Evaluation for possible embolization The animals were observed 
during the implantation period for possible neurological and pathological 
deficiencies stemming from peripheral embolization. In no case was a de­
ficiency detected. The brain and kidneys were removed from a selected 
group of dogs to check for possible infarct areas. These organs were sec­
tioned (1 cm thick) and were inspected with a low-power microscope. 
For this group, the kidneys did not present cortical infarct areas, 
nor tubules undergoing necrosis. No evidence for microcalcification was 
observed. The brain tissues did not show signs of necrosis. The sections 
were fixed in 2% buffered glutaraldehyde solution for 24 hours and a 
photographic record was made. 
Results 
Gross evaluation of implanted prostheses 
Table X V summarizes the polyethylene terephthalate prostheses im­
plantation data. The thrombogenic behavior of each implant was evaluated 
by visual observation. A percent of occlusion was assigned to each im­
plant and is indicated by a a on a scale 0 to 100% (read from left to 
^SPI Supplies, Div. of Structure Probe Inc., West Chester, Pa. 
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right). The dual hydrogel coated USCI®Sauvage^^ prostheses performed 
well during the implantation period of 21 days with the appearance of 
thin, smooth, uniform deposits on the luminal surface. The noncoated 
USCI®Sauvage^^prostheses remained patent but indicated lamellae of red 
thrombotic deposits developing on the luminal surface. A higher incidence 
of thrombotic occlusion occurred with both the hydrogel coated and non-
coated USCI DeBakey®prostheses. 
Histological evaluation 
Hydrogel coated polyethylene terephthalate The 2-stage P-HEMA 
coated USCI® Sauvage^^ prostheses implanted for 21 days shows the 
presence of a very thin layer of compacted fibrin covering the luminal 
surface of the prosthesis (Figure 60). This hemotoxylin and eosin stained 
section shows the polyethylene terephthalate fibers labeled A, the hydro­
gel coating labeled B, and the fibrin capsule C. Separation of the tissue 
capsules from the hydrogel composite material occurs during histological 
fixing and sectioning. The thickness of the fibrin capsule covering the 
luminal surfaces of this particular fabrication was found to be less than 
100 micrometers. Higher magnification views of the luminal surface 
(Figures 61a and 61b) demonstrate the occurrence of entrapped denaturing 
red blood cells within the fibrin-platelet capsule. Figure 61b shows the 
luminal surface lined with cells that resemble endothelial cells. It is 
preferable to name these cells endothelial-like cells, since it is a sub­
ject of great controversy (Baumann etal., 1976; Sauvage and Berger, 1976; 
Nomura, 1970). 
TABLE XV. Results of polyethylene terephthalate prostheses implanted in canine carotid arteries. 
Thrombogenic Behavior 
Type of Percent Occlusion 
Prosthesis 0% 100% Comments 
Indicated by & 
2-staqe HEMA coated 
USCI Sauvage. (Dog No. 
1583). Right Carotid. 
21 days implantation 
2-stage HEMA coated 
USCI Sauvage. (Dog No. 
1536). Right Carotid. 
21 days implantation 
2-stage HEMA coated 
USCI Sauvage. (Dog No. 
1607). Right Carotid. 
10 days implantation 
2-staqe HEMA coated 
USCI DeBakey. (Dog No. 
1443). Right Carotid. 
21 days implantation 
2-stage HEMA" coated 
USCI DeBakey. (Dog No. 
1580). Right Carotid. 
21 days implantation 
O 
O 
o 
o 
Encapsulated in a sheath of fibrous connective 
tissue with capillary structures; luminal sur­
face was clean and glistening; deposits were 
thin and smooth 
Encapsulated with fibrous connective tissue 
of minimal thickness; luminal surface at 
proximal end was white & smooth, red deposits 
at the distal end 
Connective tissue covered one half circumfer­
ence; luminal surface had thin, uniform de­
posits 
Fibrous connective tissue surrounded the im­
plant; luminal surface had light reddish de­
posits toward the distal end 
Encapsulated in a sheath of fibrous tissue; 
lumen was filled with concentric rings of 
thrombotic deposits; a narrow interior chan­
nel remained 
TABLE XV. (Continued) 
Type of 
Prosthesis 
2-stage HEMA coated 
USCI DeBakey. (Dog No. 
1476A). Right Carotid. 
21 days implantation 
2-stage HEMA coated 
USCI DeBakey. (Dog No. 
1509). Right Carotid. 
2 days implantation 
2-staqe HEMA coated 
USCI DeBakey. (Dog No. 
1415B). Right Carotid. 
1 minute implantation 
Non-coated USCI 
Sauvage. (Dog No. 
1437). Left Carotid. 
2 days implantation 
Non-coated USCI 
Sauvage. (Dog No. 
1435). Right Carotid. 
2 days implantation 
Non-coated USCI 
Sauvage. (Doq No. 
1332B). Left Carotid. 
2 days implantation 
Thrombogenic Behavior 
Percent Occlusion 
0% 100% 
Indicated by *• 
O 
• 
O 
o 
A 
O 
A 
o 
A 
Comments 
A thin fibrous sheath surrounded the implant; 
thick compacted thrombotic deposits occluded 
the lumen 
A very thin encapsulating material was present; 
thin red thrombotic material was evenly dis­
tributed from proximal to distal ends 
No noticeable deposits on the luminal surface 
A very thin encapsulating material surrounded 
the implant; proximally and distally, the 
lumen was red with a thin layer of thrombotic 
material; central region was free of deposits 
Observations were similar to #1437; encap­
sulation was minimal, deposits were present 
at the proximal and distal ends 
A more extensive encapsulation than #1435; red 
thrombotic deposits were evenly distributed 
TABLE XV. (Continued) 
Thrombogenic Behavior 
Type of Percent Occlusion 
Prosthesis 0% 100% 
Indicated by & 
Non-coated USCI ^ 
Sauvage. (Dog No. 
1397). Right Carotid. a 
29 days implantation 
Non-coated USCI 
OeBakey. (Dog No. 
1278). Left Carotid. 
29 days implantation 
Non-coated USCI 
OeBakey. (Dog No. (_} 
1332A). Right Carotid. a 
8 days implantation 
Non-coated USCI 
OeBakey. (Dog No. 
1415A). Right Carotid. a 
2 days implantation 
Non-coated USCI 
OeBakey. (Dog No. ^ 
1476B). Left Carotid. 
21 days implantation 
Comments 
Encapsulated in a sheath of fibrous connec­
tive tissue; many deposits were white with an 
occasional buildup of red thrombotic material 
Thick fibrous connective tissue encapsulation 
lumen was filled completely with compacted 
fibrin and thrombotic deposits 
Fibrous connective tissue encapsulation; 
red thrombotic deposits were distributed 
evenly over the luminal surface 
Thin fibrous connective tissue encapsulation; 
proximally, the surface had a thin layer of 
red deposited material 
Thick encapsulation with fibrous connective 
tissue; concentric rings of thrombotic depos 
its filled the lumen 
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Figure 60. 2-stage HEMA coated USCI ® Sauvage prosthesis implanted for 
21 days. Hemotoxylin and eosin stain. Polyethylene tereph-
thalate fibers A, P-HEMA hydrogel B, fibrin capsule C, luminal 
region D. Scale bar = 100 pm. 
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Figure 61a. 2-stage HEMA coated USCI® Sauvage prosthesis implanted 
for 21 days. Hemotoxylin and eosin stain. Luminal surface 
is designated by an arrow. Scale bar = 22 urn. 
Figure 61b. Higher magnification view of Figure 61a. The endothelial-
like cell is designated by an arrow. Hemotoxylin and eosin 
stain. Scale bar = 12 ym. 
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The tissue in contact with the exterior of the prosthesis for 21 days 
showed no signs of adverse reactions. Figure 62a is a low power micro­
graph of the exterior section of the HEMA coated USCI® Sauvage^^ pros­
thesis. The encapsulating tissue is a layer of collagenous tissue whose 
cell population is primarily fibroblasts with few inflammatory cells 
present. A higher magnification of this contact region is shown in Figure 
62b. The presence of vascular networks in the exterior encapsulating 
tissue is demonstrated in the Gomori stained section of Figure 63. The 
exterior surface of the P-HEMA coated USCI ® Sauvage^^ is labeled A. The 
vascular networks are designated by arrows. 
Noncoated polyethylene terephthalate The microscope evaluations 
of these grafts revealed a fairly characteristic histologic structure 
fR) 
which compared well with previous descriptions of the fate of Dacron^ 
vascular grafts (DeBakey et al., 1964; Wesolowski et al., 1968a; Sauvage 
et al., 1975). Three distinct layers consisting of a inner and outer 
cellular with a median layer of polyethylene terephthalate fibers of an 
uncoated USCI® Sauvage^^ prosthesis implanted for 29 days can be viewed 
in Figure 64. The outer layer surrounding the graft was a thick, dense 
layer composed mainly of fibrous connective tissue. In Figure 65a, 
fibroblasts, leukocytes, and mononuclear cells penetrated the interstices 
of the polyethylene terephthalate fabric to a small degree. For this time 
period of implantation, the ground substance from the preclotting stage of 
prosthesis preparation was still present within the fabric network 
(Figure 65b). Overlying the layer composed of fibrin coagulum and the 
polyethylene terephthalate fabric network was the zone of tissue in 
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Figure 62a. Hemotoxylin and e^in stained section of the exterior 2-stage 
HEMA coated USCI® SauvageTM prosthesis implanted for 21 
days. Polyethylene terephthalate fibers A, P-HEMA hydrogel 
B, collagenous tissue capsule C. Scale bar = 50 ym. 
Figure 62b. Higher magnification view of the exterior contact region. 
Hemotoxylin and eosin stain. Polyethylene terephthalate 
fibers A, hydrogel B, collagenous tissue C. Scale bar = 
22 ym. 
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Figure 63. Encaosulation tissue on the exterior of a 2-stage HEMA coated 
USCI® SauvageTM prosthesis. Gomori trichrome stain. Hydro-
gel coated polyethylene terephthalate fibers A, collagen tis­
sue B, capillaries and vessels designated by arrows. Scale 
bar = 50 pm. 
Figure 64. Uncoated USCI® Sauvage vascular prosthesis implanted for 
29 days in the canine carotid artery. Gomori trichrome stain. 
Three distinct layers are identified: A fibrous outer layer, 
B polyethylene terephthalate fabric layer, C fibrin coagulum 
inner layer in contact with the blood stream. Scale bar = 
100 ym. 
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Figure 65a. Gomori trichrome stain of the exterior encapsulating tissue 
penetr^'ng the uncoated polyethylene terephthalate fibers of 
a USCI® Sauvage™ vascular prosthesis implanted for 29 
days. Scale bar = 50 urn. 
Figure 65b. Higher magnification of the exterior tissue penetration into 
the preclotted velour network. Hemotoxylin and eosin stain. 
Polyethylene terephthalate fibers A, exterior tissue B, pre­
clotted coagulum C. Scale bar = 22 ym. 
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contact with the blood stream. Figure 66 demonstrates that this zone was 
composed primarily of fibrin with entrapped red blood cells, leukocytes 
within a laminated coagulum. No evidence of endothelial-like cells was 
found with samples implanted in the canine carotid artery for 29 days or 
less. 
Scanning electron microscopy evaluation 
Scanning electron microscopy techniques yielded information concern­
ing microstructure of the composite hydrogel on the prosthesis, cellular 
structure, total capsule deposition on the surface (which consists of 
erythrocytes, leukocytes, platelets, fibrin and collagen), lysis, and 
outer capsule infiltration. 
Noncoated polyethylene terephthalate Scanning and transmission 
electron microscope studies of the luminal coatings on Dacron^ pros­
theses have established the sequence of events for the healing of woven 
prostheses exposed to flowing blood (Stewart et al., 1975; Guidoin et al., 
1975, 1977). Our studies compared well with their observations. Within 
the first hour of exposure to flowing blood the surface was covered with 
masses of leukocytes, red blood cells, platelets, and some fibrin. After 
two days, the surface was covered with a thick film composed of red blood 
cells entrapped in a fibrin mesh similar to that shown in Figure 67. This 
micrograph shows a two-day implantation of uncoated USCI® Sauvage^^ 
prosthetic material which was preclotted according to the manufac­
turer's instructions to make the walls of the open fabric prosthesis im­
pervious to blood. At this 2-day post-operative stage, the fabric fibers 
were covered by a layer of coarse, particulate material formed from blood 
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Figure 66. Hemotoxylin and eosin stain of the luminal layer of an un-
coated USCI® SauvageTM vascular prosthesis implanted for 29 
days. Polyethylene terephthalate fibers A, luminal surface B. 
Scale bar = 50 pm. 
Figure 67. A luminal surface view of a fibrin-platelet entrapped red 
bloo^cell network. Scanning electron micrograph of uncoated 
USCI®Sauvage™ prosthetic material exposed to flowing blood 
for 2 days. Scale bar equals 5 ym. 15 keV. 
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elements. Portions of the graft were covered by aggregates of platelets 
and occasional leukocytes. By three to four weeks the graft was covered 
by a fibroblast-collagen matrix with adhering red blood cells. 
Hydrogel coated polyethylene terephthalate The two-stage hydrogel 
coatings imparted to the fabric substrate two types of morphologies along 
with the chemical property of fluid imbibition. The fabric support tube 
had a luminal surface formed of a smooth, homogeneous hydrogel having 
relatively small pores or microvoids (Figure 68). The fibers on the 
luminal surface were found to be covered by this homogeneous hydrogel 
coating thus imparting a smooth, blood-flow surface. The outer surface of 
the prosthesis was formed with a hydrogel having a heterogeneous micro-
structure (Figure 69) which included relatively large pores or macrovoids 
especially suited for cellular ingrowth. 
After two days post-operative, the luminal surfaces of the hydrogel 
coated prostheses were covered with a thin layer of a fibrin-platelet-red 
blood cell network. Little tissue invasion and attachment was evident at 
two days post-operative but red blood cells and leukocytes were occasion­
ally found within the heterogeneous hydrogel matrix near the exterior 
surface of the prosthesis (Figure 70). 
At 10 days the luminal surface of the graft was covered with a 
fibrin-platelet layer (Figure 71). The luminal surface layer of blcod 
elements within a fibrin matrix was found to be approximately 100 micro­
meters in thickness. By three weeks time, sections of the prosthesis 
taken 1 centimeter from the proximal anastomosis showed luminal surfaces 
with flat endothelial-like cells covering large areas (Figure 72). The 
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Figure 68. This SEM photograph shows the smooth homogeneous hydrogel 
coating on the luminal surface. Arrows indicate under­
lying polyethylene terephthalate fibers. Scale bar = 50 ym. 
15 keV. 20° tilt. 
n 
Figure 69. Scanning electron micrograph of the exterior surface of the 
hydrogel prosthesis which demonstrates a heterogeneous micro-
structured hydrogel (designated by A) within the polyethylene 
terephthalate fabric network (B). Scale bar = 50 pm. 15 keV. 
20° tilt. 
198 
Figure 70. S EM photogr^h of the ^ terior view of the two-stage HEMA 
coated USCI (E) DeBa key ©prosthesis which was implanted for two 
days. The heterogeneous nature of the hydrogel is evident 
with entrapped red blood cells. Scale bar = 10 ym. 15 keV. 
10° tilt. 
Figure 71. S EM photogrwh of the luminal surface of a two-stage HEMA 
coated USCI® Sauvage^M prosthesis which was implanted for 10 
days. The fibrin matrix with flat cellular layers is evident. 
Scale bar = 10 ijm. 15 keV. 10° tilt. 
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Figure 72. SEN ghotogr^h of the luminal surface of a two-stage HEMA 
coated USCI(E)Sauvage^M vascular prosthesis which was implant­
ed for 21 days in the canine carotid artery. This section was 
located 1 centimeter from the proximal anastomosis. Scale 
bar = 10 pm. 15 keV. 10° tilt. 
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encapsulating tissue surrounding and penetrating the exterior of the 
prosthesis was primarily composed of collagenous material. 
Conclusions 
This study represents the first attempt to utilize dual hydrogel 
formulations having controlled microstructures on a tubular fabric sub­
strate for the purpose of an arterial replacement. These dual hydrogel 
coated prostheses have demonstrated high patency rates beyond the crucial 
first 24 hours and most have remained patent throughout the 21-day im­
plantation period. 
Wesolowski and others (1968a,b) have emphasized the importance of 
porosity in long-term patency of small-caliber arterial prostheses. The 
pore diameter must be small enough to limit transprosthetic hemorrhage and 
to prevent peri prosthetic hematoma, but must be large enough to allow 
tissue ingrowth. Campbell and colleagues (1975) using expanded polytetra-
fluoroethylene in dogs found 88% patency when pore size averaged 22 ym or 
less, compared to 53% when the pore size averaged 34 pm or greater. The 
heterogeneous, microporous (within the range of 5 to 20 ym) hydrogel 
coating on the exterior of the substrate allowed for tissue ingrowth with 
no evidence of adverse cytotoxic reaction. Furthermore, early or late 
transprosthetic hemorrhage did not occur. 
Surface structural geometry characteristics and chemical properties 
are known to affect tissue reaction. Histological and scanning electron 
microscopy observations of the dual hydrogel coated USCI®Sauvage^''' pros­
theses showed early luminal surface organization and potential "endo-
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thelialization." The cellular elements contributing to luminal surface 
organization have been postulated to originate from three potential 
sources: pannus ingrowth, transprosthetic ingrowth, and circulating 
multipotential mesodermal cells deposited on the surface (Stump et al., 
1963). The serial observations of this study did not allow a determina­
tion of the precise origin of the neointima process, although it can be 
concluded that the smooth, homogeneous hydrogel coating on the luminal 
surface in conjunction with its counterpart (heterogeneous hydrogel) did 
appear to have an impact on the organization of neointima in comparison to 
noncoated prostheses. It must be emphasized that the cells were desig­
nated as "endothelial-like," based on histologic and morphologic findings 
recorded with a light microscope and scanning electron microscope, respec­
tively. 
The results of initial canine artery implantations listed in Table 
XV indicate potential benefits of the hydrogel-impregnated Dacron ® sub-
(R) 
strates compared to the uncoated Dacron ^. For this application site, an 
endothelial-like cell layer is established within three weeks on the 
(5) 
luminal surface of particular formulations of hydrogel coated Dacron^ 
materials. As the Dacron® structural material is fully impregnated 
with hydrogel, preclotting of the prosthesis is not required to achieve 
these results. These important aspects represent possible advantages of 
the hydrogel coated grafts compared with conventional noncoated pros­
theses. 
Although we have not studied grafts implanted for more than 30 days, 
the healing process of the Dacron® grafts has been documented by Stewart 
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et al. (1975) and Guidoin et al. (1975). Cells resembling fibroblasts or 
transition forms appeared between two to eight weeks. Between seven and 
twelve months an endothelial lining developed a few millimeters from the 
anastomoses. By two years the graft developed a discontinuous endo­
thelium which covers over one-half of the surface. Sauvage (1975) has 
defined the complete healing of the prosthesis as stabilization of the 
graft framework within a fibrous-tissue matrix whose flow surface is 
covered by a continuous layer of endothelium. It is important for the 
complete healing of the prostheses in that the healed flow surface (the 
endothelial covering) is highly resistant to thrombus formation. However, 
the ultimate development of a complete endothelial lining remains in dis­
pute as indicated by Stewart et al. (1975) since if an endothelial lining 
does develop, it does so only after the grafts have been functional for 
many weeks or months. A balance between the rate of deposition and re­
moval of material from the graft surfaces rather than lack of deposition 
may be responsible for maintaining graft patency. These rates at first 
depend on the interaction between various types of blood components with 
the foreign surface, alterations of the components, and the consequences 
of these alterations. The fibroblast-collagen matrix may remain platelet 
free and functional in vivo due to a "conditioning" material under proper 
conditions of blood flow. The chemical and morphological properties of 
the hydrogel impregnated Dacron ^  prostheses may present blood flow 
surfaces which allow proper conditioning protein deposition leading to an 
accelerated endothelial development. 
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DISCUSSION 
Controlled porosity has been shown to be an important factor in suc­
cessful arterial substitutes (Bradham, 1960; Harrison and Davalos, 1961; 
Berkowitz et al., 1972) and has been evaluated in knitted and woven fabrics 
(Wesolowski, 1972), flocks (Sharp et al., 1968), velours (Sauvage, 1978), 
microporous polyurethane foams (Berkowitz et al., 1972), expanded polytetra-
fluoroethylene (Matsumoto et al., 1973) and replamineform of Silastic^ 
and Bioelectric® polyurethane (Hiratzka et al., 1979). This study was 
the first attempt of utilizing dual hydrogel formulations with identified 
controlled microstructure on a fabric substrate as an arterial substitute. 
To achieve this result, a multi-faceted approach was pursued which 
led to a series of conclusions. The major findings can be listed as: 
1) The morphology of polymerized 2-hydroxyethyl methacrylate can be 
evaluated by scanning electron microscopy techniques. 
2) Both radiation and chemical initiation of 2-hydroxyethyl 
methacrylate polymerization are methods by which polyethylene 
terephthalate fibers can be coated and the interstices of the 
fabric filled with hydrogel. 
3) No cytotoxic reaction was observed upon implantation of both bulk 
hydrogel and hydrogel coated substrate specimens. 
4) Polyethylene terephthalate-hydrogel composite materials demon­
strated varying degrees of tissue ingrowth penetration which de­
pended upon the formulation parameters of the hydrogel. 
5) Procedures have been outlined by which the physical structure of 
the hydrogel can be modified and identified. 
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6) A family of hydrogel formulations was tabulated in terms of re­
sulting physical properties thus aiding in the potential matching 
of a hydrogel coating for a desired function when applied to a 
prosthesis design. 
7) After a review of the cardiovascular literature, a compound pros­
thesis design was pursued whereby the microstructure of hydrogel 
impregnating a fabric substrate would be controlled so as to allow 
sufficient permeability to cellular ingrowth from the exterior and 
yet at the same time provide a smooth, nonthrombogenic flow sur­
face. 
8) A two-stage polymerization process was developed and character­
ized which incorporated multiple controlled hydrogel layers on 
tubular fabric substrates. 
9) Dual hydrogel coated polyethylene terephthalate substrates im­
planted in the canine carotid artery demonstrate high patency 
rates and the development of early luminal surface organization 
over a 21-day implantation period. 
To the author's knowledge, no prior experiments have examined the in­
corporation of controlled microporosity hydrogel using a model in which 
multiple hydrogel coatings have been layered on a tubular fabric sub­
strate. As described, the cosolvent ratio control of hydrogel micro-
structure can be used to permit a standardized evaluation of a variety of 
microporous to macroporous hydrogels. The tabulation of a family of 
hydrogel formulations and their respective characteristics form a basis 
from which further research can be launched. Unlike previous observa-
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tions, whereby Wesolowski and coworkers (1975) state that hydrogel coated 
polyester prostheses (no formulation specifications outlined) are unde­
sirable for further study, the present in vivo experiments demonstrate the 
potential of multiple layers of hydrogel having controlled microstructure 
on a fabric substrate for an arterial replacement. Further research can 
optimize the fabrication parameters of the hydrogel coatings for a par­
ticular prosthetic application. 
206 
RECOMMENDATIONS FOR FUTURE RESEARCH 
On the basis of the experimental observations, a number of areas for 
further research are identified which will aid in optimizing a hydrogel 
coated prosthesis. These areas can be directed toward the objective of a 
healable graft which attains a viable endothelial flow surface when used 
in small diameter anatomic positions. It has been established that the 
hydrogel microstructure, chemical and physical properties can be readily 
controlled and identified. Additional investigations of hydrogel formula­
tion families having modified characteristics (i.e., microporosity, 
chemical, mechanical strength) should be performed and the results should 
be cataloged. These parameters can be coupled to in vivo experiments, the 
results of which may demonstrate the controlling factor(s) for tissue 
penetration, inner capsule thickness, and endothelial cell layer forma-
ti on. 
Taylor (1964) has shown the elastic stiffness of the arterial system 
must increase very gradually from the heart to the periphery if reflec­
tions of the pulsatile component of blood flow are to be minimized. 
Therefore, the introduction of a stiff prosthetic into the relatively 
compliant arterial tree can be expected to change the transmission char­
acteristic of the pulse wave. Because the characteristic impedance of a 
stiff tube is greater than that of the compliant vessel, pulsatile energy 
is reflected when a wave travels from a compliant to a stiff tube. One 
can only speculate about whether or not these reflections are detrimental 
to the arterial wall, leading to the possibility of initiating clotting 
factors, but it is reasonable to expect that compliance mismatch should be 
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minimized. Hydrogel formulations should be investigated to achieve an 
optimized compliance match. 
Conventional measurement of graft patency or occlusion has become 
recognized as an inadequate means for precise graft characterization. The 
author recommends that the quantitative method suggested by Sauvage et al. 
(1979) be pursued using hydrogel coated substrates. The measurement, 
called thrombus-"free" surface (TPS), would quantify the flow surface 
thrombus deposited during periods of controlled flow. After retrieval of 
the implant, microscopic examination of the flow surface for thrombus 
deposition would determine the assignment of a numerical score between 0 
and 100. By definition, the TPS score would be the percentage of the flow 
surface that remains thrombus-free, thus, a thrombus-free flow surface is 
scored 100, while a surface 90% covered with thrombus is scored 10. 
Sauvage and coworkers (1979) indicate that the TPS scores of five 
types of 4 mm diameter grafts tested fell as the controlled velocity was 
reduced. They have termed the velocity at which the average of the TPS 
scores fell below 50 as a measure of the graft's thrombotic threshold 
velocity (TTV). These workers found that their graft materials can be 
expected to accumulate a heavy thrombus deposit or to occlude at a 
velocity below its TTV. 
The author suggests this measurement approach has value in predicting 
results that could be expected with a specific hydrogel coated prosthesis 
used at a particular site within the vascular system. The procedure de­
scribed above can be advanced several steps whereby the implant exposure 
time at the specified controlled velocity is measured for a number of 
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hydrogel formulations. These data, along with the thrombus-free flow sur­
face score and the flow velocity, could be plotted on a three-dimensional 
graph (TPS versus velocity versus time). A "figure of merit" could be 
established for each formulation within the hydrogel family. The quanti­
fication of these parameters would allow the prosthetic designer to match 
a particular hydrogel fabrication to the implantation site. It would also 
permit a "safety factor" to be incorporated into the prosthesis design to 
take into account the possibility of a decrease in flow rate or velocity 
which may lead to a substantial thrombus buildup and lead to ultimate 
prosthesis failure. 
A related study would be an identification of the protein and cellu­
lar components deposited on the flow surface of a hydrogel coated pros­
thesis. The scanning electron microscope and light microscope provide a 
means of examining the luminal surface. Transmission electron microscope 
observation of the tissue would allow fora more positive endothelial cell 
identification. Stewart et al. (1975) have reported the adhesion of 
leukocytes, erythrocytes, and noncellular material to the luminal surface 
of natural and artificial blood vessels in vivo. The integration of 
information from these observations would aid in providing a better under­
standing of the early events in the deposition of cells and fibrin onto 
prosthetic walls. An understanding of the interactions between material 
parameters and biological mediators through higher levels of characteriza­
tion may lead to control over reactions which govern the desired results. 
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APPENDIX: MANUFACTURER'S SPECIFICATIONS 
Chemical description: hydroxyethyl methacrylate 
Manufacturer: Alcolac Inc. 
3440 Fairfield Road 
Baltimore, MD 
Product desription: Sipomer CL-100 
Lot number: 117k7 
Test description Specification Analysis^ 
Hydroxyethyl methacrylate and 
related products, % 99.5 MIN 99.6 
HEMA-1, % 98.4 MIN 98.7 
HEMA-2, % 1.1 MAX 0.9 
Ethylene glycol dimethacrylate, % 0.2 MAX 0.1 
Methacrylic acid, % 0.1 MAX 0.0 
Water, % 0.3 MAX 0.3 
Color, A.P.M.A. standards 100 MAX 20 
Monomethyl ether of hydroquinone, 
parts per million 500-750 585 
Appearance @ 25 degree C Clear liquid Pass 
^Analysis was performed by Alcolac Inc. 
227 
Chemical description: hydroxyethyl methacrylate 
Manufacturer: Alcolac Inc. 
3440 Fairfield Road 
Baltimore, MD 
Product description: Sipomer CL-100 
Lot number: B763E8 
Test description Specification Analysis^ 
Hydroxyethyl methacrylate and 
related products, % 99.5 MIN 99.6 
HEMA-1, % 98.4 MIN 98.5 
HEMA-2, % 1.1 MAX 1.1 
Ethylene glycol dimethacrylate, % 0.2 MAX 0.19 
Methacrylic acid, % 0.1 MAX 0.04 
Water, % 0.3 MAX 0.26 
Color, A.P.M.A. standards 100 MAX 8 
Monomethyl ether of hydro-
quinone, parts per million 500-750 600 
Appearance @ 25 degrees C Clear liquid Pass 
^Analysis was performed by Alcolac Inc. 
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Chemical description: 2-hydroxyethyl methacrylate 
Manufacturer: Haven Chemical 
5000 Langdon Street 
Philadelphia, PA 19124 
Product description: ethylene glycol monomethacrylate 
Lot number: 9-11-76 
Test description Specification Analysis 1 
Hydroxyethyl methacrylate and 
related products, % 
Ethylene glycol dimethacrylate, % 
Methacrylic acid, % 
Monomethyl ether of hydro-
quinone, parts per million 
Appearance @ 25 degrees C 
95 MIN 
1.5 MAX 
4 MAX 
200 
Clear liquid 
98.3 
1.5 
.07 
Not tested 
Clear 
1iquid 
Vhe chemical analysis was performed by the Veterinary Diagnostic 
Laboratory of Iowa State University. 
Conditions: Gas liquid chromatography 
Column - 6' X 1/4" thick-walled glass tubing 
Packing - 10% OV-225 on Gas Chrom Q (100-120 mesh) 
Detector - flame ionization detection 
Temperatures - column, ~130-150°C; isothermal injector, 
~250°C 
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Chemical description: 2-hydroxyethyl methacrylate 
Manufacturer: Haven Chemical 
5000 Langdon Street 
Philadelphia, PA 19124 
Product description: ethylene glycol monomethacrylate 
Lot number: 700-238-22 
Test description Specification Analysis^ 
Hydroxyethyl methacrylate and 
related products, % 
Ethylene glycol dimethacrylate, % 
Methacrylic acid, % 
Monomethyl ether of hydro-
quinone, parts per million 
Appearance @ 25 degrees C 
95 MIN 
1.5 MAX 
4 MAX 
200 
Clear liquid 
95.1 
3.8 
0.07 
Not tested 
Clear 
liquid 
Vhe chemical analysis was performed by the Veterinary Diagnostic 
Laboratory of Iowa State University. 
Conditions: Gas liquid chromatography 
Column - 6' X 1/4" thick-walled glass tubing 
Packing - 10% OV-225 on Gas Chrom Q (100-120 mesh) 
Detector - flame ionization detection 
Temperatures - column, 130-150°C; isothermal injector, 250°C 
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Chemical description: ethylene glycol dimethacrylate 
Manufacturer: Haven Chemical 
5000 Langdon Street 
Philadelphia, PA 19124 
Lot number: 53-94 
Properties Specification 
Ethylene glycol dimethacrylate, % 98 MIN 
Methacrylic acid, % 0.1 MAX 
Inhibiters, parts per million hydroquinone 20 to 80 
Parts per million monomethyl ether of 
hydroquinone 80 to 150 
Color, A.P.H.A. standards 50 MAX 
Appearance @ 25 degrees C Clear liquid 
